1989

Of critical importance - AIDS precautions in radiology. [videorecording]
[Nashville, Tenn.] : Envision, c1988 1 videocassette (20 min.) : sd., col. ; 3/4 in Unique Identifier : AIDSLINE AV/8900479A
(Producer) A new program on the latest recommendations by The Center for Disease Control and how to apply them specifically to the radiology department. The epidemiology modes of transmission and prevention of HIB infection are explained along with very detailed safety precautions, making this program essential view


AIDS--defining the legal issues : a legal symposium.
[Boston? : s.n., 1985?] 150 p Unique Identifier : AIDSLINE CAT/8905149
Kindregan CP; Development
Acquired immunodeficiency syndrome (AIDS). Tenth update : April 1986 through June 1986 : 552 citations.
[Bethesda, Md.] : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, [1986] 42 p (Literature search / National Library of Medicine ; no. 86-9) Unique Identifier : AIDSLINE CAT/8904606
Abrams EJ
Meeting the challenge : papers of the First National Conference on AIDS, Friday, 15 November 1985 and Saturday, 16 November 1985.
Canberra : Commonwealth Dept. of Health and Dept. of Health Victoria, 1986 xi, 203 p. : ports Unique Identifier : AIDSLINE CAT/8904890
Carr A
AIDS weekly surveillance report. Nov. 24, 1986-Feb. 13, 1989.
[Atlanta, Ga.] : The Program,, [1986-1989] v Unique Identifier : AIDSLINE CAT/8905148
AIDS : ethical guidelines for healthcare providers.
St. Louis, MO : Catholic Health Association of the U.S., c1987 v, 26 p Unique Identifier : AIDSLINE CAT/8904636
Bader D; McMillan E
[SIDA : epidemies et societes, 20 et 21 juin 1987 : compte rendu de la reunion organisee aux Pensieres a Veyrier-du-Lac, Annecy = AIDS : epidemics and societies.]
Lyon : edition Fondation Marcel Merieux, 1987 213 p. : ports Unique Identifier : AIDSLINE CAT/8905055
Merieux C
AIDS home care and hospice manual.
San Francisco, Calif. (225 30th St., San Francisco 94131) : AIDS Home Care and Hospice Program, VNA of San Francisco, c1987 195 p. : ill., ports Unique Identifier : AIDSLINE CAT/8905941
Hughes AM; Martin JP; Franks P; Hospice Program
[AIDS : la sindrome da immunodeficienza acquisita.]
Padova : Piccin, c1987 x, 523 p. : ill Unique Identifier : AIDSLINE CAT/8906408
Rondanelli EG
The:AIDS manual : a guide for health care administrators.
Owings Mills, Md. : National Health Pub., c1988- 1 v. (loose-leaf) : ill Unique Identifier : AIDSLINE CAT/8904635
DeHovitz JA; Altimont TJ
Home care of the patient with acquired immunodeficiency syndrome/human immunodeficiency viral infection.
Akron, Ohio (1200 McArthur Dr., Akron, Ohio 44320) : Visiting Nurse Service, c1988 18 leaves Unique Identifier : AIDSLINE CAT/8904809
Schlegel RA
Pharmaceutical industry response to the AIDS crisis.
Immunodeficiency Virus Epidemic Washington, D.C. (1100 Fifteenth St., N.W., Washington 20005) : Pharmaceutical Manufacturers Association, [1988] 44 p Unique Identifier : AIDSLINE CAT/8904945
AIDS, public policy and the law.
[Saint Louis, Mo. (3700 Lindell Blvd., Saint Louis 63108) : Saint Louis University School of Law, c1988] 226 p (Saint Louis University public law review ; v. 7, no. 1) Unique Identifier : AIDSLINE CAT/8905150
The:Control of human retrovirus gene expression.
Cold Spring Harbor, N.Y. : Cold Spring Harbor Laboratory, 1988 xvi, 324 p. : ill., ports Unique Identifier : AIDSLINE CAT/8905587
Franza BR; Cullen B; Wong-Staal F
AIDS, immunity, and Chinese medicine : proceedings of the Ninth Annual Symposium of the Oriental Healing Arts Institute, held October 23, 1988 in Long Beach, California, together with related essays and supplementary information on Chinese herbs and herbal formulas recommended by AIDS care-givers.
Long Beach, Calif. : The Institute, 1989 v, 115 p. : ill Unique Identifier : AIDSLINE CAT/8904637
Enger BC; Long ER
No longer immune : a counselor's guide to AIDS.
Alexandria, Va. : American Association for Counseling and Development, c1989 xi, 295 p Unique Identifier : AIDSLINE CAT/8904911
Kain CD
Opportunistic infections in patients with the acquired immunodeficiency syndrome.
New York : Dekker, c1989 xx, 445 p. : ill (Infectious disease and therapy ; v. 3) Unique Identifier : AIDSLINE CAT/8906630
Leoung G; Mills J
AIDS: MODERN CONCEPTS AND THERAPEUTIC CHALLENGES
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, 369 p., 1987.. Unique Identifier : AIDSLINE ICDB/89650434
Anonymous; No affiliation given
Molecular, biological, epidemiological, psychosocial, and clinical features of AIDS and its related diseases are reviewed. Chapters cover the following topics: the biological basis of adult T-cell leukemia/lymphoma and AIDS (human T-lymphotropic retroviruses [HTLV-I, II, and III]), lymphadenopathy/AIDS virus as the pr


HUMAN T-LYMPHOTROPIC RETROVIRUSES (HTLV-I, II, AND III): THE BIOLOGICAL BASIS OF ADULT T-CELL LEUKEMIA/LYMPHOMA AND AIDS
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 1-21, 1987.. Unique Identifier : AIDSLINE ICDB/89650435
Gallo RC; Streicher HZ; Lab. of Tumor Cell Biology, NCI, Bethesda, MD
Retroviruses in relation to leukemia and AIDS are reviewed under the following headings: general biology of retroviruses, general features of human retroviruses, characteristics of leukemic cells and of the disease associated with human T-lymphotropic virus HTLV-I, origin and spread of HTLV-I and epidemiology of adult


LYMPHADENOPATHY/AIDS VIRUS: THE PROTOTYPE HUMAN LENTIVIRUS
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 23-37, 1987.. Unique Identifier : AIDSLINE ICDB/89650436
Wain-Hobson S; Sonigo P; Alizon M; Montagnier L; Unite de Recombinaison et Expression Genetique, Institut Pasteur,; Paris, France
The virology of lymphadenopathy/human T-lymphotropic virus (LAV/HTLV-III) and the relationship of this virus to the animal lentiviruses are reviewed, including the elements making up the viral genome, evidence that the AIDS virus is a lentivirus, relevance of visna to AIDS, and prospects of handling lentiviral disease


MOLECULAR BIOLOGY OF THE HTLV FAMILY
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 39-52, 1987.. Unique Identifier : AIDSLINE ICDB/89650437
Wong-Staal F; Lab. of Tumor Cell Biology, NCI, Bethesda, MD
Genetic aspects of human T-lymphotropic virus (HTLV) are reviewed as they relate to infection of human hosts. Topics include genetic structures of HTLV-I, -II, and -III; assembling the genes for transactivation; transcriptional regulation of cellular genes by HTLV-I and -II leading to immortality; viral and cellular f


PROGRESS AND PUZZLES: MOLECULAR BIOLOGY OF HTLV-III
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 53-62, 1987.. Unique Identifier : AIDSLINE ICDB/89650438
Haseltine WA; Sodroski JG; Rosen CA; Lab. of Biochemical Pharmacology, Dana-Farber Cancer Inst.,; Boston, MA
The molecular biology of human T-lymphotropic virus (HTLV)-III is reviewed and unanswered questions are discussed. Topics include gag, pol, and env genes; features of HTLV-III that account for some of the unusual features of the virus life cycle and disease; sor, tat, and 3 orf genes; the role of tat-coded proteins in


EPIDEMIOLOGY OF HUMAN RETROVIRUSES AND RELATED CLINICAL CONDITIONS
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 91-121, 1987.. Unique Identifier : AIDSLINE ICDB/89650440
Biggar RJ; International AIDS Epidemiology, Environmental Epidemiology; Branch, NCI, Bethesda, MD
Human retroviruses are reviewed under the following headings: history and nomenclature, serology, human T-lymphotropic virus (HTLV)-I (epidemiology of clinically related conditions, and seroepidemiology), HTLV-II, and HTLV-III and AIDS (epidemiology of clinically related conditions, surveillance and registry data, ris


SPECTRUM OF HTLV-III INFECTION
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 135-42, 1987.. Unique Identifier : AIDSLINE ICDB/89650441
Groopman JE; Div. of Hematology/Oncology, Dept. of Medicine, New England; Deaconess Hosp., Boston, MA
Diseases related to human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) other than full-blown AIDS are discussed. The spectrum of disease consequent to retroviral infection includes AIDS-related complex (ARC), including lymphadenopathy, herpes zoster and oral candidiasis infection, diarrhea, hem


PATHOLOGY OF AIDS
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 143-84, 1987.. Unique Identifier : AIDSLINE ICDB/89650442
Jaffe ES; Katz DA; Macher AM; Hematopathology Section, Lab. of Pathology, NCI, Bethesda, MD
Pathological manifestations associated with AIDS are described, including the following: lymphoid and hematological lesions, opportunistic infections (protozoa, viruses, fungi, and bacteria), malignancies (Kaposi s sarcoma, non-Hodgkin s lymphoma , Hodgkin s disease, small cell carc


KAPOSI'S SARCOMA: AN OVERVIEW OF CLASSICAL AND EPIDEMIC FORMS
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 205-18, 1987.. Unique Identifier : AIDSLINE ICDB/89650443
Safai B; Dermatology Service, Dept. of Medicine, Memorial Sloan-Kettering; Cancer Center, New York, NY
Kaposi s sarcoma (KS) is reviewed under the following headings: history, epidemiology (incidence and sex, age and racial distribution), clinical manifestations and course of the disease, histopathology, associated diseases, and histogenesis. Prior to 1981, KS was considered a rare tumor that occurred in cluster distri


KAPOSI'S SARCOMA IN THE SETTING OF THE AIDS PANDEMIC
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 219-32, 1987.. Unique Identifier : AIDSLINE ICDB/89650444
Gelmann EP; Broder S; Medicine Branch, Clinical Oncology Program, NCI, Bethesda, MD
Kaposi s sarcoma (KS) associated with AIDS and human T-lymphotropic virus-III/lymphadenopathy-associated virus (HTLV-III/LAV) infection is reviewed. The occurrence of the disorder is restricted to four well-defined groups, in each of which KS appears to follow a different clinical course: (1) African KS (before the ad


AIDS-RELATED MALIGNANT B-CELL LYMPHOMAS
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 233-44, 1987.. Unique Identifier : AIDSLINE ICDB/89650445
Levine AM; Gill PS; Rasheed S; Dept. of Internal Medicine, Univ. of Southern California Sch. of; Medicine, Los Angeles, CA
The precise nature of AIDS-related lymphomas is discussed based on the authors experience treating 44 men (42 homosexual or bisexual) with malignant lymphoma. An evaluation of the clinical, pathological, immunological, and virological features of the disease was conducted in these patients (pts) to elucidate the fact


DERMATOLOGICAL (NON-KAPOSI'S SARCOMA) MANIFESTATIONS ASSOCIATED WITH HTLV-III/LAV INFECTION
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 285-302, 1987.. Unique Identifier : AIDSLINE ICDB/89650447
Resnick L; Herbst JS; Retrovirology Laboratories, Dept. of Dermatology, Mt. Sinai; Medical Center, Miami Beach, FL
Dermatological manifestations associated with human T-lymphotropic virus-III/lymphadenopathy-associated virus (HTLV-III/LAV) can be classified into three categories--infections, malignancies, and miscellaneous cutaneous eruptions--each of which is reviewed here. Mucocutaneous infections, which are extremely difficult


RAPID IN VITRO SYSTEMS FOR ASSESSING ACTIVITY OF AGENTS AGAINST HTLV-III/LAV
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 303-33, 1987.. Unique Identifier : AIDSLINE ICDB/89650448
Mitsuya H; Matsukura M; Broder S; Clinical Oncology Program, NCI, Bethesda, MD
Development of screening systems for agents active against human T-lymphotropic virus-III/lymphadenopathy-associated virus (HTLV-III/LAV)-related diseases is described, and results are reported for the following: generation of an HTLV-III/LAV cytopathic effect-sensitive T-cell clone; anti-HTLV-III/LAV activities of 2


STRATEGIES FOR THE PHARMACOLOGICAL INTERVENTION AGAINST HTLV-III/LAV
AIDS: Modern Concepts and Therapeutic Challenges. Broder S, ed. New York, Marcel Dekker, p. 335-60, 1987.. Unique Identifier : AIDSLINE ICDB/89650449
Yarchoan R; Broder S; Clinical Oncology Program, NCI, Bethesda, MD
The rationale for the use of antiviral agents against human T-lymphotropic virus-III/lymphadenopathy-associated virus (HTLV-III/LAV) infection is discussed; a strategy is outlined that has been used to develop drugs with potential clinical application; and the status is reported of several drugs (suramin, 3 -azido-3 -


EFFECTS OF POLYNUCLEOTIDES ON MONKEYS AND MAN
Dev Med Virol; 4:319-31 1988. Unique Identifier : AIDSLINE ICDB/89649864
Levy HB; Molecular Virology Section, Natl. Inst. of Allergy and Infectious; Diseases, NIH, Bethesda, MD 20982
Preclinical studies of polynucleotide use in rodents, immune modulating effects of polynucleotides in primates, including man, and clinical studies with various polynucleotides are reviewed. The clinical studies described employed polyadenylic:polyuridylic acid, in the adjuvant treatment of operable breast cancer, and


PATHOLOGY OF KAPOSI'S SARCOMA
Kaposi's Sarcoma: Pathophysiology and Clinical Management. Ziegler JL, Dorfman RF, eds. New York, Marcel Dekker, p. 23-70, 1988.. Unique Identifier : AIDSLINE ICDB/89650410
Templeton AC; Dept. of Pathology, Rush Medical Coll., Presbyterian-St. Luke's; Medical Center, Chicago, IL
Classic histopathology of Kaposi s sarcoma (KS), its clinical subtypes, evolution of cutaneous KS, differential diagnosis, and distribution of lesions and their characteristics in different tissues are reviewed. Lesions of the skin, mouth and gastrointestinal tract, respiratory tract, lymph nodes, spleen, skeleton, li


ETIOLOGY OF KAPOSI'S SARCOMA: IMMUNODEFICIENCY
Kaposi's Sarcoma: Pathophysiology and Clinical Management. Ziegler JL, Dorfman RF, eds. New York, Marcel Dekker, p. 129-50, 1988.. Unique Identifier : AIDSLINE ICDB/89650413
Penn I; Dept. of Surgery, Univ. of Cincinnati Medical Center, Cincinnati,; OH
The role of immunodeficiency in Kaposi s sarcoma (KS) is considered in four categories of patients (pts): (1) individuals with AIDS who have epidemic KS; (2) African pts with endemic KS; (3) organ transplant recipients with KS; and (4) immunosuppressed non-organ transplant pts with KS. Immunosuppression, as determined


RADIATION THERAPY FOR KAPOSI'S SARCOMA IN AIDS
Kaposi's Sarcoma: Pathophysiology and Clinical Management. Ziegler JL, Dorfman RF, eds. New York, Marcel Dekker, p. 237-48, 1988.. Unique Identifier : AIDSLINE ICDB/89650417
Harris JW; Berson AM; Reed TA; Wara WM; Dept. of Radiation Oncology, Sch. of Medicine, Univ. of; California, San Francisco, CA
Published data and the authors clinical experience are presented in a discussion of radiation therapy in patients (pts) with AIDS-associated Kaposi s sarcoma (KS). Topics include radiation therapy in nonepidemic KS; radiation therapy in epidemic KS, including specific treatment recommendations by site (cutaneous lesi


AIDS: ETIOLOGY, DIAGNOSIS, TREATMENT, AND PREVENTION. SECOND EDITION
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, 474 p., 1988.. Unique Identifier : AIDSLINE ICDB/89650896
Anonymous; No affiliation given
This book attempts to provide a comprehensive source of information on all aspects of AIDS written by the clinicians and scientists who have made the central contributions to the field. Basic considerations, clinical aspects, and public health issues associated with AIDS are discussed. Specific topics covered include


ORIGINS OF AIDS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 3-10, 1988.. Unique Identifier : AIDSLINE ICDB/89650897
Essex M; Dept. of Cancer Biology, Harvard Sch. of Public Health, Boston,; MA
AIDS was first described as a new and distinct clinical entity in 1981. The first cases were recognized because of unusual clustering of diseases such as Kaposi s sarcoma and Pneumocystis pneumonia in young homosexual men. The history of AIDS is summarized, including studies of the infectious etiology of AIDS, the ori


THE EPIDEMIOLOGY AND NATURAL HISTORY OF HUMAN IMMUNODEFICIENCY VIRUS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 33-60, 1988.. Unique Identifier : AIDSLINE ICDB/89650899
Goedert JJ; Blattner WA; Environmental Epidemiology Branch, NCI, Bethesda, MD
HIV is a sexual and blood-borne pathogen that infects and, in most persons, gradually destroys a critical component of immunity, the population of helper-inducer lymphocytes identified by the CD4+ (T4+) surface epitope. Because CD4+ cells coordinate the entire cellular immune response, HIV infections can have myriad m


STRATEGIES FOR THE DEVELOPMENT OF VACCINES TO PREVENT AIDS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 87-104, 1988.. Unique Identifier : AIDSLINE ICDB/89650902
Fischinger PJ; NCI, Bethesda, MD
Human AIDS is an expanding pandemic involving over 57,000 cases in the United States alone. As currently defined, clinical AIDS is generally lethal. Infection with the causative agent, HIV, is apparently irreversible. Current strategies of intervention are based on a few drugs of the c


CLINICAL ASPECTS OF INFECTION WITH THE AIDS RETROVIRUS: ACUTE HIV INFECTION, PERSISTENT GENERALIZED LYMPHADENOPATHY, AND AIDS-RELATED COMPLEX
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 107-20, 1988.. Unique Identifier : AIDSLINE ICDB/89650903
Yarchoan R; Pluda JM; Clinical Oncology Program, Div. of Cancer Treatment, NCI,; Bethesda, MD
It is now recognized that HIV can (either directly or indirectly) affect nearly every organ system in the body and that a wide range of clinical manifestations can result from infection with this agent. Some of these appear to result directly from infection with the virus while others may result from the altered immun


DETECTION OF HUMAN RETROVIRUSES
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 137-54, 1988.. Unique Identifier : AIDSLINE ICDB/89650905
Poiesz BJ; Ehrlich GD; Papsidero LD; Sninsky JJ; SUNY Health Science Center, Syracuse, NY
Strategies employing a variety of serologic assays to detect natural antibodies to the viral structural proteins are currently used to identify patients who have been exposed to human retroviruses and to exclude potentially infected blood products from being transfused. Although some of these techniques are suitable f


PATHOLOGIC FEATURES OF PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 155-83, 1988.. Unique Identifier : AIDSLINE ICDB/89650906
Macher AM; De Vinatea ML; Angritt P; Tuur SM; Reichert CM; Armed Forces Inst. of Pathology, Washington, DC
AIDS is a devastating new disease caused by the HIV, which renders the host profoundly immunoincompetent. The surgical and postmortem pathologic features associated with infection by HIV can be divided into four major categories: (1) morphologic manifestations of immunologic impairment; (2) secondary opportunistic inf


CENTRAL AND PERIPHERAL NERVOUS SYSTEM COMPLICATIONS OF HIV INFECTION AND AIDS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 185-97, 1988.. Unique Identifier : AIDSLINE ICDB/89650907
Brew B; Rosenblum M; Price RW; Memorial Sloan-Kettering Cancer Center, New York, NY
The neurologic complications of HIV infection, and particularly its late phase, AIDS, are both common and varied, and contribute importantly to patient (pt) morbidity and mortality. Both the CNS and peripheral nervous system (PNS) are affected by a spectrum of disorders, some of which can occur as early as the period


GASTROINTESTINAL COMPLICATIONS OF AIDS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 227-44, 1988.. Unique Identifier : AIDSLINE ICDB/89650908
Bartlett JG; Laughon B; Quinn TC; Dept. of Medicine, Johns Hopkins Univ. Sch. of Medicine,; Baltimore, MD
HIV infection and its consequences on the immune defenses may ultimately affect every organ system. The gastrointestinal (GI) tract is one of the most common sites of clinical expression, and all levels from the oral cavity to the anus are frequently involved. A source of considerable concern is that many of these con


KAPOSI'S SARCOMA IN AIDS: DIAGNOSIS AND TREATMENT
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 245-61, 1988.. Unique Identifier : AIDSLINE ICDB/89650909
Krigel RL; Friedman-Kien AE; Fox Chase Cancer Center, Philadelphia, PA 19111
The recent epidemic of a disseminated, fulminant form of Kaposi s sarcoma (KS) was first observed among young homosexual men in large urban centers in the United States . This new form of KS shall be referred to as epidemic KS in light of its association with the AIDS and to distinguish


REACTIVE AND NEOPLASTIC LYMPHOPROLIFERATIVE DISORDERS AND OTHER MISCELLANEOUS CANCERS ASSOCIATED WITH HIV INFECTION
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 263-75, 1988.. Unique Identifier : AIDSLINE ICDB/89650910
Levine AM; Univ. of Southern California Sch. of Medicine, Los Angeles, CA
Early in the AIDS epidemic, it became apparent that individuals at risk for AIDS were also at risk for development of generalized lymphadenopathy of a reactive nature. The term persistent generalized lymphadenopathy (PGL) was used to characterize this disorder, described as generalized lymphadenopathy involving at lea


AIDS IN THE PEDIATRIC POPULATION
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 339-51, 1988.. Unique Identifier : AIDSLINE ICDB/89650913
Falloon J; Eddy J; Roper M; Pizzo PA; Clinical Center, NIH, Bethesda, MD
Soon after AIDS was recognized in homosexual males and iv drug abusers, cases of an immunodeficiency with similar features were observed in children. AIDS in children is discussed, including routes of transmission, definition of AIDS in children, diagnosis of HIV infection in children, clinical manifestations, classif


INTERFERON PRODUCTION DURING IMMUNOLOGICALLY RELATED DISEASES
The Interferon System. A Current Review to 1987. Baron S et al, eds. The University of Texas Medical Branch Series in Biomedical Science, Austin, TX, University of Texas Press, p. 319-25, 1987.. Unique Identifier : AIDSLINE ICDB/89650501
Hooks JJ; Detrick B; Immunology and Virology Section, Lab. of Immunology, Natl. Eye; Inst., NIH, Bethesda, MD 20892
The process of interferon (IFN) production during the course of an immune response may be augmented or depressed in certain disease states, and it may then either modify certain responses or contribute to some of the clinical manifestations. Alterations in the IFN system can be evaluated by abnormally high IFN in the


BIOLOGICAL RESPONSE MODIFICATION IN MAN: MEASUREMENT OF INTERFERON-INDUCED PROTEINS
The Interferon System. A Current Review to 1987. Baron S et al, eds. The University of Texas Medical Branch Series in Biomedical Science, Austin, TX, University of Texas Press, p. 423-9, 1987.. Unique Identifier : AIDSLINE ICDB/89650511
Borden E; Paulnock D; Spear G; Byrne G; Merritt J; Brown R; Dept. of Human Oncology, Univ. of Wisconsin, Madison, WI 53792
Interferons (IFNs)--prototypic biological response modifiers--are the first such modifiers prepared by recombinant DNA technology to impact on treatment of human disease. The authors focus on changes in levels of major histocompatibility (MHC) proteins, 2-5A synthetase, and indoleamine-2,3-dioxygenase, as induced in v


INTERFERON USE DURING OTHER VIRUS INFECTIONS
The Interferon System. A Current Review to 1987. Baron S et al, eds. The University of Texas Medical Branch Series in Biomedical Science, Austin, TX, University of Texas Press, p. 447-52, 1987.. Unique Identifier : AIDSLINE ICDB/89650513
Cesario T; Yousefi S; Carandang G; Tilles J; Dept. of Medicine, Univ. of California Irvine Medical Center, 101; City Drive South, Orange, CA 92668
As clinical applications of human interferon (HuIFN) in treatment of respiratory viruses, herpesviruses, and hepatitis viruses are reviewed in other sections of the book, the present chapter covers therapeutic trials in which the HuIFN was used in a variety of other diseases, either known or presumed to be caused by v


CLINICAL TRIALS WITH INTERFERON IN JAPAN
The Interferon System. A Current Review to 1987. Baron S et al, eds. The University of Texas Medical Branch Series in Biomedical Science, Austin, TX, University of Texas Press, p. 461-7, 1987.. Unique Identifier : AIDSLINE ICDB/89650514
Imanishi J; Kishida T; Dept. of Microbiology, Kyoto Prefectural Univ. of Medicine,; Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602, Japan
Clinical trials with interferon (IFN) in Japan are characterized by many companies joining in the trials and the use of all types of IFN: natural and recombinant (r) human (H) IFN-alpha, -beta, and -gamma. Natural HuIFN-alpha and -beta are each administered mainly at doses of 3-10


TREATMENT OF VIRUS-ASSOCIATED TUMORS WITH INTERFERON (IFN)
The Interferon System. A Current Review to 1987. Baron S et al, eds. The University of Texas Medical Branch Series in Biomedical Science, Austin, TX, University of Texas Press, p. 477-85, 1987.. Unique Identifier : AIDSLINE ICDB/89650516
Leventhal BG; CMSC 804, Johns Hopkins Hosp., Baltimore, MD 21205
The tumors discussed in this paper, both benign and malignant, have all been consistently associated with the presence of a DNA virus; there has been no proof, however, that the virus is, in fact, the principal inducer of the malignant process in any of these tumors. Treatment of virus-associated tumors with interfero


THE LIFE-CYCLE OF HUMAN IMMUNODEFICIENCY VIRUS AS A GUIDE TO THE DESIGN OF NEW THERAPIES FOR AIDS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 79-86, 1988.. Unique Identifier : AIDSLINE ICDB/89650901
Broder S; Clinical Oncology Program, Div. of Cancer Treatment, NCI,; Bethesda, MD
Possible therapeutic interventions can be based on the emerging knowledge of the life cycle of the human immunodeficiency virus that causes AIDS and its related disorders. The characteristics of HIV as a retrovirus (cell binding and entry, integration, latency and reactivation, and protein production and assembly) are


PHARMACOLOGIC TREATMENT OF HIV INFECTION
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 277-93, 1988.. Unique Identifier : AIDSLINE ICDB/89650911
Yarchoan R; Broder S; Clinical Oncology Program, Div. of Cancer Treatment, NCI,; Bethesda, MD
In the short period of time since AIDS was recognized as a new clinical entity, the virus responsible for causing this disease (HIV) has been identified and several agents have been found to block the replication of the virus in vitro. One of these is AZT


OTHER AGENTS IN THE TREATMENT OF AIDS
AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 295-303, 1988.. Unique Identifier : AIDSLINE ICDB/89650912
Polsky B; Armstrong D; Cornell Univ. Medical Coll., New York, NY
Compounds other than nucleoside analogs have shown activity against HIV infection in vitro and have entered the early stages of clinical evaluation. Treatments other than zidovudine ( AZT ) for HIV infection are described according to their supposed sit


Age, rage, and the fear of AIDS.
J Geriatr Psychiatry. 1987;20(2):125-40. Unique Identifier : AIDSLINE MED/89109917
Myers WA; Columbia University Center for Psychoanalytic Training and; Research.
In this paper, the author has presented an in-depth case report of the ongoing analysis of an aging male homosexual, who entered analysis in his late fifties because of his fear of AIDS. This initial spur to his motivation to achieve characterological change was joined subsequently by two other factors. These were the


AIDS: not deficient but immune [letter]
J R Coll Gen Pract. 1987 Nov;37(304):510-1. Unique Identifier : AIDSLINE MED/89110874
Clarke WL; Curtis HA
AID, HIV and general practice [letter]
J R Coll Gen Pract. 1987 Nov;37(304):511. Unique Identifier : AIDSLINE MED/89110875
Gazzard B; Hawkins D
Strip aids [letter]
J R Coll Gen Pract. 1987 Nov;37(304):526. Unique Identifier : AIDSLINE MED/89110881
The worldwide need for basic infection control procedures.
Globe. 1986-87;:74-7. Unique Identifier : AIDSLINE MED/89111204
Runnells RR
[Comparison of CT and MRI findings in the diagnosis of cerebral complications in AIDS]
Neurologija. 1987;36(1-4):29-40. Unique Identifier : AIDSLINE MED/89112455
Kulic S; Henkes H; Schorner W; Felix R
[Central nervous system disorders: the dominant manifestation in the clinical spectrum of HIV infection]
Neurologija. 1987;36(1-4):3-18. Unique Identifier : AIDSLINE MED/89112456
Jevtovic D
[Primary prevention of HIV infections. Prophylactic standards in relation to behavioral risks: a public health information-education program]
Nuovi Ann Ig Microbiol. 1987 Sep-Dec;38(5-6):445-62. Unique Identifier : AIDSLINE MED/89113067
Simonetti D'Arca A; Tarsitani G
Controversy over effects of peptide T on AIDS virus intensifies [news]
Clin Pharm. 1987 Oct;6(10):752, 754. Unique Identifier : AIDSLINE MED/89119925
[Recent progress in thymic hormone research--special reference to platelet aggregability and acquired immune deficiency syndrome]
Shikwa Gakuho. 1987 Jan;87(1):109-19. Unique Identifier : AIDSLINE MED/89130216
Mizuno Y
Psychosomatics for all--past, present and future.
Psychother Psychosom. 1987;47(3-4):128-38. Unique Identifier : AIDSLINE MED/89113529
Aitken C; Rehabilitation Studies Unit, University of Edinburgh, Princess; Margaret Rose Hospital, UK.
It used to be fashionable to begin consideration of psychosomatics about philosophy of mind and body. Nowadays it is a topic about health and practical care of patients--principally about the psychological aspects of any illness. Pathogenesis is becoming understood with some risk factors clearly identifiable. The high


Clinical trial that led to FDA approval of zidovudine is published [news]
Clin Pharm. 1987 Oct;6(10):752. Unique Identifier : AIDSLINE MED/89119924
HIV infection in children: sizing up the paediatric problem.
Paediatr Perinat Epidemiol. 1987 Sep;1(2):143-51. Unique Identifier : AIDSLINE MED/89128545
Senturia YD; Peckham CS; Institute of Child Health, London.
Cases of paediatric AIDS have increased each year in the USA, as the disease has spread to the heterosexual community. In the USA the geographic distribution of perinatal AIDS cases mirrors the distribution of cases in women. To date, 503 HIV antibody positive women have been reported in the UK. It is likely that the


[Neuropathologic study of 15 cases of multinucleated giant cell encephalitis in acquired immunodeficiency syndrome (AIDS)]
Ann Pathol. 1988;8(4-5):281-9. Unique Identifier : AIDSLINE MED/89105199
Gray F; Fenelon G; Gherardi R; Favolini M; Goulon M; Guillard A; Poirier J; Departement de Pathologie Tissulaire et Cellulaire, Hopital; Henri Mondor, Creteil.
The central nervous system (CNS) of 40 patients who died of acquired immune deficiency syndrome (AIDS) between August 1982 and August 1987 was examined. In 15 cases, multinucleated giant cells (MGC) characteristic of Human Immunodeficiency Virus (HIV) infection were observed. In 3 cases ultrastructural examination dis


[Correlation between serum p24 antigen and the isolation of human immunodeficiency virus (HIV) from the lymphocytes of subjects with HIV infection]
Boll Soc Ital Biol Sper. 1988 Aug;64(8):739-45. Unique Identifier : AIDSLINE MED/89105376
Angarano G; Fiore JR; Casalino C; Monno L; Esposito M; Pastore G
Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and The Netherlands.
Ann Inst Pasteur Virol. 1988 Oct-Dec;139(4):429-37. Unique Identifier : AIDSLINE MED/89105471
de Jong JC; Paccaud MF; de Ronde-Verloop FM; Huffels NH; Verwei C; Weijers TF; Bangma PJ; van Kregten E; Kerckhaert JA; Wicki F; et al; Rijksinstituut voor Volksgezondheid en Milieuhygiene, Laboratory; of Virology, Bilthoven, The Netherlands.
Swine influenza A (H1N1) viruses were isolated from two people in Switzerland and one in the Netherlands in early 1986. In haemagglutination-inhibition and neuraminidase-inhibition assays, the three viruses were closely related to one


Low prevalence of infection by HTLV-I in populations at risk for HIV in Djibouti.
Ann Inst Pasteur Virol. 1988 Oct-Dec;139(4):443-7. Unique Identifier : AIDSLINE MED/89105473
Fox E; Constantine NT; Abbatte EA; Said-Salah; Rodier G; US Naval Medical Research Unit 3 (NAMRU-3), Cairo.
In order to determine whether HTLV-I (a recently discovered retrovirus causing T-cell leukaemias and lymphomas, as well as tropical spastic paraparesis) was present in Djibouti in 1988, we investigated 576 subjects belonging to various groups at risk of acquiring HIV, a related r


Evaluation of a particle agglutination test for detection of antibodies to HIV1.
Ann Inst Pasteur Virol. 1988 Oct-Dec;139(4):463-6. Unique Identifier : AIDSLINE MED/89105477
Lyons SF; Gous MF; McGillivray GM; Medical Research Council Aids Virus Research Unit, National; Institute for Virology, Johannesburg, South Africa.
Full text of AIDS, HIV policy statement [news]
Bull Fifth Dist Dent Soc State N Y. 1988 Jan;5(68):9-10. Unique Identifier : AIDSLINE MED/89105666
CDS goes after AIDS data.
CDS Rev. 1988 May;81(4):15. Unique Identifier : AIDSLINE MED/89106224
Ethical issues involved in the growing AIDS crisis. Council on Ethical and Judicial Affairs.
Conn Med. 1988 Jul;52(7):427-8. Unique Identifier : AIDSLINE MED/89106683
Molecular analysis of an AIDS-associated Burkitt's lymphoma: near-identity with endemic cases.
Curr Top Microbiol Immunol. 1988;141:75-9. Unique Identifier : AIDSLINE MED/89106768
Haluska FG; Russo G; Andreeff M; Croce CM
[References and recommendations of the German Hospital Society--compiled in cooperation with the Federal Medical Board--on HIV infection. HIV test for patients--patient education and consent to testing]
Chirurg. 1988 Aug;59(8):suppl 133-4. Unique Identifier : AIDSLINE MED/89106804
Serological survey of human immunodeficiency virus infection in Ethiopia.
Ethiop Med J. 1988 Oct;26(4):179-84. Unique Identifier : AIDSLINE MED/89107174
Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
Barrier techniques heeded [news]
Dent Assist. 1988 May-Jun;57(3):28. Unique Identifier : AIDSLINE MED/89107658
AIDS news.
Dent Assist. 1988 May-Jun;57(3):31. Unique Identifier : AIDSLINE MED/89107659
Women and AIDS.
Dent Assist. 1988 May-Jun;57(3):32. Unique Identifier : AIDSLINE MED/89107660
Saliva key to AIDS treatment?
Dent Assist. 1988 Jul-Aug;57(4):6. Unique Identifier : AIDSLINE MED/89107669
Early detection of HIV infection.
Dent Hyg (Chic). 1988 Jun;62(6):262. Unique Identifier : AIDSLINE MED/89107681
Viral disease in dentistry: current concerns for the dentist.
Gen Dent. 1988 Mar-Apr;36(2):108-12. Unique Identifier : AIDSLINE MED/89107939
Mjos DP; Miller RI
AIDS hotline for teens.
GMDA Bull. 1988 Jun;55(6):186. Unique Identifier : AIDSLINE MED/89108138
AIDS counseling and testing.
Health Soc Work. 1988 Summer;13(3):167-9. Unique Identifier : AIDSLINE MED/89108180
Leukefeld CG
Comprehensive AIDS-related services.
Health Soc Work. 1988 Summer;13(3):234-5. Unique Identifier : AIDSLINE MED/89108188
[A German Public Health Service study. The risk of HIV in dental practice? (news)]
Fortschr Med. 1988 Jun 20;106(18):13. Unique Identifier : AIDSLINE MED/89108198
[Clinical tests in the United States. Initial success with an AIDS vaccine (news)]
Fortschr Med. 1988 Jun 20;106(18):13. Unique Identifier : AIDSLINE MED/89108199
[Immune status. Slim chance for infected hemophiliacs (news)]
Fortschr Med. 1988 Jun 20;106(18):13. Unique Identifier : AIDSLINE MED/89108200
[A critique of scientific consensus: the heresy of Peter Duesberg (news)]
Fortschr Med. 1988 Jul 10;106(20):11. Unique Identifier : AIDSLINE MED/89108209
Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.
Hepatogastroenterology. 1988 Dec;35(6):300-3. Unique Identifier : AIDSLINE MED/89108257
Porres JC; Carreno V; Mora I; Gutiez J; Moreno A; Cajal SR; Marron JA; Bartolome J; Gastroenterology Department, Fundacion Jimenez Diaz, Madrid,; Spain.
A total of 24 chronic carriers of HBsAg, HBeAg and hepatitis B virus (HBV)-DNA were included in a controlled trial. The patients were randomly assigned to four groups: Group I (n = 6): control; group II (n = 6): 2.5 MU; group III (n = 6): 5 MU and group IV (n = 6): 10 MU rIFN-alpha/m2 body surface 3 times weekly i.m.


Biopsy pathology of the gastrointestinal tract in human immunodeficiency virus-associated disease: a 5 year experience in Zurich.
Histopathology. 1988 Nov;13(5):531-40. Unique Identifier : AIDSLINE MED/89108327
Stamm B; Grant JW; Institute of Pathology, University Hospital, Zurich,; Switzerland.
Patients with human immunodeficiency virus (HIV)-associated disease are subject to a wide variety of unusual opportunistic infections and to the development of malignant tumours. These complications frequently manifest themselves within the gastrointestinal tract and endoscopic biopsies may contribute to their diagnos


AHA opposes routine testing of patients for AIDS, reaffirms use of universal precautions [news]
Hosp Community Psychiatry. 1988 Sep;39(9):1008-9. Unique Identifier : AIDSLINE MED/89108338
Practices reported by incarcerated drug abusers to reduce risk of AIDS.
Hosp Community Psychiatry. 1988 Sep;39(9):966-72. Unique Identifier : AIDSLINE MED/89108349
Valdiserri EV; Hartl AJ; Chambliss CA; Lenape Valley Foundation, Doylestown, Pennsylvania.
The nation s response to AIDS has failed to effectively curb the spread of AIDS among intravenous (IV) drug users, who are primarily responsible for transmitting the disease to heterosexuals and children. A study assessing awareness of AIDS among 58 county jail inmates--27 IV drug abusers and 31 nonintravenous drug ab


Knowledge about AIDS among psychiatric inpatients.
Hosp Community Psychiatry. 1988 Sep;39(9):986-8. Unique Identifier : AIDSLINE MED/89108352
Bear JW; Dwyer PC; Lewitter-Koehler S; Department of Psychiatry, University of California, San; Francisco.
AIDS related legislation.
Ill Dent J. 1988 May-Jun;57(3):194. Unique Identifier : AIDSLINE MED/89108479
Human trials of AIDS vaccine [news]
Ill Dent J. 1988 May-Jun;57(3):198. Unique Identifier : AIDSLINE MED/89108480
[Superficial mycotic infections in AIDS and other HIV-infection related syndromes]
G Ital Dermatol Venereol. 1988 Jun;123(6):297-301. Unique Identifier : AIDSLINE MED/89108542
Calzavara-Pinton PG; Carlino A; Cadeo GP; Pancera C; Manganoni AM
HIV-IgM serology [letter]
Infection. 1988 Sep-Oct;16(5):301-2. Unique Identifier : AIDSLINE MED/89108631
Bedarida G; Crocchiolo P; Cambie G; D'Agostino F; Uberti Foppa C; Berto E; Grisi ME; Arcidiacono I; Ronsivalle MG; Pasquali M; et al
AIDS risk from needles less than 1%.
Hawaii Dent J. 1988 May;19(5):13. Unique Identifier : AIDSLINE MED/89108961
U.S. AIDS cases top 50,000.
Hawaii Dent J. 1988 May;19(5):13. Unique Identifier : AIDSLINE MED/89108962
AIDS and hepatitis B in Hawaii.
Hawaii Dent J. 1988 May;19(5):14-5. Unique Identifier : AIDSLINE MED/89108963
Full text of AIDS, HIV policy statement.
Hawaii Dent J. 1988 May;19(5):18. Unique Identifier : AIDSLINE MED/89108964
No choice about gloves [news]
Hawaii Dent J. 1988 May;19(5):6. Unique Identifier : AIDSLINE MED/89108966
OSHA guidelines mandatory [news]
Hawaii Dent J. 1988 May;19(5):6, 8. Unique Identifier : AIDSLINE MED/89108967
AIDS-related dementia: a case report of rapid cognitive decline.
J Clin Psychol. 1988 Nov;44(6):1024-8. Unique Identifier : AIDSLINE MED/89109608
Morgan MK; Clark ME; Hartman WL; Psychology Service, Veterans Administration Medical Center, Bay; Pines, Florida 33542.
Little is known psychometrically about the pattern of cognitive decline associated with acquired immunodeficiency syndrome (AIDS)-related dementia . Pre- and posttest results are presented to illustrate a case example of rapid cognitive decline. Increased psychometric assessment is


AIDS Awareness Week: an operational model.
J Am Coll Health. 1988 Jul;37(1):36-9. Unique Identifier : AIDSLINE MED/89109815
Bernstein D; Roaman CA
AIDS not found worldwide.
J Houston Dist Dent Soc. 1988 Aug;60(1):41. Unique Identifier : AIDSLINE MED/89110034
Periodontal disease and AIDS [news]
J Mass Dent Soc. 1988 Spring;38(2):58. Unique Identifier : AIDSLINE MED/89110211
Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study.
J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1063-8. Unique Identifier : AIDSLINE MED/89110312
Bukasa KS; Sindic CJ; Bodeus M; Burtonboy G; Laterre C; Sonnet J; Department of Neurology, St-Luc Hospital, University of Louvain,; Brussels, Belgium.
CSF and serum samples from 16 AIDS patients were tested for the presence of anti-HIV antibodies either by classical serological methods or by an immunoblot technique based on agarose gel isoelectric focusing and transfer of the specific IgG antibodies onto HIV antigens-loaded nitrocellulose sheets. This method enabled


Multimodality evoked potentials in HTLV-I associated myelopathy.
J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1094-6. Unique Identifier : AIDSLINE MED/89110320
Kakigi R; Shibasaki H; Kuroda Y; Endo C; Oda K; Ikeda A; Hashimoto K; Department of Internal Medicine, Saga Medical School, Japan.
Multimodality evoked potentials (EPs) consisting of somatosensory EPs (SEPs), visual EPs (VEPs) and brainstem auditory EPs (BAEPs) were studied in 16 cases with HTLV-I associated myelopathy (HAM). Median nerve SEPs were normal in all cases. In posterior tibial nerve SEPs, the potential recorded at the 12th thoracic sp


HLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS.
J Acquir Immune Defic Syndr. 1988;1(1):13-7. Unique Identifier : AIDSLINE MED/89110700
Mann DL; Murray C; Yarchoan R; Blattner WA; Goedert JJ; Laboratory of Human Carcinogenesis, National Cancer Institute,; Bethesda, Maryland 20892.
HLA-A, -B, -C, -DR, and -DQ antigen phenotypes were determined in 266 Caucasian homosexual men, 90 of whom were HIV-1 seronegative, 94 HIV-1 seropositive AIDS-free, and 82 with a diagnosis of AIDS [36 with Kaposi s sarcoma (KS), 34 with opportunistic infection (OI), and 12 with KS and OI]. No significant differences i


Lack of relation between human T-lymphotropic virus type I infection and systemic lupus erythematosus in Jamaica, West Indies.
J Acquir Immune Defic Syndr. 1988;1(1):18-22. Unique Identifier : AIDSLINE MED/89110701
Murphy EL Jr; De Ceulaer K; Williams W; Clark JW; Saxinger C; Gibbs WN; Blattner WA; Viral Epidemiology Section, National Cancer Institute, Bethesda,; MD 20892.
To determine whether systemic lupus erythematosus (SLE) is associated with human T-lymphotropic virus, type I (HTLV-I) infection in Jamaica , an endemic area for the virus, we studied 63 patients with SLE at the University Hospital of the West Indies in Kingston. Antibodies to HTLV


Neuroepidemiology of acquired immunodeficiency syndrome.
J Acquir Immune Defic Syndr. 1988;1(1):31-40. Unique Identifier : AIDSLINE MED/89110704
Levy RM; Janssen RS; Bush TJ; Rosenblum ML; Department of Neurological Surgery, School of Medicine,; University of California, San Francisco 94143.
Data from the Centers for Disease Control (CDC) and from the hospitals affiliated with the University of California, San Francisco show a significant incidence of neurological complications in AIDS patients and suggest that patients from different risk groups and geographic regions are at different relative risk for s


Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian Tyrol.
J Acquir Immune Defic Syndr. 1988;1(1):65-6. Unique Identifier : AIDSLINE MED/89110706
Fuchs D; Unterweger B; Hausen A; Reibnegger G; Werner ER; Hengster P; Hinterhuber H; Dierich MP; Wachter H; Blattner WA; et al; Institute of Medical Chemistry and Biochemistry, University of; Innsbruck, Austria.
A serologic study of HIV infection in Liberia [letter]
J Acquir Immune Defic Syndr. 1988;1(1):67-8. Unique Identifier : AIDSLINE MED/89110707
Mintz E; Peale R; Mathur SK; Prince A; Brotman B
Interim report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic: Chairman's recommendations--Part I.
J Acquir Immune Defic Syndr. 1988;1(1):69-103. Unique Identifier : AIDSLINE MED/89110708
Watkins JD; Conway-Welch C; Creedon JJ; Crenshaw TL; DeVos RM; Gebbie KM; Lee BJ 3d; Lilly F; O'Connor JC; Primm BJ; et al
Cardiomyopathy associated with the acquired immune deficiency syndrome.
J Acquir Immune Defic Syndr. 1988;1(2):105-10. Unique Identifier : AIDSLINE MED/89110710
Kaminski HJ; Katzman M; Wiest PM; Ellner JJ; Gifford DR; Rackley R; Iskandar SS; Lederman MM; Department of Medicine, Case Western Reserve University,; Cleveland, Ohio.
Three cases of congestive cardiomyopathy complicating the acquired immune deficiency syndrome (AIDS) are reported. In one case, acute cardiac decompensation resulted in prolonged but ultimately reversible cardiogenic shock. In the second case, clinical signs of cardiac disease were precipitated by acute renal failure


Seroprevalence and demographic information of patients at risk for human immunodeficiency virus (HIV) infection in Manitoba, Canada.
J Acquir Immune Defic Syndr. 1988;1(2):138-42. Unique Identifier : AIDSLINE MED/89110715
Hammond GW; Buchanan D; Malazdrewicz R; Conway B; Tate R; Sekla L; Fast M; Ronald AR; Cadham Provincial Laboratory, University of Manitoba, Winnipeg,; Canada.
Two hundred fifty individuals from high risk categories were enrolled in a seroprevalence survey for human immunodeficiency virus (HIV) infections in Winnipeg. The overall seroprevalence in the Manitoba AIDS Virus Epidemiology Study (MAVES) was 5.2%. Of 2651 diagnostic and screening specimens in the province of Manito


Human immunodeficiency virus and human T-lymphotropic virus type I infection among homosexual men in Kingston, Jamaica.
J Acquir Immune Defic Syndr. 1988;1(2):143-9. Unique Identifier : AIDSLINE MED/89110716
Murphy EL; Gibbs WN; Figueroa JP; Bain B; LaGrenade L; Cranston B; Blattner WA; Viral Epidemiology Section, National Cancer Institute, Bethesda,; MD 20892.
From August 1985 through January 1986, 125 homosexual or bisexual men from the Kingston area were enrolled in a study to evaluate risk factors for infection with human immunodeficiency virus (HIV) and human T-lymphotropic virus type I (HTLV-I). Twelve men (10%) were seropositive for HIV and 6 (5%) for HTLV-I; 1 man ha


Prevalence of HIV infection in New York call girls.
J Acquir Immune Defic Syndr. 1988;1(2):150-4. Unique Identifier : AIDSLINE MED/89110717
Seidlin M; Krasinski K; Bebenroth D; Itri V; Paolino AM; Valentine F; Department of Medicine, New York University Medical Center, New; York.
In order to evaluate the frequency of sexual transmission of human immunodeficiency virus (HIV) among promiscuous heterosexuals, we studied the prevalence of HIV infection among a group of predominantly Caucasian call girls and women working for escort services and massage parlors in New York City. In the 78 subjects


Self-care behaviors and informational needs of seropositive homosexual/bisexual men.
J Acquir Immune Defic Syndr. 1988;1(2):155-61. Unique Identifier : AIDSLINE MED/89110718
Lovejoy NC; Moran TA; Paul S; Department of Physiological Nursing, San Francisco General; Hospital/University of California.
Patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC) are developing beliefs, behaviors, and a knowledge bases that may affect their health status, sense of well-being, and health care needs. However, little documentation of these changes exists. Consequently, the purpose of this study


AZT inhibits HIV-1 replication in monocytes [letter]
J Acquir Immune Defic Syndr. 1988;1(2):162-3. Unique Identifier : AIDSLINE MED/89110719
Skinner MA; Matthews TJ; Greenwall TK; Bolognesi DP; Hebdon M
No evidence of HTLV-I infection in intravenous drug abusers in West Germany [letter]
J Acquir Immune Defic Syndr. 1988;1(2):163-4. Unique Identifier : AIDSLINE MED/89110720
Kramer A; Goedert JJ; Blattner WA; Marcus U
Scientific forum on AIDS: a summary. Does HIV cause AIDS?
J Acquir Immune Defic Syndr. 1988;1(2):165-72. Unique Identifier : AIDSLINE MED/89110721
Ginsberg HS; Department of Medicine, College of Physicians and Surgeons of; Columbia University, New York, New York.
Confronting AIDS: update 1988. Executive summary. Institute of Medicine/National Academy of Sciences.
J Acquir Immune Defic Syndr. 1988;1(2):173-86. Unique Identifier : AIDSLINE MED/89110722
The global picture of AIDS.
J Acquir Immune Defic Syndr. 1988;1(3):209-16. Unique Identifier : AIDSLINE MED/89110724
Mann JM; Global Programme on AIDS, World Health Organization, Geneva,; Switzerland.
The role of mathematical models in the study of HIV transmission and the epidemiology of AIDS.
J Acquir Immune Defic Syndr. 1988;1(3):241-56. Unique Identifier : AIDSLINE MED/89110726
Anderson RM; Group, Department of Pure and Applied Biology, Imperial College,; London University, England.
The role of mathematical models in the study of human immunodeficiency virus (HIV) transmission, the epidemiology and demographic impact of acquired immune deficiency syndrome (AIDS), and the course of infection within an individual is reviewed. Attention is focused on the part models can play in short-term prediction


HIV infection among persons who inject illicit drugs: problems and prospects.
J Acquir Immune Defic Syndr. 1988;1(3):267-73. Unique Identifier : AIDSLINE MED/89110728
Des Jarlais DC; Friedman SR; New York State Division of Substance Abuse Services, NY 10013.
Intravenous drug use continues as the second most common risk behavior associated with acquired immune deficiency syndrome (AIDS) in the United States and Europe. Recently there has been increased public and research attention to this problem. Five areas of public health concern for AI


AIDS care: providing care for the HIV infected.
J Acquir Immune Defic Syndr. 1988;1(3):274-83. Unique Identifier : AIDSLINE MED/89110729
Wofsy CB; Department of Medicine, University of California, San Francisco.
To meet the needs of human immunodeficiency virus (HIV) infected individuals, innovative approaches to health care delivery have been developed that could affect the entire worldwide medical care system. Innovations include dedicated inpatient and outpatient AIDS treatment and research units, extensive community servi


The new AIDS virus--ineffective and unjust laws.
J Acquir Immune Defic Syndr. 1988;1(3):304-12. Unique Identifier : AIDSLINE MED/89110732
Kirby M; Court of Appeal, Supreme Court of New South Wales, Sydney,; Australia.
Public alarm about the spread of AIDS leads to public demand for drastic laws to contain the epidemic and to punish those who spread it. In this paper, attention is drawn to the limitations of the law in achieving the modification of human behavior. Successes and failures in public health education campaigns, directed


Collaboration across borders.
J Acquir Immune Defic Syndr. 1988;1(3):313-4. Unique Identifier : AIDSLINE MED/89110733
Mahler H; World Health Organization, Geneva, Switzerland.
Decreased whole blood 5-hydroxytryptamine (serotonin) in AIDS patients.
J Acquir Immune Defic Syndr. 1988;1(4):324-5. Unique Identifier : AIDSLINE MED/89110735
Launay JM; Copel L; Callebert J; Corvaia N; Lepage E; Bricaire F; Saal F; Peries J; F.R.A. Claude Bernard Neurochimie des Communications Cellulaires,; Hopital Claude, Bernard, Paris, France.
Significantly (p less than 0.001) decreased whole blood unconjugated serotonin levels were detected in AIDS patients as compared to patients with advanced cancers and to healthy individuals.


Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestations of HIV infection.
J Acquir Immune Defic Syndr. 1988;1(4):346-53. Unique Identifier : AIDSLINE MED/89110739
Ryder MI; Winkler JR; Weinreb RN; Department of Stomotatology, University of California, San; Francisco 94143-0650.
Alterations in polymorphonuclear leucocyte (PMN) function are frequently associated with intraoral disease. The purpose of this study was to evaluate if alterations exist in three early stimulatory events of PMN function in individuals with intraoral manifestations of human immunodeficiency virus (HIV) infection. Peri


Oral defense mechanisms are impaired early in HIV-1 infected patients.
J Acquir Immune Defic Syndr. 1988;1(4):361-6. Unique Identifier : AIDSLINE MED/89110741
Yeh CK; Fox PC; Ship JA; Busch KA; Bermudez DK; Wilder AM; Katz RW; Wolff A; Tylenda CA; Atkinson JC; et al; Clinical Investigations and Patient Care Branch, NIDR, Bethesda,; MD 20892.
We have examined the hypothesis that individuals infected with human immune deficiency virus type 1 (HIV-1) experience significant, specific alterations in mechanisms protecting the oral cavity prior to the appearance of AIDS-related systemic opportunistic infections. In a study of 13 early-stage, stable anti-HIV anti


Prognostic usefulness of the Walter Reed staging classification for HIV infection.
J Acquir Immune Defic Syndr. 1988;1(4):367-74. Unique Identifier : AIDSLINE MED/89110742
MacDonell KB; Chmiel JS; Goldsmith J; Wallemark CB; Steinberg J; Byers E; Phair JP; Department of Medicine, Northwestern University Medical School,; Chicago, IL 60611.
We evaluated the usefulness of both the Walter Reed (WR) staging classification and the component criteria used in the system in predicting progression to AIDS. The WR classification was applied to a cohort of 431 men who were seropositive for the human immunodeficiency virus on entry into a prospective study. The WR


Hospice care of the intravenous drug user AIDS patient in a skilled nurse facility.
J Acquir Immune Defic Syndr. 1988;1(4):375-80. Unique Identifier : AIDSLINE MED/89110743
Bulkin W; Brown L; Fraioli D; Giannattasio E; McGuire G; Tyler P; Friedland G; Ritter Scheuer Hospice, Beth Abraham Hospital, Bronx, NY 10467.
We report on the initial experience in hospice care for a predominantly poor, black and Hispanic intravenous drug user AIDS population in New York City. Hospice care was provided in a skilled nursing facility with a certified hospice program delivering home care and inpatient care. A formal education program preceded


Human immunodeficiency virus seroprevalence and drug-using behavior in Milwaukee intravenous drug abusers.
J Acquir Immune Defic Syndr. 1988;1(4):381-5. Unique Identifier : AIDSLINE MED/89110744
Belongia EA; Golubjatnikov R; McClellan-Tilson B; Wiesen RL; Vergeront JM; Davis JP; Section of Acute and Communicable Disease Epidemiology, Wisconsin; Division of Health, Madison 53701.
We assessed human immunodeficiency virus (HIV) antibody prevalence and drug-using behaviors among intravenous drug abusers (IVDAs) enrolled in Milwaukee drug treatment programs. Six (2.3%) of 266 study participants were positive for HIV antibody by Western blot assay. A history of needlesharing was reported by 91% of


Education in preventing HIV infection in Greek registered prostitutes.
J Acquir Immune Defic Syndr. 1988;1(4):386-9. Unique Identifier : AIDSLINE MED/89110745
Papaevangelou G; Roumeliotou A; Kallinikos G; Papoutsakis G; Trichopoulou E; Stefanou T; WHO Collaborating AIDS Reference Centre, Athens School of; Hygiene, Greece.
From March 1984 to November 1985, 350 Greek registered prostitutes were screened for anti-HIV. Twelve of them (3.4%) were found to be positive. To monitor and control the further spread of HIV infection, an intensive educational campaign was established and screening every 3 months was implemented. Until October 1986,


HIV, HTLV-1, and HBV infections in a cohort of Italian intravenous drug abusers: analysis of risk factors.
J Acquir Immune Defic Syndr. 1988;1(4):405-11. Unique Identifier : AIDSLINE MED/89110748
Titti F; Rezza G; Verani P; Butto S; Sernicola L; Rapicetta M; Sarrecchia B; Oliva C; Rossi GB; Laboratory of Virology, Istituto Superiore di Sanita, Rome,; Italy.
A seroepidemiological survey of a group of 291 intravenous drug abusers (IVDAs), 45 household contacts of IVDAs, and 39 laboratory workers has been carried out to determine the prevalence of HIV-1, HIV-2, HTLV-1, and HBV antibodies in the sera, as well as to evaluate the role of various risk factors. Among i.v. drug a


AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers.
J Acquir Immune Defic Syndr. 1988;1(4):412-3. Unique Identifier : AIDSLINE MED/89110749
Bortolotti F; Stivanello A; Dall'Armi A; Rinaldi R; La Grasta F; Clinica Medica 2 of the University, Padua, Italy.
HIV-1 seroprevalence in male prostitutes in northeast Italy [letter]
J Acquir Immune Defic Syndr. 1988;1(4):414-5. Unique Identifier : AIDSLINE MED/89110750
Tirelli U; Vaccher E; Bullian P; Saracchini S; Errante D; Bullian P; Zagonel V; Serraino D
The multiple benefits of an AIDS control program [letter]
J Acquir Immune Defic Syndr. 1988;1(4):415. Unique Identifier : AIDSLINE MED/89110751
Evans AS
Prevalence of HTLV-I and HIV infection among white parenteral drug abusers.
J Acquir Immune Defic Syndr. 1988;1(4):415-7. Unique Identifier : AIDSLINE MED/89110752
Glaser JB; Coleman P; Slamon D; Papsidero L; Ehrlich G; Poiesz BJ; Duggan D
Infectious diseases update: AIDS.
J R Coll Gen Pract. 1988 Apr;38(309):179. Unique Identifier : AIDSLINE MED/89110898
AIDS: the Surgeon General's update [news]
J Mich Dent Assoc. 1988 Jun;70(6):307. Unique Identifier : AIDSLINE MED/89110978
Key AIDS molecule may open avenues for drug research [news]
J Mich Dent Assoc. 1988 Jun;70(6):307. Unique Identifier : AIDSLINE MED/89110979
Differential diagnosis of psychiatric comorbidity in substance abusers.
J Subst Abuse Treat. 1988;5(4):201-6. Unique Identifier : AIDSLINE MED/89111113
Kosten TR; Kleber HD; Yale University School of Medicine, Department of Psychiatry, New; Haven, CT.
The differential diagnosis of psychiatric comorbidity in substance abusers is important in order to provide effective pharmacological and psychotherapeutic treatments for the comorbid psychiatric disorders. Differential diagnosis of an underlying psychiatric disorder depends on the type of drug abused and the phase of


A community-based support group for HIV positive i.v. drug abusers: the HERO program.
J Subst Abuse Treat. 1988;5(4):263-6. Unique Identifier : AIDSLINE MED/89111120
Greif GL; Price C; University of Maryland at Baltimore, School of Social Work and; Community Planning 21201.
The I.V. drug abuser who has a history of non-compliance is perhaps the most difficult to reach among those at risk for contracting AIDS. This article details one approach being attempted at HERO, that of a community-based support group run by an indeginous worker where the emphasis is on support, education, and outre


[Improvement in anti-hemophilic preparations and its problems. 6. Function analysis of human plasma proteins passed through the microporous regenerated cellulose membrane (BMM) hollow fiber]
Rinsho Ketsueki. 1988 May;29(5):662-5. Unique Identifier : AIDSLINE MED/89111306
Okuyama K; Fukushima Y; Miura Y; Honma R; Manabe S; Ishikawa G; Satani M; Komuro K
[AIDS with fever, giant splenomegaly and severe pancytopenia]
Rinsho Ketsueki. 1988 May;29(5):748-55. Unique Identifier : AIDSLINE MED/89111322
Matsubara M; Masuda G; Terada H; Nihkura H
[Adult T-cell leukemia with giant cell transformation of leukemic cells in ascites]
Rinsho Ketsueki. 1988 Sep;29(9):1465-70. Unique Identifier : AIDSLINE MED/89111346
Sakuma T; Satoh T; Satodate R; Katoh C; Madarame T; Iwai K
[Successful treatment of an adult T-cell leukemia with alpha-interferon]
Rinsho Ketsueki. 1988 Sep;29(9):1476-81. Unique Identifier : AIDSLINE MED/89111348
Fujimoto T; Imamura N; Saito O; Fujimura K; Okada K; Kuramoto A
[Syndrome of inappropriate secretion of antidiuretic hormone in the central nervous system involvement of adult T-cell leukemia]
Rinsho Ketsueki. 1988 Sep;29(9):1482-7. Unique Identifier : AIDSLINE MED/89111349
Kawasaki C; Hayashi S; Shibuya T; Otsuka T; Nagafuchi S; Ishibashi H; Harada M; Niho Y
[Our way to deal with AIDS and HIV-infected patients at the department of infectious diseases]
Krankenpfl J. 1988 Dec 1;26(12):585-7. Unique Identifier : AIDSLINE MED/89111501
Trompeter A
New videos address AIDS.
J Sch Health. 1988 Aug;58(6):239. Unique Identifier : AIDSLINE MED/89111509
Kerr DL; American School Health Association, Kent, OH 44240-0708.
[Difficulties of investigation of antibodies against human immunodeficiency virus type 2 using ELISA (letter)]
Med Clin (Barc). 1988 Oct 29;91(14):556-7. Unique Identifier : AIDSLINE MED/89111738
Soriano Vazquez V; Ribera Crusafont A; Tor Aquilera J; Muga Bustamante R
[Diffuse alopecia in patients with human immunodeficiency virus infection (letter)]
Med Clin (Barc). 1988 Sep 24;91(9):357. Unique Identifier : AIDSLINE MED/89111753
Espana Alonso A; Torroba Alvarez L; Buzon Rueda L
[Recurrent hemophagocytic syndrome and human immunodeficiency virus infection (letter)]
Med Clin (Barc). 1988 Sep 24;91(9):359. Unique Identifier : AIDSLINE MED/89111756
Garcia Diaz JD; Guillen Camargo V; Alonso Navas F
[Prevention of the transmission of HIV infections in an odontosmatological environment. Study in a closed community]
Minerva Stomatol. 1988 Oct;37(10):797-800. Unique Identifier : AIDSLINE MED/89112108
De Mercato R; Rossano F; Noce S; D'Ambrosio C; Siciliano V; Perna E; Iovinella V; Bassi A
[The course of HIV infection and the effects of zidovudine]
Ned Tijdschr Geneeskd. 1988 Dec 31;132(53):2403-4. Unique Identifier : AIDSLINE MED/89112388
van Wijngaarden JK
'Who was that masked man?' Elicits a different response now.
Occup Health Saf. 1988 Nov;57(12):20, 22. Unique Identifier : AIDSLINE MED/89112684
Densmore G
Gloves deserve applause.
Occup Health Saf. 1988 Dec;57(13):20, 37. Unique Identifier : AIDSLINE MED/89112691
Leary MM
The global AIDS campaign: Britain's leading role.
Nurs J India. 1988 Oct;79(10):259-60. Unique Identifier : AIDSLINE MED/89113078
Kelsey J
Health teams in school. A step towards primary prevention.
Pediatrician. 1988;15(3):137-42. Unique Identifier : AIDSLINE MED/89113125
Bergstrom E; School Health Service, Community of Umea, Sweden.
Health education in schools is a subject that many people talk about but few do something about. One reason for this is that it is an interdisciplinary subject. This paper describes a community model with a ten-point program. Local health teams with collaboration between the school health service and the teachers are


AIDS. What to do.
Practitioner. 1988 Feb 8;232(1442):133-8. Unique Identifier : AIDSLINE MED/89113224
Heley A
AIDS and HIV infection.
Practitioner. 1988 Apr 8;232(1446):379-80. Unique Identifier : AIDSLINE MED/89113252
Forster G
The 'worried well'.
Practitioner. 1988 Apr 8;232(1446):383-4, 386. Unique Identifier : AIDSLINE MED/89113253
Harvey N
Preparation for and interpretation of the HIV test.
Practitioner. 1988 Apr 8;232(1446):388, 390-1. Unique Identifier : AIDSLINE MED/89113254
Lowick V
The seropositive male.
Practitioner. 1988 Apr 8;232(1446):393-4, 397. Unique Identifier : AIDSLINE MED/89113255
The general practitioner and community care of HIV+ patients.
Practitioner. 1988 Apr 8;232(1446):398, 400, 403. Unique Identifier : AIDSLINE MED/89113256
Goodson C
[Guilt and atonement in the age of free sexuality: the case of AIDS]
Psyche (Stuttg). 1988 Jul;42(7):637-44. Unique Identifier : AIDSLINE MED/89113798
Bollinger L
[Desensitization to sulfamide in a patient with AIDS and cerebral toxoplasmosis (letter)]
Rev Clin Esp. 1988 Oct;183(6):332-3. Unique Identifier : AIDSLINE MED/89113857
Laguna Cuesta F; Diaz Mora F; Puente Puente S; Mateu Paris B
[HIV infection in the hemophiliac patient]
Rev Invest Clin. 1988 Jul-Sep;40(3):237-9. Unique Identifier : AIDSLINE MED/89113983
Ayala Gaytan JJ; Rico Bazaldua G; Canales Garcia RA; Herrera Sanchez P; Pompa Garza MT
Kikuchi's histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis.
Semin Diagn Pathol. 1988 Nov;5(4):329-45. Unique Identifier : AIDSLINE MED/89114000
Dorfman RF; Berry GJ; Department of Pathology, Stanford University Medical Center, CA; 94305.
Kikuchi s necrotizing lymphadenitis has now become recognized in many parts of the world as a well-defined clinicopathologic entity with a remarkable predilection for cervical lymph nodes of young women. The morphologic features encountered in lymph nodes are distinctive and should enable pathologists to establish the


[Patients with AIDS-related brain diseases hospitalized in psychiatric institutions. Experiences from a regional psychiatric hospital]
Schweiz Rundsch Med Prax. 1988 Dec 13;77(50):1371-5. Unique Identifier : AIDSLINE MED/89114063
Vadasz F; Huber T
[AIDS--considered from a different viewpoint]
Schweiz Rundsch Med Prax. 1988 Dec 27;77(52):1440-1. Unique Identifier : AIDSLINE MED/89114073
Are gloves really necessary?
R I Dent J. 1988 Summer;21(2):5-7, 9. Unique Identifier : AIDSLINE MED/89114140
Neiburger EJ
[Platelet-associated immunoglobulin G (PAIgG) and circulating immune complexes in asymptomatic and symptomatic HIV-seropositive patients]
Schweiz Med Wochenschr. 1988 Dec 10;118(49):1847-50. Unique Identifier : AIDSLINE MED/89114340
Lauper M; Castelli D; Buchs J; Pichler W; Nydegger U; Hamatologisches Zentrallabor, Universitat Bern.
Circulating immune complexes and platelet associated immunoglobulins G (PAIgG) were measured in 14 clinically asymptomatic and 9 diseased HIV infected subjects and compared to their platelet counts in the peripheral blood. In both groups, circulating immune complexes were found to be increased even in the presence of


A review of peripheral tuberculous arthritis.
Semin Arthritis Rheum. 1988 Nov;18(2):142-9. Unique Identifier : AIDSLINE MED/89114409
Garrido G; Gomez-Reino JJ; Fernandez-Dapica P; Palenque E; Prieto S; Rheumatology Unit, Hospital Primero de Octubre, Madrid, Spain.
There is a clear difference between TB infection and TB. Transition from the former to the latter involves host factors and perhaps environmental elements. Currently, more individuals with immunosuppressive situations caused by aging, debilitating diseases, immunosuppressive therapies, and HIV-III infection are predis


AIDS, OSHA and self determination.
Tex Dent J. 1988 Jul;105(7):3. Unique Identifier : AIDSLINE MED/89114634
Willingham DB
Periodontal disease and AIDS [news]
Wis Dent Assoc J. 1988 May;64(5):262. Unique Identifier : AIDSLINE MED/89114827
Infection control update.
Wis Dent Assoc J. 1988 Jun;64(6):295-6. Unique Identifier : AIDSLINE MED/89114828
Sampson E; Englander J; Jones R
Infection control update.
Wis Dent Assoc J. 1988 Aug;64(8):419-20. Unique Identifier : AIDSLINE MED/89114833
Sampson E; Englander J; Jones R
'Sequential' ELISA for anti-HIV should not replace the standard competitive method.
Vox Sang. 1988;55(4):244-5. Unique Identifier : AIDSLINE MED/89115178
Challis P; Dow BC; Mitchell R; Barr A; Barbara JA; North London Blood Transfusion Centre, Edgware, Middlesex, UK.
Western blot testing among Zimbabwean HIV patients [letter]
Vox Sang. 1988;55(4):247-8. Unique Identifier : AIDSLINE MED/89115180
Emmanuel JC; Smith HJ; Paterson LE
[What is the National Social Welfare Board for? A colossus with a vague role (interview by Monika Trozell)]
Vardfacket. 1988 Sep 22;12(17):14-6. Unique Identifier : AIDSLINE MED/89115421
Holmstrom U
[Dry facts and naked personal things]
Vardfacket. 1988 Sep 22;12(17):21. Unique Identifier : AIDSLINE MED/89115424
Trozell M
[Evaluation of the effectiveness of informing the population about AIDS by means of a telephone questionnaire]
Zh Mikrobiol Epidemiol Immunobiol. 1988 Oct;(10):20-2. Unique Identifier : AIDSLINE MED/89115647
Pokrovskii VV; Akimov AI
The questioning of the population of Moscow, carried out over the telephone, revealed that the information campaign conducted in 1987 was partially effective.


Distribution of group-specific component subtypes in multiple sclerosis.
Acta Neurol Scand. 1988 Nov;78(5):443-4. Unique Identifier : AIDSLINE MED/89115761
Lindblom B; Wetterling G; Link H; State Institute for Blood Group Serology, Linkoping University; Hospital, Sweden.
Genetic subtypes of group-specific component (Gc), a protein possibly influencing susceptibility to human immunodeficiency virus infection, were assessed by isoelectric focusing of plasma from 88 patients with multiple sclerosis (MS) and related to frequencies among 3394 control individuals subjected to paternity stud


Histo- and immunopathological features of terminal AIDS. An autopsy case of a Japanese man with neurological signs as initial symptoms.
Acta Pathol Jpn. 1988 Oct;38(10):1313-27. Unique Identifier : AIDSLINE MED/89115858
Miyayama H; Takeya M; Takahashi K; Koito A; Hattori T; Takatsuki K; Second Department of Pathology, Kumamoto University Medical; School, Japan.
An autopsy case of a 37-year-old Japanese man, confirmed as an AIDS patient infected by an undetermined route of transmission, is presented. The initial symptoms of full-blown AIDS in this case were neurological, and the patient died of severe pneumonia 9 months after onset. The main histo- and immunopathological feat


Angiocentric and angiodestructive infiltration of adult T-cell leukemia/lymphoma (ATLL) in the skin. Report of two cases.
Am J Dermatopathol. 1988 Dec;10(6):487-96. Unique Identifier : AIDSLINE MED/89116455
Manabe T; Hirokawa M; Sugihara K; Sugihara T; Kohda M; Department of Pathology, Kawasaki Medical School, Kurashiki,; Japan.
This report describes the clinical and pathological features of cutaneous lesions observed in a 73-year-old woman with terminal adult T-cell leukemia/lymphoma (ATLL) and a 42-year-old man who had chronic ATLL with persistent nasal stuffiness and rhinorrhea of 2 years duration. Histology of the skin lesions from these


Assessing medical student interviews of HIV patients: a randomized trial of a simple intervention.
Proc Annu Conf Res Med Educ. 1988;27:216-20. Unique Identifier : AIDSLINE MED/89116866
Vincent DS; Cooper GS; Harvey J; Noel GL; Department of Medicine, Walter Reed Army Medical Center,; Washington, DC 20307.
A simple intervention to teach second year medical students how to interview HIV patients was assessed using an Objective Structured Clinical Examination. The results showed that students omitted a broad range of content issues relating to the social support system of healthy HIV patients.


An assessment of entering freshman medical students' knowledge of and attitudes toward AIDS.
Proc Annu Conf Res Med Educ. 1988;27:221-5. Unique Identifier : AIDSLINE MED/89116867
Barkley SE; Mason JL; Kappelman MM; Office of Medical Education, University of Maryland, School of; Medicine, Baltimore 21201.
The purpose of this survey was to determine entering freshman medical student awareness of and attitudes toward AIDS. It is encouraging to find that, in general, students are well informed about AIDS before entering medical school; they have very real concerns about the possibility of contracting AIDS themselves as fu


AIDS perspectives: Thailand 1989.
Asian Pac J Allergy Immunol. 1988 Dec;6(2):67-9. Unique Identifier : AIDSLINE MED/89117706
Phanuphak P; Department of Medicine, Chulalongkorn University, Bangkok,; Thailand.
Pediatric AIDS--prepare now for the future [news]
Bol Asoc Med P R. 1988 Nov;80(11):439. Unique Identifier : AIDSLINE MED/89117719
Genital ulcers important HIV risk factor in gay men [news]
Bol Asoc Med P R. 1988 Nov;80(11):444. Unique Identifier : AIDSLINE MED/89117723
Evolution of the structural proteins of human immunodeficiency virus: selective constraints on nucleotide substitution.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):399-407. Unique Identifier : AIDSLINE MED/89118009
Brown AL; Monaghan P; Department of Genetics, University of Edinburgh, UK.
We have estimated the frequency of synonymous (KS) and amino acid replacement nucleotide substitutions (KA) among gag and env genes of published HIV sequences. The ratio of KS to KA can be used as an indicator of the intensity of the selective constraints on the amino acid sequence of a protein. By this approach we ha


Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):457-66. Unique Identifier : AIDSLINE MED/89118015
Hartmann H; Vogt MW; Durno AG; Hirsch MS; Hunsmann G; Eckstein F; Deutsches Primatenzentrum GmbH, Abt. Virologie und Immunologie,; Gottingen, FRG.
Nucleoside analogs were synthesized and tested for anti-HIV-1 activity in two in vitro test systems using MT-4 cells and peripheral blood lymphocytes. Cytotoxicity was assessed in both assays and additionally in several human lymphoblastoid cell lines. One analog, 3 -fluoro-3 -deoxythymidine, exhibited higher antivira


HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):475-85. Unique Identifier : AIDSLINE MED/89118017
Dalgleish A; Richardson J; Matutes E; Cruickshank K; Newell A; Sinclair A; Thorpe R; Brasher M; Weber J; Catovsky D; et al; MRC Clinical Research Centre, Harrow.
All 17 patients with tropical spastic paraparesis (TSP) in a series seen in the United Kingdom have antibodies to the human T cell leukemia virus type 1 (HTLV-1). Cultured peripheral blood lymphocytes from these patients formed multinucleated giant cells and reacted with sera and monoc


Absence of infection with human immunodeficiency virus in Peruvian prostitutes.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):493-9. Unique Identifier : AIDSLINE MED/89118019
Golenbock DT; Guerra J; Pfister J; Golubjatnikov R; Tejada A; Abugattas J; Kemper R; Maki DG; Department of Medicine, University of Wisconsin School of; Medicine, Madison.
We serologically tested 140 female prostitutes (mean age, 30 years) from the port city of Callao, Peru , for evidence of infection with human immunodeficiency virus (HIV), Chlamydia trachomatis, Treponema pallidum, herpes simplex vir


B cell all in an anti-HIV positive patient: achievement of a complete response with aggressive chemotherapy.
Br J Haematol. 1988 Dec;70(4):501-2. Unique Identifier : AIDSLINE MED/89118161
Milpied N; Bourhis JH; Garand R; Harousseau JL; Department of Clinical Haematology, C.H.U. Nantes, France.
HIV spread in the San Francisco cohort: scaling of the effective logistic rate for seropositivity.
Bull Math Biol. 1988;50(4):345-9. Unique Identifier : AIDSLINE MED/89118671
Rosen G
Surgical glove perforation.
Br J Surg. 1988 Oct;75(10):966-8. Unique Identifier : AIDSLINE MED/89118902
Dodds RD; Guy PJ; Peacock AM; Duffy SR; Barker SG; Thomas MH; Department of Surgery, St. Peter's Hospital, Chertsey, Surrey.
In a study to investigate the incidence and significance of surgical glove perforation, bacterial contamination of surgeons hands and gloves before and after operation was measured and the gloves tested for damage. Perforations were found in 74 of 582 gloves (12.7 per cent) and occurred in 34.5 per cent of operations


Natural killer activity from normal peripheral blood lymphocytes against a human T lymphotropic retrovirus type III (HTLV-III)-infected cell line.
Diagn Clin Immunol. 1988;5(6):297-303. Unique Identifier : AIDSLINE MED/89119709
Sirianni MC; De Sanctis G; Macchi B; Soddu S; Ensoli F; Aiuti F; Fontana L; Department of Allergy and Clinical Immunology, University of; Rome, La Sapienza, Italy.
An H9-HTLV-III-infected cell line was used as a target in a short-term (3-hr) Cr release assay to assess its sensitivity to lysis by peripheral blood lymphocytes (PBL) from normal donors. The single cell cytotoxicity assay (SCCA) on poly-L-lysine-coated coverslips was used to investigate further the mechanism of bindi


Immunoresponsiveness in hemophilia: lymphocyte- and phagocyte-mediated functions.
Diagn Clin Immunol. 1988;5(6):318-25. Unique Identifier : AIDSLINE MED/89119713
Antonaci S; Jirillo E; Stasi D; De Mitrio V; La Via MF; Bonomo L; Medicina Clinica, University of Bari Medical School, Bari, Italy.
Several deficits of immune response have been reported in hemophiliacs. In order to evaluate the overall immune function in this disease, we have investigated peripheral blood mononuclear cells (PBMC) surface phenotype, lymphokine production, B cell responsiveness, monocyte- and polymorphonuclear (PMN) cell-mediated r


Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco.
Diagn Clin Immunol. 1988;5(6):381-7. Unique Identifier : AIDSLINE MED/89119724
Krowka JF; Stites DP; Moss AR; Casavant CH; Carlson JR; Chermann JC; Barre-Sinoussi F; Rodgers RP; Bacchetti P; McHugh TM; et al; Department of Laboratory Medicine, University of California, San; Francisco 94143.
Serum and leukocytes from a cohort of homosexual males were analyzed to determine the interrelationships of antibodies to human immunodeficiency virus (HIV), serum HIV antigen levels, and phenotypical differences in lymphocyte subpopulations of HIV antibody-positive (HIV Ab+) and HIV antibody-negative (HIV Ab-) homose


Public and health staff knowledge about AIDS.
Community Med. 1988 Aug;10(3):221-7. Unique Identifier : AIDSLINE MED/89119996
Smithson RD
New laws and their importance to disease prevention.
Del Med J. 1988 Dec;60(12):721-3. Unique Identifier : AIDSLINE MED/89121171
Silverman PR; Wolfe DE
Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection.
Gene. 1988 Sep 7;68(2):213-9. Unique Identifier : AIDSLINE MED/89121503
Artelt P; Morelle C; Ausmeier M; Fitzek M; Hauser H; Cell Biology and Genetics Section, GBF-Gesellschaft fur; Biotechnologische Forschung mbH., Braunschweig, (F.R.G.).
We have constructed two related types of multi-cloning mammalian expression vectors. The first, pMPSVEH/HE, carries the promoter of the myeloproliferative sarcoma virus (MPSV). This promoter was found to be stronger than both the SV40 early and the trans-activated human immunodeficiency virus promoters in many cell li


Persistent diarrhoea in Zairian AIDS patients: an endoscopic and histological study.
Gut. 1988 Dec;29(12):1687-91. Unique Identifier : AIDSLINE MED/89121605
Colebunders R; Lusakumuni K; Nelson AM; Gigase P; Lebughe I; van Marck E; Kapita B; Francis H; Salaun JJ; Quinn TC; et al; Projet SIDA, Department of Public Health, Kinshasa, Zaire.
To determine the aetiology of persistent diarrhoea in African patients with acquired immunodeficiency syndrome (AIDS), 42 patients with human immunodeficiency virus (HIV) and persistent diarrhoea were enrolled in a microbiological, endoscopic, and histological study. Cryptosporidium was the intestinal parasite most of


[AIDS of the eye--a retrospective analysis of 70 HIV-infected patients]
Fortschr Ophthalmol. 1988;85(4):420-6. Unique Identifier : AIDSLINE MED/89121701
Fabricius EM; Jager H; Prantl F; Hogel B; Greite JH
[Sexually transmitted diseases/AIDS. Few foreign travelers are HIV positive (news)]
Fortschr Med. 1988 Jul 20;106(21):13-4. Unique Identifier : AIDSLINE MED/89121750
[Autologous blood donation--the solution to many problems? Fear of AIDS--preservation of autologous blood is now implemented commercially]
Fortschr Med. 1988 Jul 30;106(22):20. Unique Identifier : AIDSLINE MED/89121758
Hartung HD
[AIDS. High probability of the disease for HIV-infected patients? (news)]
Fortschr Med. 1988 Aug 10;106(23):14. Unique Identifier : AIDSLINE MED/89121764
[No insurance protection in AIDS. Legal cases in insurance: AIDS, organ damage (news)]
Fortschr Med. 1988 Aug 10;106(23):18. Unique Identifier : AIDSLINE MED/89121766
Bopp A
[National Institute. USA promotes AIDS research with a new Institute (news)]
Fortschr Med. 1988 Aug 20;106(24):13. Unique Identifier : AIDSLINE MED/89121772
Popular health.
Hygie. 1988;7(4):18-21. Unique Identifier : AIDSLINE MED/89122042
Crawley D
The education-knowledge road to Health for All--strategy for the 1990's.
Hygie. 1988;7(4):26-31. Unique Identifier : AIDSLINE MED/89122044
Grant JP; United Nations Children's Fund (UNICEF), New York, NY 10017.
Priorities for the work of the International Union for Health Education.
Hygie. 1988;7(4):32-4. Unique Identifier : AIDSLINE MED/89122045
Tolsma DD; Public Health Practice, Centers for Disease Control, Atlanta, Ga; 30333.
IVth International Conference on AIDS.
Hastings Cent Rep. 1988 Aug-Sep;18(4):suppl 14. Unique Identifier : AIDSLINE MED/89122572
Nolan K; Hastings Center.
What is the difference between an HIV and a CBC?
Hastings Cent Rep. 1988 Aug-Sep;18(4):18-20. Unique Identifier : AIDSLINE MED/89122584
Howell JD; Cohen C; Residential College, University of Michigan, Ann Arbor.
AIDS, judges, and the right to medical care [see comments]
Hastings Cent Rep. 1988 Aug-Sep;18(4):20-2. Unique Identifier : AIDSLINE MED/89122585
Annas GJ; Boston University School of Public Health.
[Skin manifestations of syphilis maligna in HIV infection. Clinical observations in 3 cases]
Hautarzt. 1988 Jul;39(7):463-6. Unique Identifier : AIDSLINE MED/89122610
Schroter R; Nher H; Petzoldt D; Universitats-Hautklinik Heidelberg.
Three cases of acquired immune deficiency with unusual dermatological symptoms of early syphilis are reported. All three patients were promiscuous homosexual men with confirmed HIV infections and signs of an impaired immune status. One patient was apparently healthy, one had the AIDS-related complex and one was suspec


[Preservation of the sperm of HIV positive patients (letter)]
Hautarzt. 1988 Jul;39(7):480. Unique Identifier : AIDSLINE MED/89122614
Parsch EM; Parsch L
[Acute primary stage of HIV infection and progression to AIDS with Kaposi sarcoma 24 months later]
Hautarzt. 1988 Aug;39(8):514-8. Unique Identifier : AIDSLINE MED/89122620
Bratzke B; Orfanos CE; Universitats-Hautklinik, Klinikum Steglitz, Freien Universitat; Berlin.
The case is reported of a 31-year-old homosexual male who developed distinct maculopapular and papulovesicular exanthema with aphthous-like, painful lesions of the oral mucosa, together with marked general symptoms (fever, diarrhoea, lymphadenopathy). This clinical picture suggested the primary acute phase of an initi


Histiocytic diseases of bone marrow.
Hematol Oncol Clin North Am. 1988 Dec;2(4):657-67. Unique Identifier : AIDSLINE MED/89122935
Lee RE; University of Pittsburgh School of Medicine, Pennsylvania.
The disease most likely to be associated with large numbers of bone marrow storage histiocytes is Gaucher s disease. In our community of western Pennsylvania, eastern Ohio, and West Virginia, we have encountered 30 patients with Gaucher s disease during the past 25 years. During the same 25 years, a group of about 20


Plasmapheresis in the treatment of acute relapsing inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection: a case report.
J Clin Apheresis. 1988;4(4):149-51. Unique Identifier : AIDSLINE MED/89123193
Wuest D; Goldfinger D; Taft B. Schreiber Blood Bank, Cedars-Sinai Medical Center, Los; Angeles, CA 90048.
Neurologic complications, including both the acute and chronic forms of inflammatory demyelinating polyradiculoneuropathy (IDP) are becoming more prevalent among patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related-complex (ARC). Although the etiology of the above radiculoneuropathies is not kn


Acid hydrolysis of serum samples to increase detection of HIV antigen.
J Virol Methods. 1988 Dec;22(2-3):143-8. Unique Identifier : AIDSLINE MED/89123712
Mathiesen T; Sundqvist VA; Albert J; Ohlsson E; Wahren B; Department of Virology, National Bacteriological Laboratory,; Stockholm, Sweden.
Sera from 32 HIV-infected patients and 20 controls were assayed for HIV antigen (HIV-Ag) and antibodies following acid hydrolysis. Acid hydrolysis, followed by neutralization immediately prior to the assay, was found to be a simple means to solubilize immune complexes and allowed recovery of 40-50% of complexed antige


Grant for AIDS research [news]
J Adv Nurs. 1988 Jul;13(4):525-6. Unique Identifier : AIDSLINE MED/89124115
Sexual partner selectiveness effects on homosexual HIV transmission dynamics.
J Acquir Immune Defic Syndr. 1988;1(5):486-504. Unique Identifier : AIDSLINE MED/89125354
Koopman J; Simon C; Jacquez J; Joseph J; Sattenspiel L; Park T; Department of Epidemiology, University of Michigan, Ann Arbor.
Deterministic simulation models are used to show that HIV transmission dynamics in homosexual populations can be strongly affected by sexual partner selectiveness. The type of selectiveness or biased mixing examined is where individuals with similar new partnership formation rates are more likely to form a pair than w


Lack of transmission of HIV through human bites and scratches.
J Acquir Immune Defic Syndr. 1988;1(5):505-7. Unique Identifier : AIDSLINE MED/89125355
Tsoukas CM; Hadjis T; Shuster J; Theberge L; Feorino P; O'Shaughnessy M; Division of Clinical Immunology, Montreal General Hospital,; Canada.
To examine the relative risk of transmission of the human immuno-deficiency virus (HIV) through bites and scratches, we studied 198 health care workers, 30 of whom were traumatized in this fashion while caring for an aggressive AIDS patient. This violent patient frequently bit or scratched others, his mouth had blood


The natural history of human immunodeficiency virus infection in screened HIV positive U.S. Air Force personnel: a preliminary report.
J Acquir Immune Defic Syndr. 1988;1(5):508-15. Unique Identifier : AIDSLINE MED/89125356
Reid MJ; Goetz DW; Zajac RA; Houk RW; Boswell RN; Department of Medicine, Wilford Hall USAF Medical Center,; Lackland AFB, San Antonio, TX 78236.
We prospectively studied 157 HIV antibody-positive U.S. Air Force personnel identified by universal ELISA screening and confirmed by Western blot. They were initially evaluated and then re-evaluated at least once at approximately 1 year intervals. In order to determine which if any demographic and serologic cofactors


[A clinical analysis of 54 patients with adult T-cell leukemia-lymphoma (ATL)]
Nippon Hifuka Gakkai Zasshi. 1988 Sep;98(10):997-1014. Unique Identifier : AIDSLINE MED/89126051
Kuroki Y; Tada S; Tajiri A; Inoue S
The challenge of AIDS.
J S C Med Assoc. 1988 Dec;84(12):588-90. Unique Identifier : AIDSLINE MED/89126386
Gash JR
[Acquired immunodeficiency syndrome (AIDS) in tropical regions: African foci (editorial)]
Med Trop (Mars). 1988 Oct-Dec;48(4):325-6. Unique Identifier : AIDSLINE MED/89126886
Aubry P
[Clinical manifestations of infection with (HIV) human immunodeficiency virus in Africans. Comparison of cases observed in Africa and Europe]
Med Trop (Mars). 1988 Oct-Dec;48(4):327-35. Unique Identifier : AIDSLINE MED/89126887
Coulaud JP; Institut de Medecine et d'Epidemiologie Tropicales, Hopital; Claude Bernard, Paris.
The AIDS case definition of Bangui WHO workshop is more convenient for Africa and increases the number of cases reported to WHO. Natural history of HIV infection is the same in Africa as in the developed countries of western world. The clinical pattern of African Aids is mainly the result of opportunistic infections a


[Human immunodeficiency virus infections (HIV-1 and HIV-2) in Dakar. Epidemiologic and clinical aspects]
Med Trop (Mars). 1988 Oct-Dec;48(4):337-44. Unique Identifier : AIDSLINE MED/89126888
Barabe P; Digoutte JP; Tristan JF; Peghini M; Griffet P; Jean P; Seignot P; Sarthou JL; Leguenno B; Berlioz C; et al; Medecin Chef des Services Medicaux, Hopital Principal de; Dakar.
The authors report on the results of an investigation carried out on 109 HIV seropositives ascertained by the Dakar Central Hospital between February 20, 1987 and May 31, 1988. These seropositives affected 44 patients with AIDS (0.78% of admitted patients) and 65 seropositive people of which 43 blood donors (1.35% of


[Human immunodeficiency virus (HIV) infection in Mali]
Med Trop (Mars). 1988 Oct-Dec;48(4):345-9. Unique Identifier : AIDSLINE MED/89126889
Pichard E; Guindo A; Grossetete G; Fofana Y; Maiga YI; Koumare B; Traore S; Maiga M; Brun-Vezinet F; Rosenheim M; Medecine Interne C.D. Hopital National du Point G, Bamako,; Mali.
This review summarises epidemiological and clinical data of HIV infection who was recognized in Mali since 1985. The most important rate of seropositivity for HIV is observed in the prostitutes group (40%). The estimated seroprevalence for adult population is between 1% and 5%. 46 ca


[Clinical aspects of human immunodeficiency virus (HIV) infection in Central Africa: 6 years' experience at a hospital in an endemic area]
Med Trop (Mars). 1988 Oct-Dec;48(4):351-7. Unique Identifier : AIDSLINE MED/89126890
Lesbordes JL; Medecin des Hopitaux des Armees, Service de Medecine Interne; et Cardiologie, Centre Hospitalier des Armees Hippolyte Larrey,; Toulouse, France.
In Bangui ( Central African Republic ), where seroprevalence of HIV is 11% in the adult population, AIDS presents some clinical aspects different from the ones known in the west; the clinical experience reported in this paper is based on 504 cases infested by HIV grou


[Principle aspects of acquired immunodeficiency syndrome (AIDS) in adults in Burundi]
Med Trop (Mars). 1988 Oct-Dec;48(4):359-66. Unique Identifier : AIDSLINE MED/89126891
Laroche R; Floch JJ; Ndabaneze; Kadende P; Kamanfu G; Service de Sante des Armees, Centre Hospitalier de Kamenge,; Bujumbura, Burundi.
The authors describe their experience of the infection by the virus of the human immunodeficiency HIV-1 in Burundi . The acquired immunodeficiency syndrome was brought to light in 1983 by the emergence of cryptococcal meningitis, Kaposi s sarcomas, disseminated candidiasis. 109 cas


[Clinical and developmental aspects of acquired immunodeficiency syndrome in the Congo (the experience of the medical service of the Hopital Central des Armees Pierre Mobengo - Brazzaville)]
Med Trop (Mars). 1988 Oct-Dec;48(4):367-72. Unique Identifier : AIDSLINE MED/89126892
Beuzit Y; Mayoulou-Niamba JB; Loemba H; Makuwa M; Service de Medecine, Hopital Central des Armees Pierre; Mobengo, Brazzaville, R.P.C.
During a period of 20 months, 204 cases of AIDS were diagnosed among adults in the Medicine Department of the Pierre Mobengo Armed Forces Central Hospital, Brazzaville. The authors review the clinical and evolutive aspects in admitted patients during these period of time, taking into consideration the problems of diag


[Acquired immunodeficiency syndrome (AIDS) in Gabon. Apropos of 23 cases at the internal medicine service of the hospital centers in Libreville and Franceville, 1985-1987]
Med Trop (Mars). 1988 Oct-Dec;48(4):373-4. Unique Identifier : AIDSLINE MED/89126893
Klotz F; Boguikouma JB; Delaporte E; Peteers M; Ndong JB; Delmarre B; Nguemby Mbina C; Medecin des Hopitaux des Armees, Centre; Hospitalo-Universitaire de Libreville.
In 1986 prevalence rates of anti-HIV1 antibodies in randomly selected asymptomatic gabonese population ranged from 0.2% in rural areas to, 1.8% in Libreville (the largest town). We report the first description of AIDS cases observed in the hospitals of Libreville and Franceville between 1985 and 1987. 23 patients (14


[Epidemiologic surveillance of the acquired immunodeficiency syndrome in 6 states of Central Africa]
Med Trop (Mars). 1988 Oct-Dec;48(4):381-9. Unique Identifier : AIDSLINE MED/89126895
Merlin M; Josse R; Trebucq A; Mouanda V; Kouka-Bemba D; Service de sante des Armees, OCEAC, Younde.
Since 1985, OCEAC, the organization for control of widespread endemic disease in Central Africa, has managed an epidemiological surveillance programme concerning HIV infection and AIDS in six countries of the Sub-Region: Cameroon , Tchad,


[Prevalence of carriers of antibodies against human immunodeficiency virus (HIV-1 and HIV-2) in South Cameroon. Results of attempts to isolate retroviruses]
Med Trop (Mars). 1988 Oct-Dec;48(4):391-5. Unique Identifier : AIDSLINE MED/89126896
Durand JP; Musi S; Josse R; Trebucq A; Gelas H; Garrigue G; Institut Pasteur, Dakar.
In this work are summarized the results of the serological investigations about HIV1 and HIV2 done since 1986 in the Republic of Cameroon , using the Henderson s cluster sampling method (2). With regard to neighbour countries results, the prevalence of specific antibodies against


[Evaluation of the work conducted by the Madagascar Pasteur Institute in the study of human immunodeficiency virus (HIV) seropositivity in that country]
Med Trop (Mars). 1988 Oct-Dec;48(4):397-9. Unique Identifier : AIDSLINE MED/89126897
Genin C; Coulanges P; Rasamindrakotroka A; Laboratoire de Biologie Medicale, l'Institut Pasteur de; Madagascar.
Since late 1985, the Institut Pasteur de Madagascar has studied the problem of the distribution of HIV in the island. With the approval and cooperation of the Malagasy Ministry of Health, a number of different surveys have been undertaken, particularly of those sections of the


[Tuberculosis and human immunodeficiency virus infection in the Central African Republic]
Med Trop (Mars). 1988 Oct-Dec;48(4):401-7. Unique Identifier : AIDSLINE MED/89126898
Cathebras P; Vohito JA; Yete ML; Lagarde R; Vohito MD; Ramiara JP; Mbolidi CD; Nama J; Ngbali J; Siopathis MR; et al; Hopitaux (Medecine Interne). Centre de Formation et de; Recherches en Medecine et Sante Tropicales, Hopital; Houphouet-Boigny, Marseille.
In order to determine the proportion of tuberculosis (TB) patients in Bangui ( Central African Republic ) infected with human immunodeficiency virus (HIV), we collected prospectively serum samples from all new TB patients seen at the University Hospital in Bangui duri


[Zona in human immunodeficiency virus (HIV-1) infection in Bangui (Central Africa)]
Med Trop (Mars). 1988 Oct-Dec;48(4):409-11. Unique Identifier : AIDSLINE MED/89126899
Lesbordes JL; Coulaud X; Medecin des Hopitaux des Armees, Toulouse, France.
In Bangui ( Central African Republic ) where HIV1 prevalence was 7.8% in 1987, 61 cases of herpes zoster have been studied: 17 during AIDS and 44 isolated cases. During AIDS, herpes zoster has no prognosis value. When it seems to be isolated, herpes zoster is closely


[Immunization against the human immunodeficiency virus in Zaire]
Med Trop (Mars). 1988 Oct-Dec;48(4):417-23. Unique Identifier : AIDSLINE MED/89126901
Zagury D; Salaun JJ; Bernard J; Dechazal L; Goussard B; Lurhuma Z; l'Institut P. et M. Curie, Universite de Jussieu, Paris, France.
The first experimental immunization of human against the AIDS retrovirus HIV-1 was started in a series of HIV seronegative healthy volunteers in november 1986. Priming used a vaccinia virus recombinant (V25) expressing Gp 160 env determinants of HTLV III B at the surface of infected cells. This priming which induced a


[The AIDS patient with miliary tuberculosis, toxoplasmosis and herpes infection]
Med Klin. 1988 Aug 12;83(16):528-31. Unique Identifier : AIDSLINE MED/89126982
Zaiss AW; Neumann H; Friedburg HA; Senn HJ; Ruhle KH; Matthys H
Look-back: transfusion-acquired HIV infection at Duke University Medical Center.
N C Med J. 1988 Dec;49(12):657-61. Unique Identifier : AIDSLINE MED/89127539
Allen PJ; Koepke JA
AIDS and employment.
Occup Health (Lond). 1988 Nov;40(11):711-2. Unique Identifier : AIDSLINE MED/89128064
Teasdale E
AIDS and Ohio--the statistics.
Ohio Med. 1988 Dec;84(12):935. Unique Identifier : AIDSLINE MED/89128110
The moral myths of opium, AIDS, and MAACs [letter]
Ophthalmic Surg. 1988 Nov;19(11):825-6. Unique Identifier : AIDSLINE MED/89128167
MacKool RJ
A proposed scale to measure beliefs about the consequences of employing homosexuals.
Psychol Rep. 1988 Oct;63(2):547-51. Unique Identifier : AIDSLINE MED/89129228
O'Brien FP; Vest MJ
Posttraumatic stress syndrome-like symptoms among AIDS caregivers.
Psychol Rep. 1988 Oct;63(2):656-8. Unique Identifier : AIDSLINE MED/89129235
Trice AD
AIDS phobia: report of 4 cases.
Psychopathology. 1988;21(1):26-30. Unique Identifier : AIDSLINE MED/89129266
Ross MW; AIDS Programme, South Australian Health Commission, Adelaide.
Psychological reactions to sexually transmissible disease (STD) infection are common, occurring in up to 85% of some patients with STDs: Hart has suggested that they are among the most common conditions encountered in venereology. Previous psychiatric disturbances in STD patients, however, are relatively uncommon and


[AIDS dementia (editorial)]
Rev Prat. 1988 Sep 22;38(20):1384-5. Unique Identifier : AIDSLINE MED/89129977
Brunet P
Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient.
Scand J Infect Dis. 1988;20(5):561-3. Unique Identifier : AIDSLINE MED/89130044
Westblom TU; Belshe RB; Marshall University School of Medicine, Department of Medicine,; Huntington, West Virginia 25755-9410.
A 47-year-old patient with AIDS and cerebral toxoplasmosis was treated with sulfadiazine pyrimethamine for 5 days. After developing a severe rash his regimen was changed to clindamycin 600 mg q 6 h intravenously and pyrimethamine 25 mg daily, given for 37 days. This resulted in improvement of clinical symptoms and com


[AIDS information]
Z Gesamte Hyg. 1988 Nov;34(11):671. Unique Identifier : AIDSLINE MED/89131110
[Kaposi sarcoma of the gastrointestinal tract in AIDS. Morphologic findings and differential diagnostic aspects]
Z Gastroenterol. 1988 Jul;26(7):351-7. Unique Identifier : AIDSLINE MED/89131112
Prantl F; Institut fur Pathologie, Akademisches Lehrkrankenhaus der; Universitat Munchen.
At autopsies of 20 patients with AIDS, 7 cases with gastrointestinal involvement by Kaposi s sarcoma were observed. The lesions were found in nearly all parts of the digestive canal; although we observed a certain accumulation in the upper gastrointestinal tract. Macroscopically the spectrum of appearances extended fr


[Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study]
Z Gastroenterol. 1988 Jul;26(7):380-7. Unique Identifier : AIDSLINE MED/89131116
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Buschenfelde KH; I. Medizinische Klinik, Johannes-Gutenberg-Universitat Mainz.
The HBsAg carrier state may present as chronic active hepatitis which may proceed to cirrhosis of the liver and to primary liver cell carcinoma. The large scale production of interferons made these substances available for long-term treatment. A deficiency in interferon production in chronic type B hepatitis presented


[AIDS: epidemiology and prevention (editorial)]
Soz Praventivmed. 1988;33(7):317. Unique Identifier : AIDSLINE MED/89131271
Somaini B
[The prevention of AIDS among young people]
Soz Praventivmed. 1988;33(7):319-25. Unique Identifier : AIDSLINE MED/89131272
Michaud PA; Stutz T; Samuel M; Service de la sante publique et de la planification sanitaire,; Lausanne.
In the first section of the article, the authors consider the epidemiological data available in Switzerland mid-june 1988, concerning persons between 15 to 24, either already suffering from AIDS or HIV-positive. These data are compared with those from Europe and the


[AIDS epidemiology and prevention in i.v. drug addicts]
Soz Praventivmed. 1988;33(7):326-30. Unique Identifier : AIDSLINE MED/89131273
Uchtenhagen A; Psychiatrischen Universitatsklinik, Zurich.
The incidence of AIDS cases in intravenous drug abusers is growing faster than in other risk groups, in Switzerland as well as in Europe in general. By end of May 1988, 27% of all AIDS cases registered nationally were injecting drugs. The prevalence of HIV antibodies is known


Selected aspects of AIDS among homosexual men.
Soz Praventivmed. 1988;33(7):331-5. Unique Identifier : AIDSLINE MED/89131274
Samuel MC; Engel RR; Swiss Federal Office of Public Health, Bern.
This report is a brief summary of important points concerning AIDS and homosexual men. We present the current overall figures of the cumulative AIDS incidence for Switzerland , the United States and the world and similar figures for homosexual m


[Epidemiology and prevention of AIDS in the population]
Soz Praventivmed. 1988;33(7):340-4. Unique Identifier : AIDSLINE MED/89131276
Somaini B; Billo N; Dubois JA; Staub R
Routes of transmission of HIV which play an important role in the population are known. Sexual transmission, infection through needle sharing by i.v. drug addicts, accidental blood contacts and transmission from the infected pregnant mother to her child are seen. The number of new infections depends on the number of a


[Ethical aspects of AIDS information and prevention]
Soz Praventivmed. 1988;33(7):345-7. Unique Identifier : AIDSLINE MED/89131277
Bondolfi A; Institut fur Sozialethik der Universitat Zurich.
Ethical implications are inherent to any information policy in conjunction with AIDS. It is difficult, in this context, to differentiate clearly between bio-medical recommendations and suggestions directly oriented to sexual behaviour. In the strict context of prevention policy, the author attempts to demonstrate how


[Continuous evaluation of the general effect of the campaign against AIDS in Switzerland]
Soz Praventivmed. 1988;33(7):348-52. Unique Identifier : AIDSLINE MED/89131278
Lehmann P; Hausser D; Dubois-Arber F; Gutzwiller F; Institut universitaire de medecine sociale et preventive,; Lausanne.
Since 1985 the Swiss Federal Office of Public Health and the Swiss AIDS Foundation are promoting AIDS prevention campaigns. A multimedia information campaign with the main slogan STOP-AIDS began in Feb. 1987 and is still under way. Multiplying effects are stimulated. An evaluation program is following continuously the


[I protect others' and my life. Adolescents and their adaptation to the dangers of AIDS. A survey of trade school students]
Soz Praventivmed. 1988;33(7):353-8. Unique Identifier : AIDSLINE MED/89131279
Schroder I; Mathey MC; Arbeitsgemeinschaft fur Sozialforschung, Zurich.
170 trade school students (main inquiry 142) between 18 and 21 in eight cantons were questioned via group discussions and questionnaire on their attitude to the STOP AIDS campaign, to the messages put across by the campaign and to the use of condoms. About half the trade school students recognise the personal appeal.


Circulating antigen of Toxoplasma gondii in patients with AIDS: significance of detection and structural properties.
Zentralbl Bakteriol Mikrobiol Hyg [A]. 1988 Nov;270(1-2):302-9. Unique Identifier : AIDSLINE MED/89131357
Hassl A; Aspock H; Flamm H; Abteilung fur Medizinische Parasitologie, Universitat Wien.
232 sera and 40 cerebrospinal fluid samples of altogether 125 patients in stages III or IV of a HIV-infection were tested for circulating antigen of Toxoplasma gondii by means of a three-layer enzyme-linked immunosorbent assay. Circulating antigen was detected in 32 sera of 20 patients (= 16% of all persons investigat


[Kaposi's disease in AIDS]
Ann Med Interne (Paris). 1988;139(6):379-80. Unique Identifier : AIDSLINE MED/89133285
Gorin I; Deleuze J; Leibowitch M; Escande JP; Hopital Tarnier-Cochin, Service de Dermatologie, Paris.
[Treatment by external drainage of perirenal abscess in AIDS]
Ann Med Interne (Paris). 1988;139(6):403-4. Unique Identifier : AIDSLINE MED/89133289
Grateau G; Soffer M; Fritz P; Bonnin A; Sereni D; Cremer GA; Departement de Medecine Interne, Hopital Cochin, Paris.
Fever of undetermined origin in a young white heroin addict with a positive HIV (human immunodeficiency virus), serology was secondary to a staphylococcal perinephric abscess. Ultrasound examination and tomodensitometry allowed the diagnostic. Percutaneous drainage led to complete recovery. Interventional radiology as


Andrology, semen banks, and IVF centers: HIV/ARC/STD.
Arch Androl. 1988;21(2):75-119. Unique Identifier : AIDSLINE MED/89133611
Hafez ES; Arias E; Reproductive Health Center, Kiawah Island, South Carolina 29455.
Patterns of change in sexual behavior among gay men in New York City.
Arch Sex Behav. 1988 Dec;17(6):481-97. Unique Identifier : AIDSLINE MED/89133785
Siegel K; Bauman LJ; Christ GH; Krown S; Memorial Sloan-Kettering Cancer Center, New York, New York.
In the absence of a vaccine or effective treatment for AIDS, health education remains the most effective strategy for stemming the spread of the epidemic. Among homosexual and bisexual men, who continue to account for the majority of AIDS cases, sexual practices have been identified as the principal risk factor. Conse


Clinicopathological presentations of oral Kaposi's sarcoma in AIDS.
Aust Dent J. 1988 Oct;33(5):395-9. Unique Identifier : AIDSLINE MED/89133938
Barrett AP; Bilous AM; Buckley DJ; Kefford RF; Packham DR
AIDS [letter] [published erratum appears in S D J Med 1988 Aug;41(8):3]
S D J Med. 1988 Jul;41(7):25-6. Unique Identifier : AIDSLINE MED/89114397
Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome.
J Acquir Immune Defic Syndr. 1988;1(1):23-30. Unique Identifier : AIDSLINE MED/89110703
Kaplan LD; Hopewell PC; Jaffe H; Goodman PC; Bottles K; Volberding PA; Medical Service, San Francisco General Hospital Medical Center,; California.
To determine the distinguishing features of pulmonary Kaposi s sarcoma (KS) in patients with the acquired immunodeficiency syndrome (AIDS), we compared three groups of patients, 16 with endobronchial KS, 15 with endobronchial KS and an opportunistic lung infection, and 40 with Pneumocystis carinii pneumonia (PCP) with


HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNA.
J Acquir Immune Defic Syndr. 1988;1(2):131-7. Unique Identifier : AIDSLINE MED/89110714
Yuille MA; Hugunin M; John P; Peer L; Sacks LV; Poiesz BJ; Tomar RH; Silverstone AE; Department of Microbiology and Immunology, State University of; New York Health Science Center, Syracuse 13210.
In order to improve understanding of how HIV-1 infection down-modulates cell surface membrane expression of CD4, we have measured several parameters of CD4 expression in the human tumor T-cell lines CEM and MOLT-4 at different times after infection. Three independent HIV-1 isolates were used including one that encodes


Prospects for HIV vaccines.
J Acquir Immune Defic Syndr. 1988;1(3):295-303. Unique Identifier : AIDSLINE MED/89110731
Ada GL; Department of Immunology and Infectious Diseases, Johns Hopkins; School of Hygiene and Public Health, Baltimore, MD 21205.
This article initially discusses the types of responses elicited by infectious agents, such as viruses and the role of each response in preventing, limiting, and clearing the infection. An important response is the generation of immunological memory, in both the B and T cell compartments. Generally, attenuated viral v


Cell lines that express stably env gene products from three strains of HIV-1.
J Acquir Immune Defic Syndr. 1988;1(4):317-23. Unique Identifier : AIDSLINE MED/89110734
Terwilliger E; Proulx J; Sodroski J; Haseltine WA; Laboratory of Biochemical Pharmacology, Dana-Farber Cancer; Institute, Boston, Massachusetts.
The products of the env gene of HIV-1 play critical roles in determining the host range of the virus and it cytopathicity, as well as forming an important focus of an infected individual s immune response to the virus. We describe the isolation and characterization of separate HeLa cell lines expressing the env gene p


Improved HIV antiglycoprotein antibody detection by immunoblotting on a hydrophobic membrane.
J Acquir Immune Defic Syndr. 1988;1(4):333-9. Unique Identifier : AIDSLINE MED/89110737
Lauritzen E; Pluskal M; AIDS Laboratory, Statens Seruminstitut, Copenhagen, Denmark.
Immobilon-P Transfer Membrane (IM), a hydrophobic membrane, has been tested as a substrate for immunoblotting (Western blotting) in a routine serological assay for human immunodeficiency virus (HIV). Comparison of IM to nitrocellulose (NC) has shown the following advantages: (a) better retention of total HIV antigens,


The possible role of corticosteroid therapy for pneumocystis pneumonia in the acquired immune deficiency syndrome (AIDS).
J Acquir Immune Defic Syndr. 1988;1(4):354-60. Unique Identifier : AIDSLINE MED/89110740
Walmsley S; Salit IE; Brunton J; Department of Medicine, Toronto General Hospital, Ontario,; Canada.
Twenty-one episodes of Pneumocystis carinii pneumonia (PCP) and the acquired immune deficiency syndrome (AIDS) were treated with corticosteroids in the form of intravenous methylprednisolone or oral prednisone. A standard dose of 80 mg/day x 5 days was given for 15 episodes, whereas 6 patients received variable doses


[Immunologic disorder in children with hemophilia]
Pediatr Pol. 1988 May;63(5):319-25. Unique Identifier : AIDSLINE MED/89112897
Boguslawska-Jaworska J; Pejcz J; Dobaczewski G; Hlladyszowska A; Czerchawski L
Blocking AIDS.
Practitioner. 1988 Apr 8;232(1446):369. Unique Identifier : AIDSLINE MED/89113248
HIV antibody testing in Jefferson County, Alabama. The current picture and changes in time.
Ala J Med Sci. 1988 Oct;25(4):372-4. Unique Identifier : AIDSLINE MED/89116405
Levin VR
Use of intravenous acyclovir for treatment of herpes zoster ophthalmicus in patients at risk for AIDS.
Ann Ophthalmol. 1988 Dec;20(12):480-2. Unique Identifier : AIDSLINE MED/89116787
Seiff SR; Margolis T; Graham SH; O'Donnell JJ; Department of Ophthalmology, San Francisco General Hospital,; California.
Patients who are homosexual, intravenous drug abusers, or have received multiple blood transfusions are at greater risk to contract the immunosuppressive disorders of acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). These persons also have a greater chance of developing serious neurologic comp


Comparative analysis of gp41 antigens by enzyme-linked immunosorbent assays for detecting antibodies to human immunodeficiency virus type 1.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):487-92. Unique Identifier : AIDSLINE MED/89118018
Zweig M; Bladen SV; Dubois GC; Samuel KP; Showalter SD; Papas TS; Program Resources, Inc., National Cancer Institute-Frederick; Cancer Research Facility, MD.
We have compared the antigenic qualities of human immunodeficiency virus type 1 (HIV-1) gp41 glycoprotein with a synthetic oligopeptide (peptide R21S) and a bacterially synthesized protein (protein 566), which are homologous with the N-terminal region of gp41, in enzyme-linked immunosorbent assays (ELISA) for detectin


[An analysis of lymphocyte surface markers in HTLV-I-associated myelopathy (HAM)]
Rinsho Shinkeigaku. 1988 Oct;28(10):1192-6. Unique Identifier : AIDSLINE MED/89119891
Kuwasaki N; Yasuda K; Shoji H; Kaji M; Ayabe M
FokI method of gene synthesis.
Gene. 1988 Aug 15;68(1):101-7. Unique Identifier : AIDSLINE GENBANK/M22043
Mandecki W; Bolling TJ; Corporate Molecular Biology, Abott Laboratories, Abbott Park, IL; 60064.
An accurate, fast and simple method is presented for synthesis of a gene, or any DNA fragment with a defined sequence. The method is based on the observation that large (approx. 100 bp long) inserts can be cloned into a plasmid using a technique of oligodeoxynucleotide (oligo)-directed double-strand (ds) break repair.


[Pneumonias in AIDS are in the foreground. Clinical symptoms are rarely typical--by no means waive therapy (news)]
Fortschr Med. 1988 Jul 20;106(21):18. Unique Identifier : AIDSLINE MED/89121751
Hartung HD
[An autopsy case of acquired immuno-deficiency syndrome associated with P. carinii pneumonia with a rapid clinical course resembling ARDS]
Nippon Kyobu Shikkan Gakkai Zasshi. 1988 Apr;26(4):415-20. Unique Identifier : AIDSLINE MED/89126202
Mikami M; Nakamura S; Baba M; Koseki T; Kanemura T; Kihara N; Fujikawa T; Tanaka M; Kawahara Y; Nagaoka S
[AIDS and the lung]
Med Klin. 1988 Aug 12;83(16):526-7. Unique Identifier : AIDSLINE MED/89126981
Ruhle KH; Costabel U; Zaiss A; Matthys H
T-cell chronic lymphocytic leukaemia: the spectrum of mature T-cell disorders.
Nouv Rev Fr Hematol. 1988;30(5-6):347-51. Unique Identifier : AIDSLINE MED/89128386
Matutes E; Brito-Babapulle V; Worner I; Sainati L; Foroni L; Catovsky D; MRC Leukaemia Unit, Royal Postgraduate Medical School, London,; UK.
Mature (post-thymic) T-cell malignancies comprise a heterogeneous group of diseases with distinct clinical, morphological and immunophenotypic features. As some of these features overlap in the various disorders, it is essential to use a number of diagnostic criteria to define the clinicopathological entities, namely:


[A case from practice (124). Patient: Mr. B. S., born 1949, buyer]
Schweiz Rundsch Med Prax. 1988 Dec 20;77(51):1413-5. Unique Identifier : AIDSLINE MED/89129848
Suter D
[AIDS and other acquired T cell immunodeficiency syndromes]
Rev Prat. 1988 Dec 1;38(29):2161-4. Unique Identifier : AIDSLINE MED/89129993
Bach JF; Vittecoq D
Effect of folic and folinic acid on cytopenia occurring during co-trimoxazole treatment of Pneumocystis carinii pneumonia [see comments]
Scand J Infect Dis. 1988;20(6):685-6. Unique Identifier : AIDSLINE MED/89130062
Bygbjerg IC; Lund JT; Hording M; Department of Infectious Diseases, Rigshospitalet, Copenhagen,; Denmark.
12 AIDS/ARC patients with or suspected of Pneumocystis carinii pneumonia were treated with co-trimoxazole and received supplementary folic or folinic acid to avoid peripheral blood cytopenia. Most patients developed decreased numbers of neutrophils and hemoglobin while receiving co-trimoxazole. Supplementary folate/fo


Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets.
Acta Neurol Scand. 1988 Dec;78(6):449-54. Unique Identifier : AIDSLINE MED/89131610
Provinciali L; Laurenzi MA; Vesprini L; Giovagnoli AR; Bartocci C; Montroni M; Bagnarelli P; Clementi M; Varaldo PE; Institute of Microbiology, University of Ancona, Italy.
Serum and CSF from 32 patients with idiopathic ALS, 30 age-matched controls and 30 MS patients were investigated regarding immunoglobulin concentration and virus-specific antibodies, the lymphocytes in the peripheral blood and lymphocyte subsets were also investigated. ALS patients results were compared with findings


Hospital dental departments engaged in HIV, AIDS research [letter]
J Can Dent Assoc. 1988 Dec;54(12):883. Unique Identifier : AIDSLINE MED/89105924
Epstein JB
Anorectal and colonic disease and the immunocompromised host.
Dis Colon Rectum. 1988 Dec;31(12):971-6. Unique Identifier : AIDSLINE MED/89106877
Hyder JW; MacKeigan JM; Ferguson Clinic, Grand Rapids, Michigan 49503.
The immunocompromised host is becoming increasingly ubiquitous in the authors patient population. There are growing numbers of long-term transplant recipients, and combination chemotherapy is producing many long-term survivors. Of greatest concern is that the number of patients with human immunodeficiency virus (HIV)


Multicopy expression vector based on temperature-regulated lac repressor: expression of human immunodeficiency virus env gene in Escherichia coli.
Gene. 1988 Oct 30;70(2):415-7. Unique Identifier : AIDSLINE MED/89108027
Bukrinsky MI; Barsov EV; Shilov AA; D.I. Ivanovski Institute of Virology, Academy of Medical Sciences; of the USSR, Moscow.
A new expression vector (pBB1) has been constructed for the regulated expression of genes in Escherichia coli. Based on the pUC plasmids, the pBB1 carries lacIts allele of the lac repressor gene. This makes it possible to control expression of cloned genes by shifting the temperature from 30 degrees C to 42 degrees C.


[Social and psychological impact of AIDS on the family]
Harefuah. 1988 Apr 15;114(8):390-3. Unique Identifier : AIDSLINE MED/89108167
Soskolne V
Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virus protease.
Gene Anal Tech. 1988 Nov-Dec;5(6):109-15. Unique Identifier : AIDSLINE MED/89108246
Copeland TD; Oroszlan S; Laboratory of Molecular Virology and Carcinogenesis,; NCI-Frederick Cancer Research Facility, MD 21701.
The genetic locus and primary structure of the human immunodeficiency virus (HIV) protease was determined by comparing the data of protein analyses with the published data of the gene analysis. The complete sequence of HIV-1 and HIV-2 protease was synthesized by solid-phase peptide synthesis. The synthetic protease wa


The physician's role in the prevention of AIDS.
J Am Osteopath Assoc. 1988 Jul;88(7):877-90. Unique Identifier : AIDSLINE MED/89108862
Calabrese LH; Kelley D
Pathogenesis of infection with the human immunodeficiency virus--a personal view.
J Infect. 1988 Nov;17(3):221-9. Unique Identifier : AIDSLINE MED/89110107
Mims CA; Department of Microbiology, United Medical School, Guy's; Hospital, London, U.K.
Selected public health observations derived from Multicenter AIDS Cohort Study.
J Acquir Immune Defic Syndr. 1988;1(1):2-7. Unique Identifier : AIDSLINE MED/89110702
Ginzburg HM; Fleming PL; Miller KD; NIAID/AIDS Program, Bethesda, MD 20892.
Selected findings from the Multicenter AIDS Cohort Study (MACS) of homosexual/bisexual men are reviewed. High risk sexual behaviors, the use of drugs/alcohol, condom use, and behavior change are addressed in a public health context. The potential significance of education/behavior modification programs as strategies f


Central nervous system dysfunction in acquired immunodeficiency syndrome.
J Acquir Immune Defic Syndr. 1988;1(1):41-64. Unique Identifier : AIDSLINE MED/89110705
Levy RM; Bredesen DE; Department of Neurological Surgery, School of Medicine University; of California, San Francisco 94143.
Nearly 40% of AIDS patients develop neurological complications during the course of their illness, and about 10% experience neurological symptoms as the initial manifestations of AIDS. The most common neurological complication (14% of AIDS patients) is human immunodeficiency virus (HIV) encephalopathy, but opportunist


Replication and pathogenesis of the AIDS virus.
J Acquir Immune Defic Syndr. 1988;1(3):217-40. Unique Identifier : AIDSLINE MED/89110725
Haseltine WA; Dana-Farber Cancer Institute, Boston, MA 02115.
Some of the major features of the acquired immune deficiency syndrome may be understood in terms of the characteristics of the virus. Life-long infection is a consequence of the life cycle of retroviruses, the formation of stably integrated viral genetic information into host-cell DNA. The silent infection, controlled


Antiviral therapy.
J Acquir Immune Defic Syndr. 1988;1(3):257-66. Unique Identifier : AIDSLINE MED/89110727
Oberg B; Department of Virology, Karolinska Institute, Stockholm, Sweden.
The complicated machinery used by HIV for multiplication offers several targets for therapy and the viral enzymes appear to be particularly appropriate targets. For the HIV reverse transcriptase, this has been demonstrated by the clinical effect of zidovudine, but less toxic drugs are needed. The HIV protease is anoth


Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: higher positivity rates by particle agglutination assay [corrected] [published erratum appears in J Acquir Immune Defic Syndr 1989;2(2):214]
J Acquir Immune Defic Syndr. 1988;1(4):340-5. Unique Identifier : AIDSLINE MED/89110738
Ishizaki J; Okayama A; Tachibana N; Yokota T; Shishime E; Tsuda K; Mueller N; Second Department of Medicine, Miyazaki Medical School, Japan.
Higher positivity rates for prevalence of anti-HTLV-I antibody have been reported for the gelatin particle agglutination (PA) assay when compared to that of the indirect immunofluorescence assay using acetone-fixed HTLV-I producing cells (IF-FA). To evaluate the discrepancy between these two screening methods, PA-posi


[The diagnostic value of immunologic findings in the differentiation of chronic liver diseases]
Leber Magen Darm. 1988 Dec;18(6):290-2, 295, 298 passim. Unique Identifier : AIDSLINE MED/89111811
Manns M; Meyer zum Buschenfelde KH; Arnold W; Medizinische Klinik und Poliklinik,; Johannes-Gutenberg-Universitat Mainz.
Various types of virus induced and non-virus induced chronic active hepatitis (CAH) as well as chronic non-suppurative destructive cholangitis (PBC) and primary sclerosing cholangitis have to be distinguished. Classical autoimmune type lupoid CAH is characterized by antinuclear antibodies (ANA), liver membrane antibod


Further isolation of HIV strains in Palermo: some biological properties of the new isolates.
Microbiologica. 1988 Oct;11(4):329-37. Unique Identifier : AIDSLINE MED/89112018
Lupo G; Spadaro F; Portera M; Torregrossa MV; Russo Alesi D; Vitale F; Romano N; Istituto di Igiene G. D'Alessandro, Universita degli Studi,; Palermo, Italy.
21 HIV strains were isolated from peripheral mononuclear cells of 31 adult and pediatric patients with AIDS or ARC and 10 apparently healthy HIV seropositive individuals. Viral isolation rate was correlated to the clinical status of patients, being very high in patients with AIDS or ARC, and lower in apparently health


Microbiologic correlates underscoring the diagnosis of opportunistic infections in patients with AIDS.
Mt Sinai J Med. 1988 Oct;55(5):374-82. Unique Identifier : AIDSLINE MED/89112237
Bottone EJ; Janda JM; Clark RB; Robin T; Reitano M; Damsker B
AIDS/HIV resource list.
Practitioner. 1988 Apr 8;232(1446):405. Unique Identifier : AIDSLINE MED/89113257
[Epidemiologic aspects of the transmission of HIV]
Rev Clin Esp. 1988 Oct;183(6):313-7. Unique Identifier : AIDSLINE MED/89113850
Casabona J
[Pulmonary manifestations of acquired immunodeficiency syndrome]
Rev Mal Respir. 1988;5(6):551-64. Unique Identifier : AIDSLINE MED/89113935
de Wit S; Van Laethem Y; Clumeck N; Clinique des Maladies Infectieuses, Hopital Universitaire; Saint-Pierre, Bruxelles, Belgique.
After reviewing the immunological anomalies provoked by the human immuno-deficiency virus (HIV) as well as their implications in pulmonary pathology, the authors enumerate the diagnostic and therapeutic methods currently available in the treatment of patients suffering from AIDS and pulmonary diseases. The clinical fe


AIDS-related lymphadenopathies.
Semin Diagn Pathol. 1988 Nov;5(4):365-75. Unique Identifier : AIDSLINE MED/89114002
Said JW; Department of Pathology, Cedars Sinai Medical Center, Los; Angeles, CA 90048.
Lymphoid proliferations in the acquired immunodeficiency syndrome reflect the profound immunologic imbalances induced by the lymphotropic human immunodeficiency virus, and comprise a range of lymphoproliferative disorders from benign lymphadenopathy to malignant lymphoma. Persistent generalized lymphadenopathy (PGL) i


[Malaria in Switzerland]
Schweiz Med Wochenschr. 1988 Dec 10;118(49):1838-43. Unique Identifier : AIDSLINE MED/89114338
Fernex M; Recherche clinique, F. Hoffmann-La Roche & Cie SA, Bale.
Some 200 cases of malaria are officially reported yearly in Switzerland . It is estimated that 2000-8000 Swiss travellers are infected by the anopheles mosquito annually, with 90% protected by chemoprophylaxis. An attack of malaria appears to have a better prognosis when the sy


[Use of immunomorphologic methods in detecting antigens of the human immunodeficiency virus]
Vopr Virusol. 1988 Sep-Oct;33(5):570-5. Unique Identifier : AIDSLINE MED/89115242
Ivannikova TA; Selimova LM; Korolev MB; Tashenova AA; Zhdanov VM
A comparative evaluation of the effectiveness of detection of human immunodeficiency virus (HIV) in persistently infected culture of T-lymphocytes by means of different morphological and immunomorphological methods: fluorescent antibody method (FAM), immune electron microscopy (IEM), negative staining, and ultrathin s


Chemotherapeutic approach of AIDS.
Verh K Acad Geneeskd Belg. 1988;50(2):166-217. Unique Identifier : AIDSLINE MED/89115510
De Clercq E
[Heterosexual transmission of human immunodeficiency viruses]
Vestn Dermatol Venerol. 1988;(7):28-31. Unique Identifier : AIDSLINE MED/89115519
Zaides VM
Community consultation in socially sensitive research. Lessons from clinical trials of treatments for AIDS.
Am Psychol. 1988 Jul;43(7):573-81. Unique Identifier : AIDSLINE MED/89116660
Melton GB; Levine RJ; Koocher GP; Rosenthal R; Thompson WC
[Tumors of the nasal cavity in human immunodeficiency virus infection. A case of polyclonal lymphoid hyperplasia]
Ann Otolaryngol Chir Cervicofac. 1988;105(7):543-7. Unique Identifier : AIDSLINE MED/89116796
Pulik M; Lida H; Blanchereau C; Unite d'Hematologie, Centre Hospitalier Victor Dupouy,; Argenteuil.
HIV virus infection is frequently accompanied by polyclonal or monoclonal lymphoid proliferations. The authors report the first case of a tumour of the cavum in a Haitian subject with HIV infection. This large tumour was associated with parotid swelling and a buccal and ocular sicca syndrome. Histological examination


Update: HIV-1 gene nomenclature [editorial]
AIDS Res Hum Retroviruses. 1988 Dec;4(6):vii-viii. Unique Identifier : AIDSLINE MED/89118008
Laurence J
Expression and purification of protein segments encoded by the envelope and 3'-orf genes of human immunodeficiency virus type 1.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):419-31. Unique Identifier : AIDSLINE MED/89118011
DuBois GC; Samuel KP; Hanson CA; Zweig M; Showalter SD; Papas TS; National Cancer Institute, Frederick Cancer Research Facility, MD; 21701-1013.
The pJL6 expression vector and its derivatives, pJLA16 and pANH-1, have been used for the synthesis and high-level expression in Escherichia coli of restriction enzyme fragments derived from the envelope and 3 -orf genes of the BH10 and BH8 clones, respectively, of the human immunodeficiency virus (HIV-1). These bacte


Should AIDS patients be dialyzed?
ASAIO Trans. 1988 Oct-Dec;34(4):907-11. Unique Identifier : AIDSLINE MED/89118046
Pennell JP; Bourgoignie JJ; Health and Human Values Program, University of Miami School of; Medicine, FL 33101.
Should AIDS patients be dialyzed? For asymptomatic HIV carriers and patients with ARC developing renal failure, dialysis is medically beneficial and may delay death from uremia for months or even years. In contrast, dialysis will not prevent a rapid death from AIDS, per se, and thus may be futile. While there may be c


The acquired immunodeficiency syndrome and intravenous drug abuse.
Bull Narc. 1988;40(1):21-34. Unique Identifier : AIDSLINE MED/89118686
Battjes RJ; Leukefeld CG; Pickens RW; Haverkos HW; National Institute on Drug Abuse, Rockville, Maryland.
Intravenous drug abusers constitute 25 per cent of the cases of the acquired immunodeficiency syndrome (AIDS) in adults in the United States of America and 21 per cent of such cases in Europe. The potential for the rapid spread of the human immunodeficiency virus (HIV) among intravenou


[Isolation of human immunodeficiency virus from AIDS patient]
Chung Hua Liu Hsing Ping Hsueh Tsa Chih. 1988 Jun;9(3):135-7. Unique Identifier : AIDSLINE MED/89119505
Zeng Y
[Sero-epidemiologic study of several sexually transmitted diseases (including HIV infection) in a rural zone of the Central African Republic]
Bull Soc Pathol Exot Filiales. 1988;81(4):692-8. Unique Identifier : AIDSLINE MED/89119664
Belec PL; Gresenguet G; Georges-Courbot MC; Villon A; Martin MH; Georges AJ; Institut Pasteur de Bangui, Republique centrafricaine.
A study of several sexually transmitted diseases (STD) (HIV1, HIV2, hepatitis B and syphilis) was performed among high school students and hospitalized patients in Bozoum, a rural town in the Central African Republic (CAR). The rate of injection for each disease (HB


Zidovudine and other drugs against HIV.
Drug Ther Bull. 1988 Dec 28;26(26):101-4. Unique Identifier : AIDSLINE MED/89120595
[Syphilis and AIDS. Historical parallels]
Fortschr Med. 1988 Jul 20;106(21):439-42. Unique Identifier : AIDSLINE MED/89121754
Krech T
[The role of Langerhans cells in acquired immunologic deficiency syndrome]
Hautarzt. 1988 Aug;39(8):487-90. Unique Identifier : AIDSLINE MED/89122615
Belsito DV; Baer RL; Thorbecke GJ; Abteilungen fur Dermatologie und Pathologie, New York University; School of Medicine.
[The epidermis as an immune organ]
Hautarzt. 1988 Aug;39(8):534-43. Unique Identifier : AIDSLINE MED/89122625
Wolff K; I. Universitats-Hautklinik Wien.
The epidermis possesses everything required for initiation of an immune response. It harbors antigen-presenting Langerhans cells, it produces immune modulatory cytokines, and (so far shown only in the murine system) it contains a distinct T cell population. Both upregulating and downregulating signals, leading to eith


Review of current therapy in human immunodeficiency viral infections.
J Am Osteopath Assoc. 1988 Aug;88(8):998-1002. Unique Identifier : AIDSLINE MED/89122722
Gulick PG
Bone marrow findings in immunodeficiency syndromes.
Hematol Oncol Clin North Am. 1988 Dec;2(4):637-56. Unique Identifier : AIDSLINE MED/89122934
Duggan MJ; Weisenburger DD; Sun NC; Purtilo DT; Department of Pathology and Microbiology, University of Nebraska; Medical Center, Omaha.
We have summarized the findings in selected congenital and acquired immunodeficiency disorders that frequently display blood and bone marrow abnormalities. Many other immunodeficiency syndromes were not discussed, as bone marrow abnormalities are infrequently seen in them. Examination of the bone marrow is not usually


An improved method for the detection of HIV antigen in the blood of carriers.
J Virol Methods. 1988 Dec;22(2-3):125-31. Unique Identifier : AIDSLINE MED/89123710
Kageyama S; Yamada O; Mohammad SS; Hama S; Hattori N; Asanaka M; Nakayama E; Matsumoto T; Higuchi F; Kawatani T; et al; Department of Virology, Tottori University School of Medicine,; Yonago, Japan.
The measurement of HIV antigen levels in sera or plasma of HIV-infected individuals is critical for determining the existence of antigen or infectious virus before seroconversion and for prognosis. Pretreatment of sera or plasma of HIV carriers by heating at 70 degrees C for 10 min at an acidic pH enabled us to estima


Increased detection of human immunodeficiency virus antigen carriers by simultaneous assay of plasma and extracts from resting and phytohaemagglutinin-stimulated peripheral blood mononuclear cells.
J Virol Methods. 1988 Dec;22(2-3):329-36. Unique Identifier : AIDSLINE MED/89123730
Ruiz-Arguelles A; Ponce-de-Leon S; Presno-Bernal M; Ponce-de-Leon A; Ortiz-Lopez R; Rojas G; Department of Immunology, Laboratorios Clinicos de Puebla,; Mexico.
Antigenaemia due to human immunodeficiency virus (HIV) is thought to be significant either before the appearance of a specific antibody response, or after its decline during terminal stages. In order to increase the rate of detection of HIV antigen carriers, regardless of the stage or despite the presence of specific


Interaction of human immunodeficiency virus with human sperm in vitro.
J Acquir Immune Defic Syndr. 1988;1(5):431-5. Unique Identifier : AIDSLINE MED/89125348
Bagasra O; Freund M; Weidmann J; Harley G; Department of Microbiology, UMDNJ-SOM, Camden 08103.
Transmission of human immunodeficiency virus (HIV) in semen by sexual intercourse is believed to be a major etiological factor in the spread of the disease. In order to explore the role of sperm in this transmission, cell-free HIV-1(IIIB) was coincubated with human sperm for 5 h. After incubation, unattached HIV-1 was


Projecting the medical costs of AIDS and ARC in the United States.
J Acquir Immune Defic Syndr. 1988;1(5):466-85. Unique Identifier : AIDSLINE MED/89125353
Hay JW; Osmond DH; Jacobson MA; Hoover Institution, Stanford University, CA 94305.
We projected the direct medical costs of acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) for the United States during the period 1987-1991, by applying current epidemiologic projections to state-of-the-art medical decision algorithms for diagnosis and treatmen


Medicaid waiver for AIDS and ARC patients [editorial]
J S C Med Assoc. 1988 Dec;84(12):596. Unique Identifier : AIDSLINE MED/89126387
Bryan CS
[Randomization of a population for a clinical trial of immunization against the human immunodeficiency virus (HIV)]
Med Trop (Mars). 1988 Oct-Dec;48(4):413-6. Unique Identifier : AIDSLINE MED/89126900
Dechazal L; Goussard B; Salaun JJ; Bernard J; Zagury D; Medecin Chef de l'A.M.T. Francaise, Kinshasa, Zaire.
Serum HIV antibodies has been investigated in different subpopulation from four different regions in Zaire by Elisa (Elavia Pasteur) and Western Blot. Seropositive prevalence differed from 2.4% (rural population) to 12.5% (urban population) according to the regions. When the group


[The diagnostic significance of bronchoalveolar lavage in AIDS]
Med Klin. 1988 Aug 12;83(16):520-2, 540. Unique Identifier : AIDSLINE MED/89126979
Costabel U; Ruhle KH; Kroegel C; Matthys H
[Therapy of pulmonary complications in AIDS]
Med Klin. 1988 Aug 12;83(16):523-5. Unique Identifier : AIDSLINE MED/89126980
Kroegel C; Hess G; Costabel U; Wurtemberger G; Ruhle KH; Matthys H
[Update oncology '88: the age of biological factors]
Med Klin. 1988 Aug 12;83(16):532-8. Unique Identifier : AIDSLINE MED/89126983
Pfreundschuh M
[Pathogenesis and immunologic findings in AIDS]
Monatsschr Kinderheilkd. 1988 Aug;136(8):414-29. Unique Identifier : AIDSLINE MED/89127335
Wahn V; Universitats-Kinderklinik Dusseldorf.
As the numbers of children suffering from AIDS are slowly increasing in West Germany it is essential for pediatricians to be aware of events leading to clinically overt disease. This review summarizes events involved in viral attachment to CD4-bearing cells, intracellular replicat


Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination.
Nephron. 1988;50(2):133-6. Unique Identifier : AIDSLINE MED/89127651
Donati D; Gastaldi L; Department of Nephrology, General Hospital Varese, Italy.
Uremic patients are at high risk of hepatitis B virus (HBV) infection and, despite the availability and efficacy of hepatitis B vaccine, a high rate of non responders has been reported. Forty uremic patients undergoing maintenance hemodialysis who failed to produce any measurable anti-HBs antibody response after 4 adm


Looking for the latest AIDS facts? ... AIDSLINE may help.
Ohio Med. 1988 Dec;84(12):936. Unique Identifier : AIDSLINE MED/89128111
AIDS in Ohio [letter]
Ohio Med. 1988 Sep;84(9):707. Unique Identifier : AIDSLINE MED/89128118
Offner P
HTLV-I infection and chronic lymphocytic leukemia.
Nouv Rev Fr Hematol. 1988;30(5-6):267-73. Unique Identifier : AIDSLINE MED/89128368
Mann DL; LeSane F; Boumpas D; Dean M; Blattner WA; Biochemical Epidemiology Section, National Cancer Institute,; Bethesda, MD 20892.
We have captured the immunoglobulin genes of CLL cells by fusing the peripheral blood lymphocytes from CLL cells with the B lymphoblastoid line. The hybridoma cell line established from the fusion of CLL cell from two patients who were HTLV-I seropositive produced antibody directed against HTLV-I proteins. The antibod


[Cytopenia in patients with HIV infection]
Rev Clin Esp. 1988 Nov;183(8):397-400. Unique Identifier : AIDSLINE MED/89129569
Martinez Santos P; Jauregui Ibabe C; Garcia Aguado C; Huescar Huescar MT; Ortega Calderon A; Sanchez Alonso MJ
AIDS-related mycobacterial disease.
Springer Semin Immunopathol. 1988;10(4):375-91. Unique Identifier : AIDSLINE MED/89130324
Collins FM; Trudeau Institute, Inc., Saranac Lake, NY 12983.
[Morbidity caused by Neisseria gonorrhoeae and Chlamydia trachomatis in mothers and children in Kenya]
Verh K Acad Geneeskd Belg. 1988;50(4):367-92. Unique Identifier : AIDSLINE MED/89131173
Piot P; Laga M
Prostitutes: a high risk group for HIV infection?
Soz Praventivmed. 1988;33(7):336-9. Unique Identifier : AIDSLINE MED/89131275
Piot P; Laga M; Institute of Tropical Medicine, Antwerp.
Female prostitutes are at increased risk for sexually transmitted diseases and HIV infection. However, the prevalence rate of HIV infection among prostitutes varies geographically, with the highest rates occurring in Africa and in areas with large numbers of HIV infected intravenous drug users (IVDU). In Europe the mo


Advances in human retroviruses.
Adv Cancer Res. 1988;51:307-60. Unique Identifier : AIDSLINE MED/89131916
Dalgleish A; Malkovsky M; MRC Clinical Research Centre, Division of Immunology, Harrow,; Middlesex, England.
[Comparative study of 2 commercial tests for the detection of HIV-1 antigens in blood and cerebrospinal fluid using immunoenzymology]
Ann Biol Clin (Paris). 1988;46(9):725-9. Unique Identifier : AIDSLINE MED/89133153
Bonnici JF; Teyssou R; Morvan J; Carteron B; Fleury HJ; du Pasquier P; Laboratoire de Virologie, Hopital Pellegrin, Bordeaux.
The authors have carried out, on 150 sera of patients seropositive for the human immunodeficiency virus type I (HIV I) and 11 cerebrospinal fluid of which 5 were patient infected by the HIV I, a comparative study of two commercial tests for the detection of HIV I antigen (Diagnostic Pasteur and Abbott laboratories). A


High prevalence of tuberculosis in AIDS patients in Spain.
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):785-8. Unique Identifier : AIDSLINE MED/89107220
Bouza E; Martin-Scapa C; Bernaldo de Quiros JC; Martinez-Hernandez D; Menarguez J; Gomez-Rodrigo J; Cosin J; Sagues-Cifuentes MJ; Servicio de Microbiologia Clinica, Hospital General Gregorio; Maranon, Madrid, Spain.
A total of 67 cases of tuberculosis was diagnosed in the first 100 cases of AIDS, diagnosed according to the former CDC criteria, at a hospital in Madrid, Spain . This is the highest known prevalence of tuberculosis in AIDS patients both within and outside Spain. The clinical manifes


Absence of antibodies to HTLV-I/II in French patients with hematological malignancies [letter]
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):815-6. Unique Identifier : AIDSLINE MED/89107229
Agius G; Vaillant V; Biggar RJ; Brizard A; Ranger S; Dindinaud G; Castets M
Isolation of human immunodeficiency virus type 2 from a homosexual man in Belgium [letter]
Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):816-8. Unique Identifier : AIDSLINE MED/89107230
Vanderborght B; De Leys RJ; Nijs P; Van der Groen G; Merregaert J; Prinsen H; Van Heuverswyn H
[Is there a need for infectiology in gynecology and obstetrics?]
Geburtshilfe Frauenheilkd. 1988 Jul;48(7):533-4. Unique Identifier : AIDSLINE MED/89107873
Petersen EE; Univ.-Frauenklinik Freiburg.
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.
J Acquir Immune Defic Syndr. 1988;1(2):125-30. Unique Identifier : AIDSLINE MED/89110713
Parks WP; Parks ES; Fischl MA; Leuther MD; Allain JP; Nusinoff-Lehrman S; Barry DW; Makuch RW; Department of Pediatrics, University of Miami School of Medicine,; FL 33136.
Two independent measures of human immunodeficiency virus type 1 (HIV-1) infection, virus isolation, and serum levels of p24 antigen were evaluated in a double-blind randomized clinical trial of the safety and efficacy of a nucleoside analogue, 3 -azido-3 -deoxythymidine (


[Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates]
Rinsho Ketsueki. 1988 May;29(5):628-34. Unique Identifier : AIDSLINE MED/89111301
Ikematsu S; Yorifuji H; Arai M; Fukutake K
[Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency]
Rinsho Ketsueki. 1988 May;29(5):649-54. Unique Identifier : AIDSLINE MED/89111304
Yoshioka A
[Cryptococcus neoformans--infection in AIDS]
Psychiatr Neurol Med Psychol Beih. 1988;40:70-1. Unique Identifier : AIDSLINE MED/89113479
Marg E
Neutrophil alkaline phosphatase in AIDS [letter] [see comments]
Acta Haematol. 1988;80(4):229. Unique Identifier : AIDSLINE MED/89115737
Grozdea J; Brisson-Lougarre A; Vergnes H; Blum C; Alie-Daram S; Martin J; Bierme R
[Liver biopsy findings in AIDS (letter)]
Bol Asoc Med P R. 1988 Nov;80(11):436. Unique Identifier : AIDSLINE MED/89117718
Marcial Rojas R
Bibliography of the current world literature on AIDS.
AIDS. 1988 Oct;2(5):A43-50. Unique Identifier : AIDSLINE MED/89117816
Prophylactic and maintenance therapy for opportunist infections in AIDS.
AIDS. 1988 Oct;2(5):335-43. Unique Identifier : AIDSLINE MED/89117818
Pinching AJ; St Mary's Hospital Medical School, London, UK.
Antibodies to soluble CD4 in HIV-1-infected individuals.
AIDS. 1988 Oct;2(5):345-51. Unique Identifier : AIDSLINE MED/89117819
Thiriart C; Goudsmit J; Schellekens P; Barin F; Zagury D; De Wilde M; Bruck C; Molecular and Cellular Biology Department, Smith Kline-RIT,; Rixensart, Belgium.
A direct enzyme immunoassay (EIA) using the recombinant soluble form of CD4 (sCD4) produced in rodent cells as antigen was applied to detect antibodies to CD4 in sera from HIV-1- and HIV-2-infected patients. High titers of antibodies to sCD4 were found in sera from 12.6% of the HIV-1-infected persons included in this


Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules.
AIDS. 1988 Oct;2(5):353-61. Unique Identifier : AIDSLINE MED/89117820
Chams V; Jouault T; Fenouillet E; Gluckman JC; Klatzmann D; Laboratoire de Biologie et Genetique, Groupe Hospitalier; Pitie-Salpetriere, Paris, France.
The use of purified recombinant soluble CD4 (sT4) allowed the detection of high titers of anti-CD4 immunoglobulins in the sera of three out of 33 HIV-infected patients. Binding of these antibodies to sT4 was first detected by enzyme-linked immunosorbent assay (ELISA), and their reactivity in the assay was blocked in a


Transmission of HIV-1 within a statewide prison system.
AIDS. 1988 Oct;2(5):363-7. Unique Identifier : AIDSLINE MED/89117821
Brewer TF; Vlahov D; Taylor E; Hall D; Munoz A; Polk BF; Department of Health Policy and Management, Johns Hopkins; University, Baltimore, Maryland 21205.
To assess the incidence of infection with HIV-1 in the Maryland state prison system, inmates with excess sera stored from specified intake periods between April and June 1985 and 1986 were approached in May 1987 to volunteer for venipuncture. Of the 2286 inmates for whom intake specimens were stored, 1038 (45.4%) no l


HIV surveillance by testing saliva.
AIDS. 1988 Oct;2(5):369-71. Unique Identifier : AIDSLINE MED/89117822
Johnson AM; Parry JV; Best SJ; Smith AM; de Silva M; Mortimer PP; Academic Department of Genito-Urinary Medicine, University; College, Middlesex School of Medicine, London.
Saliva specimens were tested for HIV antibody (anti-HIV) by an immunoglobulin G (IgG) antibody capture radioimmunoassay (GACRIA) and three sensitive commercial assays. In tests on 460 seronegative subjects and 196 seropositive subjects GACRIA was 99.8% specific and 100% sensitive. The Wellcome HIV monoclonal and Abbot


Syringe HIV seroprevalence and behavioural and demographic characteristics of intravenous drug users in Sydney, Australia, 1987.
AIDS. 1988 Oct;2(5):373-7. Unique Identifier : AIDSLINE MED/89117823
Wolk J; Wodak A; Morlet A; Guinan JJ; Wilson E; Gold J; Cooper DA; Albion Street (AIDS) Centre, Surry Hills, Australia.
The contents of needles and syringes returned by intravenous drug users to two Sydney needle and syringe exchange centres were analysed for HIV antibodies by the enzyme-linked immunosorbent assay (ELISA). Reactive and borderline samples were further tested by the Western blot method. Basic demographic and needle shari


Damage to jejunal intrinsic autonomic nerves in HIV infection.
AIDS. 1988 Oct;2(5):379-82. Unique Identifier : AIDSLINE MED/89117824
Griffin GE; Miller A; Batman P; Forster SM; Pinching AJ; Harris JR; Mathan MM; Department of Communicable Diseases, St George's Hospital Medical; School, London, UK.
Jejunal biopsies from 11 HIV-infected male homosexuals, without secondary enteropathogen infection, were examined at ultrastructural and light microscope level. Subjects were clinically categorized into four groups: asymptomatic (3), AIDS-related complex (4), persistent generalized lymphadenopathy (1), and AIDS (3). A


Isolation and characterization of HIV-2 from an AIDS patient in Ghana.
AIDS. 1988 Oct;2(5):383-8. Unique Identifier : AIDSLINE MED/89117825
Ishikawa K; Tsujimoto H; Nakai M; Mingle JA; Osei-Kwasi M; Aggrey SE; Nettey VB; Afoakwa SN; Fukasawa M; Kodama T; et al; Department of Animal Pathology, Tokyo University, Japan.
This report describes the isolation and characterization of a retrovirus of the HIV-2 group from a Ghanaian AIDS patient which has different restriction patterns from previously reported HIV-2 viruses. The virus was morphologically very similar to HIV-1 and HIV-2, and had Mg2+-dependent reverse transcriptase. Like pre


Detection of HIV-2 antibodies using five commercial HIV enzyme immunoassays.
AIDS. 1988 Oct;2(5):389-90. Unique Identifier : AIDSLINE MED/89117826
Peeters M; Delaporte E; Dazza MC; Brun-Vezinet F; Laboratoire de Virologie, Hopital Claude Bernard, Paris, France.
Suppression of HIV p24 antigen and induction of HIV anti-p24 antibody by alpha interferon in patients with chronic hepatitis B [published erratum appears in AIDS 1989 Jan;3(1):following A54]
AIDS. 1988 Oct;2(5):391-3. Unique Identifier : AIDSLINE MED/89117827
Brook MG; Gor D; Forster SM; Harris W; Jeffries DJ; Thomas HC; Department of Infectious Diseases, Royal Free Hospital, London,; UK.
Five HIV p24 antigen (p24Ag)-positive patients received alpha interferon during trials of therapy for hepatitis B. Four of these showed marked falls in p24Ag during treatment. One of the two patients who became p24Ag-negative [corrected] developed anti-p24 antibodies (anti-p24). Five out of nine p24Ag-negative HIV-ant


Determinants of reported burnout in health professionals associated with the care of patients with AIDS.
AIDS. 1988 Oct;2(5):395-7. Unique Identifier : AIDSLINE MED/89117828
Ross MW; Seeger V; STD Services, South Australian Health Commission, Australia.
Decline of naturally acquired antibodies to hepatitis B surface antigen in HIV-1 infected homosexual men [letter]
AIDS. 1988 Oct;2(5):400-1. Unique Identifier : AIDSLINE MED/89117830
Laukamm-Josten U; Muller O; Bienzle U; Feldmeier H; Uy A; Guggenmoos-Holzmann I
Poor lifestyle modification among intravenous drug users assisted at a sexually transmitted disease clinic for HIV infection diagnosis, Madrid, 1987 [letter]
AIDS. 1988 Oct;2(5):401-2. Unique Identifier : AIDSLINE MED/89117831
de la Loma A; Garcia S; del Romero J
Significance of HIV antibody testing as a preventive measure in intravenous drug users [letter]
AIDS. 1988 Oct;2(5):402-3. Unique Identifier : AIDSLINE MED/89117832
Sasse H; Salmaso S; Conti S; Rezza G
Antibody detection of HIV envelope and core proteins [letter]
AIDS. 1988 Oct;2(5):403-4. Unique Identifier : AIDSLINE MED/89117833
Burns SM; Hargreaves FD; Inglis JM; Brettle RP
HIV p24 antigen in brains of children with AIDS: the antigen-containing cells do not react with monoclonal antibody to OKT4 or macrophage markers [letter]
AIDS. 1988 Oct;2(5):404-5. Unique Identifier : AIDSLINE MED/89117834
Pekovic DD; Lapointe N; Geoffroy G; Ajdukovic D; Michaud J
Reactivity to gag- and env-related proteins in immunoblot assay is not necessarily indicative of HIV infection [letter] [see comments]
AIDS. 1988 Oct;2(5):405-6. Unique Identifier : AIDSLINE MED/89117835
Bukrinsky MI; Chaplinskas SA; Syrtsev VA; Bravkilene LA; Philippov YV
HIV-2-induced AIDS in southern Africa [letter]
AIDS. 1988 Oct;2(5):406-7. Unique Identifier : AIDSLINE MED/89117836
Lyons SF; Clausen L; Schoub BD
AIDS in East Germany [news]
BMJ. 1988 Nov 26;297(6660):1360-1. Unique Identifier : AIDSLINE MED/89118571
Cooling NJ
Clinical picture of primary HIV infection presenting as a glandular-fever-like illness.
BMJ. 1988 Nov 26;297(6660):1363-8. Unique Identifier : AIDSLINE MED/89118572
Gaines H; von Sydow M; Pehrson PO; Lundbegh P; Department of Infectious Disease, Roslagstull Hospital,; Karolinska Institute, Stockholm, Sweden.
The clinical symptoms and signs were assessed in 20 consecutive patients developing infection with the human immunodeficiency virus (HIV). All were male homosexuals and all presented with a glandular-fever-like illness. Changes in laboratory values were compared with findings in 40 HIV negative male homosexual control


Effects of surface-active agents on drug susceptibility levels and ultrastructure of Mycobacterium avium complex organisms isolated from AIDS patients.
Diagn Microbiol Infect Dis. 1988 Sep;11(1):11-9. Unique Identifier : AIDSLINE MED/89119976
Naik SP; Samsonoff WA; Ruck RE; Wadsworth Center for Laboratories and Research, New York State; Department of Health, Albany 12201-0509.
The multiple-drug-resistance property of Mycobacterium avium complex (MAC) is mainly attributed to a cell envelope permeability barrier. MAC treated with subinhibitory levels of dimethyl sulfoxide (DMSO) and ethylenediaminetetraacetic acid (disodium salt) (EDTA) did not have altered minimum inhibitory concentration (M


A comparison of three methods for detection of antibodies against the major core protein p24 of human immunodeficiency virus.
J Virol Methods. 1988 Dec;22(2-3):119-24. Unique Identifier : AIDSLINE MED/89123709
Lindhardt BO; Pedersen C; Ulrich K; Kusk P; Laboratory of Tumor Virology, Fibiger Institute, Copenhagen,; Denmark.
The native major core protein p24 of the human immunodeficiency virus (HIV) was immunoaffinity purified by a monoclonal antibody and used to develop an indirect enzyme-linked immunosorbent assay (inELISA) for detecting p24 antibodies in human sera. Its ability to detect p24 antibodies was compared to that of the immun


Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.
J Clin Immunol. 1988 Nov;8(6):464-72. Unique Identifier : AIDSLINE MED/89123740
Sei Y; Tsang PH; Roboz JP; Sarin PS; Wallace JI; Bekesi JG; Department of Neoplastic Diseases, Mount Sinai School of; Medicine, New York, New York 10029.
A double-blind longitudinal study for the presence of human immunodeficiency virus type 1 (HIV-1) neutralizing antibodies (NAb) in the sera of 36 patients with acquired immune deficiency syndrome (AIDS), 149 prodromal homosexual subjects, and 33 heterosexual subjects has been carried out. All AIDS patients and 68% of


Monocyte functional studies in asymptomatic, human immunodeficiency disease virus (HIV)-infected individuals.
J Clin Immunol. 1988 Nov;8(6):486-94. Unique Identifier : AIDSLINE MED/89123743
Braun DP; Kessler H; Falk L; Paul D; Harris JE; Blaauw B; Landay A; Department of Internal Medicine, Rush-Presbyterian-St. Luke's; Medical Center, Chicago, Illinois 60612.
Various aspects of monocyte-associated function were evaluated in the peripheral blood mononuclear cells of male homosexuals who were infected with the human immunodeficiency disease virus (HIV). The functional assessments included indomethacin-sensitive regulation of blastogenesis and lymphokine-activated killer (LAK


Antibodies to HIV-1 in sera from patients with mycobacterial infections.
Int J Lepr Other Mycobact Dis. 1988 Dec;56(4):546-51. Unique Identifier : AIDSLINE MED/89124565
ShivRaj L; Patil SA; Girdhar A; Sengupta U; Desikan KV; Srinivasan H; Central JALMA Institute for Leprosy (ICMR), Taj Ganj, Agra,; India.
Sera from 478 persons (348 leprosy patients, 33 tuberculosis patients, 29 healthy contacts of leprosy patients, 38 normal healthy Indians, and 30 normal healthy Europeans) were screened for anti-HIV-1 IgG antibodies by ELISA. None was positive. In addition, 132 samples (from 43 leprosy patients, 21 tuberculosis patien


Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations.
J Acquir Immune Defic Syndr. 1988;1(5):436-40. Unique Identifier : AIDSLINE MED/89125349
Reddy MM; Sorrell SJ; Lange M; Grieco MH; R. A. Cooke Institute of Allergy, St. Luke's-Roosevelt Hospital; Center, New York, NY 10019.
Tumor necrosis factor (TNF) and HIV P24 antigen levels were determined in the serum of intravenous drug abusers (IVDAs), homosexuals, and patients with lymphadenopathy or acquired immune deficiency syndrome (AIDS). The mean TNF level in the serum of normal controls was 12 +/- 5 compared to 112 +/- 25 pg/ml in the seru


Acquired immunodeficiency syndrome transmitted by transplanted kidney: clinical course during maintenance haemodialysis.
Nephrol Dial Transplant. 1988;3(5):681-3. Unique Identifier : AIDSLINE MED/89127927
Imbasciati E; De Cristofaro V; Sama F; Pagliari B; Baretta A; Servizio di Nefrologia, Ospedale di Sondrio, Italy.
We describe the clinical course of a 39-year-old man who developed AIDS during maintenance haemodialysis. The infection had been transmitted by cadaveric kidney transplantation from a donor with a history of i.v. drug abuse. Fever, splenomegaly, hypergammaglobulinaemia and thrombocytopenia were the first signs, and ap


Branhamella catarrhalis septicemia in an infant with AIDS.
Scand J Infect Dis. 1988;20(5):559-60. Unique Identifier : AIDSLINE MED/89130043
Wong VK; Ross LA; Division of Infectious Diseases, Children's Hospital of Los; Angeles, California.
Branhamella catarrhalis was isolated in blood culture from a 6-month-old infant with AIDS. The child had a nasopharyngeal infection with respiratory syncytial virus and pneumonitis with Pneumocystis carinii. Commensal organisms such as B. catarrhalis may be potential pathogens in infants with AIDS.


Communicable diseases--the dentist at risk.
Ann R Australas Coll Dent Surg. 1986 Oct;9:167-71. Unique Identifier : AIDSLINE MED/89133479
Lucas CR
AIDS victims knock at door.
Dentist. 1988 Jan-Feb;66(1):1, 44-5. Unique Identifier : AIDSLINE MED/89106817
Hartley M
Dentists wear gloves, balk at treating victims.
Dentist. 1988 Jan-Feb;66(1):1, 46-7. Unique Identifier : AIDSLINE MED/89106818
Hartley M
Dental discrimination?
Dentist. 1988 May-Jun;66(3):1, 24. Unique Identifier : AIDSLINE MED/89106822
Hartley M
Greene clinic provides care for Los Angeles AIDS victims.
Dentist. 1988 May-Jun;66(3):25. Unique Identifier : AIDSLINE MED/89106823
Formaker J
Infectious disease update.
GMDA Bull. 1988 Jun;55(6):186-7. Unique Identifier : AIDSLINE MED/89108139
Up-to-the-minute news on AIDS.
Ill Dent J. 1988 Jul-Aug;57(4):278-9. Unique Identifier : AIDSLINE MED/89108488
Coburn S
Dental care for AIDS patients [editorial]
Hawaii Dent J. 1988 May;19(5):3, 14. Unique Identifier : AIDSLINE MED/89108965
Lock F
AIDS in Arkansas. AIDS 1988.
J Ark Med Soc. 1988 Jul;85(2):73-85. Unique Identifier : AIDSLINE MED/89109064
Boswell RN
Strategies for journal publication.
J Neurosci Nurs. 1988 Dec;20(6):386-9. Unique Identifier : AIDSLINE MED/89110144
Hodges LC; Poteet GW; School of Nursing, East Carolina University, Greenville, NC; 27858-4353.
Publication in professional journals has become an expectation not only of neuroscience nurse educators but practitioners as well. Through publication, the neuroscience nurse demonstrates commitment to the profession and specialty area by sharing clinical insights and knowledge with colleagues practicing in the field.


More on AIDS.
J Oreg Dent Assoc. 1988 Summer;57(4):31-2. Unique Identifier : AIDSLINE MED/89110612
Woolley LH
Effect of lithium carbonate in HIV-infected patients with immune dysfunction.
J Acquir Immune Defic Syndr. 1988;1(2):119-24. Unique Identifier : AIDSLINE MED/89110712
Parenti DM; Simon GL; Scheib RG; Meyer WA 3d; Sztein MB; Paxton H; DiGioia RA; Schulof RS; Division of Infectious Diseases, George Washington University; Medical Center, Washington, DC 20037.
Ten homosexual men received oral lithium carbonate at doses that maintained their serum lithium concentrations between 0.5 and 1.5 mEq/L. Prior to treatment all patients had HIV isolated from PHA-activated peripheral blood lymphocytes (PBLs) using a quantitative antigen-capture enzyme-linked immunosorbent assay (ELISA


[Indications of dental treatment measures for HIV-infected and AIDS patients]
Quintessenz. 1988 May;39(5):939-40. Unique Identifier : AIDSLINE MED/89113631
Knolle G
[Newest results in AIDS research--of special interest to dentist. Are dental protective measures excessive?]
Quintessenz. 1988 Jun;39(6):1095-6. Unique Identifier : AIDSLINE MED/89113639
Knolle G
[Seborrheic dermatitis and HIV infection (letter)]
Rev Clin Esp. 1988 Oct;183(6):332. Unique Identifier : AIDSLINE MED/89113856
Espana Alonso A; Torroba Alvarez L; Montilla de Mora P; Buzon Rueda LM
Clouded crystal ball.
Sci Am. 1988 Sep;259(3):32-5. Unique Identifier : AIDSLINE MED/89114377
Beardsley T
Is AIDS a communicable disease?
Wis Dent Assoc J. 1988 May;64(5):241. Unique Identifier : AIDSLINE MED/89114825
Van Scotter DE
[Use of a continuous human T-lymphocyte H9 culture for screening chemical preparations that suppress the reproduction of the human immunodeficiency virus]
Vopr Virusol. 1988 Sep-Oct;33(5):565-9. Unique Identifier : AIDSLINE MED/89115241
Nesterchuk SL; Barinskii IF
Studies were carried out on the effectiveness of ribamidil, sodium phosphonoformate, cortisone, and deksazon as inhibitors of human immunodeficiency virus (HIV) reproduction which was tested by immunofluorescence. The drugs were screened in H9/IIIB culture permissively infected with HIV virus, and in H9 culture subseq


Infectious complications in patients with HIV infection.
AIDS. 1988 Oct;2(5):327-34. Unique Identifier : AIDSLINE MED/89117817
Gold JW; Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection.
Clin Exp Immunol. 1988 Oct;74(1):7-13. Unique Identifier : AIDSLINE MED/89119850
Hagler DN; Deepe GS; Pogue CL; Walzer PD; Cincinnati VA Medical Center, University of Cincinnati College of; Medicine, OH 45220.
Proliferative responses by human peripheral blood mononuclear cells and rat spleen cells were measured to Pneumocystis carinii in a blastogenic assay using organisms obtained from rat lungs and propagated in tissue culture as the antigen. Responses occurred only in subjects with known prior exposure to P. carinii and


Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells.
J Clin Immunol. 1988 Nov;8(6):453-8. Unique Identifier : AIDSLINE MED/89123738
Katz JD; Nishanian P; Mitsuyasu R; Bonavida B; Department of Microbiology & Immunology, UCLA School of Medicine; 90024.
The acquired immunodeficiency syndrome (AIDS) is defined in clinical terms by the development of Kaposi s sarcoma and/or severe opportunistic infections in persons without predisposing conditions. A hallmark of the syndrome has been a decrease in the number of CD4+ T helper cells. The reduction in the frequency of the


Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS).
J Clin Immunol. 1988 Nov;8(6):473-8. Unique Identifier : AIDSLINE MED/89123741
Ziegler-Heitbrock HW; Stachel D; Schlunk T; Gurtler L; Schramm W; Froschl M; Bogner JR; Riethmuller G; Institute for Immunology, University of Munich, F.R.G.
In a selected group of human immunodeficiency virus (HIV)-infected patients we confirm the expansion of a CD8+ T-lymphocyte subset, i.e., the CD8+/Leu7+ cells, which account for 30% of the lymphocytes, compared to 3% in the control donors. In addition, a CD8+ T-lymphocyte subset that coexpresses class II (DR) antigens


Precautions reported to be used against cross-infection and attitudes to the dental treatment of HIV-positive patients in routine clinical dental practice in Scotland.
J Dent. 1988 Dec;16(6):258-63. Unique Identifier : AIDSLINE MED/89124041
Pitts NB; Nuttall NM
Synthesis and evaluation of a series of 1-(3-alkyl-2,3-dideoxy-alpha,beta-D-erythro-pentofuranosyl)thymin- es.
Carbohydr Res. 1988 Dec 1;183(2):261-75. Unique Identifier : AIDSLINE MED/89106164
Agyei-Aye K; Baker DC; Department of Chemistry, University of Alabama, Tuscaloosa; 35487-0336.
A series of 1-(3-alkyl-2,3-dideoxy-alpha,beta-D-erythro-pentofuranosyl)thymin- es (3 -alkyl-3 -deoxythymidines) has been prepared from 5-O-(tert-butyldiphenylsilyl)-2,3-dideoxy-D-glycero-pent-2- enono-1,4-lactone ((S)-5-[(tert-butyldiphenylsilyl)oxymethyl]-2(5H)- furanone) by Michael addition of the appropriate organo


Neopterin levels in long-term hemodialysis.
Clin Nephrol. 1988 Oct;30(4):220-4. Unique Identifier : AIDSLINE MED/89106476
Fuchs D; Hausen A; Reibnegger G; Werner ER; von Dittrich P; Wachter H; Institute of Medical Chemistry and Biochemistry, University of; Innsbruck, Austria.
We studied 20 patients on long-term hemodialysis. Concentrations of neopterin and creatinine were quantified in serum and in exchange buffers before, during and after treatment sessions. Neopterin is a low molecular weight product released by human macrophages upon stimulation with interferon gamma. It permits the qua


Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
Crit Rev Immunol. 1988;8(4):315-39. Unique Identifier : AIDSLINE MED/89106700
Farrar WL; Harel-Bellan A; Ferris DK; Biochemical and Molecular Neuroimmunology, National Cancer; Institute, Frederick, Maryland.
The CD4 surface determinant, previously associated as a phenotypic marker for helper/inducer subsets of T lymphocytes, has now been critically identified as the binding/entry protein for human immunodeficiency viruses (HIV). The human CD4 molecule is readily detectable on monocytes, T lymphocytes, and brain tissues. S


Characterization of cytomegalovirus isolates from patients with AIDS by DNA restriction analysis.
Epidemiol Infect. 1988 Dec;101(3):483-94. Unique Identifier : AIDSLINE MED/89107440
Taylor DL; Taylor-Robinson D; Jeffries DJ; Tyms AS; Department of Medical Microbiology, St Mary's Hospital Medical; School, Paddington, London.
Thirty-seven isolates of cytomegalovirus ( CMV ) were obtained from a group of 20 promiscuous homosexual men, either suffering from the acquired immunodeficiency syndrome (AIDS) at the time of CMV isolation, or who developed AI


Viral diseases of concern to the dental team.
Dent Assist. 1988 May-Jun;57(3):12-5. Unique Identifier : AIDSLINE MED/89107655
Parks ET
AIDS and dentistry: a complex challenge.
Dent Assist. 1988 May-Jun;57(3):7-11. Unique Identifier : AIDSLINE MED/89107663
Runnells RR
A heat-shock-inducible eukaryotic expression vector.
Gene. 1988 Nov 15;71(1):207-10. Unique Identifier : AIDSLINE MED/89108041
Schweinfest CW; Jorcyk CL; Fujiwara S; Papas TS; Laboratory of Molecular Oncology, National Cancer Institute,; Frederick, MD 21701-1013.
We describe a construct, pHS/Cla, containing the Drosophila melanogaster hsp70 promoter which serves as an inducible expression vector in mammalian cells. The construct was made in the plasmid pAT153, a derivative of pBR322. In transient transfections of human H9 T-cells, the transactivator of transcription protein of


Central motor and sensory conduction in adrenoleukomyeloneuropathy, cerebrotendinous xanthomatosis, HTLV-1-associated myelopathy and tabes dorsalis.
J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1069-74. Unique Identifier : AIDSLINE MED/89110313
Ugawa Y; Kohara N; Shimpo T; Mannen T; Department of Neurology, School of Medicine, University of Tokyo,; Japan.
Central motor and sensory conduction was studied by percutaneous electrical stimulation of brain and spinal cord and by somatosensory evoked potential techniques respectively, in patients with adrenoleukomyeloneuropathy, cerebrotendinous xanthomatosis, human T-cell lymphotropic virus-1-associated myelopathy and tabes


AIDS: animal retrovirus models and vaccines.
J Acquir Immune Defic Syndr. 1988;1(3):284-94. Unique Identifier : AIDSLINE MED/89110730
Kurth R; Kraus G; Werner A; Hartung S; Centner P; Baier M; Norley S; Lower J; Paul-Ehrlich-Institut, Frankfurt/Main, F.R.G.
[Acquired immunodeficiency syndrome (AIDS) with cytomegalovirus adrenalitis and Pneumocystis carinii pneumonia]
Rinsho Ketsueki. 1988 May;29(5):711-7. Unique Identifier : AIDSLINE MED/89111315
Shimizu E; Tsujimoto M; Nakamine H; Ohta K; Takenaka T; Maeda J
Lentiviruses of animals are biological models of the human immunodeficiency viruses.
Microb Pathog. 1988 Sep;5(3):149-57. Unique Identifier : AIDSLINE MED/89111896
Narayan O; Zink MC; Huso D; Sheffer D; Crane S; Kennedy-Stoskopf S; Jolly PE; Clements JE; Division of Comparative Medicine, Johns Hopkins University School; of Medicine, Baltimore, MD 21205.
Increased incidence of malignant lymphoma in AIDS: a comparison of risk groups and possible etiologic factors.
Mt Sinai J Med. 1988 Oct;55(5):383-9. Unique Identifier : AIDSLINE MED/89112238
Beckhardt RN; Farady N; May M; Torres RA; Strauchen JA
[Antiviral drugs--1988]
Schweiz Med Wochenschr. 1988 Dec 10;118(49):1830-7. Unique Identifier : AIDSLINE MED/89114337
Hirschel B; Division des maladies infectieuses, Hopital cantonal; universitaire, Geneve.
Acyclovir ( Zovirax ) and zidovudine (Retrovir) dominate antiviral therapy. They interfere with the multiplication of herpes viruses (acyclovir) and HIV (zidovudine) by incorporation into nascent DNA chains and interruption of the further li


Cytomegalovirus gastritis as an initial manifestation of a patient with adult T-cell leukemia.
Acta Haematol. 1988;80(4):216-8. Unique Identifier : AIDSLINE MED/89115730
Furukawa Y; Nakamura H; Sakamoto S; Miura Y; Department of Medicine, Jichi Medical School, Tochigi-ken, Japan.
A 39-year-old woman was admitted to the hospital because of epigastric pain and diagnosed as having gastritis. After 3 months, she developed generalized lymphadenopathy, and a biopsy revealed diffuse proliferation of CD4 positive lymphoid cells. She was positive for human T-cell leukemia virus type-I antibody and the


AIDS and dialysis [letter]
Am J Nephrol. 1988;8(6):512. Unique Identifier : AIDSLINE MED/89116298
Berlyne GM
Statistics from the World Health Organization and the Centers for Disease Control.
AIDS. 1988 Oct;2(5):409-12. Unique Identifier : AIDSLINE MED/89117837
Amino acid sequence similarity between retroviral and E. coli RNase H and hepadnaviral gene products [letter]
AIDS Res Hum Retroviruses. 1988 Dec;4(6):ix-xi. Unique Identifier : AIDSLINE MED/89118007
Schodel F; Weimer T; Will H; Sprengel R
Genomic organization of the human spumaretrovirus and its relatedness to AIDS and other retroviruses.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):467-73. Unique Identifier : AIDSLINE MED/89118016
Maurer B; Flugel RM; Institut fur Virusforschung, Deutsches Krebsforschungszentrum,; Heidelberg, FRG.
The human spumaretrovirus (HSRV) isolated from a nasopharynx carcinoma patient 17 years ago has a RNA genome 11 kb in size. It encodes besides the gag, pol, and env genes several novel genes (S1 and bel 1, 2, and 3) that are comparable to the regulatory genes R, X, tat, art, and 3 -orf of the human (HIVs) and simian i


[A potential AIDS vaccine tester (news)]
Fortschr Med. 1988 Jul 30;106(22):14-5. Unique Identifier : AIDSLINE MED/89121756
Involvement of oncogene-coded growth factors in the neoplastic process.
Gene Amplif Anal. 1986;4:161-76. Unique Identifier : AIDSLINE MED/89121973
Robbins KC; King CR; Giese NA; Leal F; Igarashi H; Aaronson SA; Laboratory of Cellular and Molecular Biology, National Cancer; Institute, Bethesda, Maryland 20892.
Retroviruses in dermatology.
Int J Dermatol. 1988 Sep;27(7):463-7. Unique Identifier : AIDSLINE MED/89122380
Lisby G; Lisby S; Wantzin GL; Department of Dermatology, Bispebjerg Hospital, Copenhagen,; Denmark.
Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses.
J Acquir Immune Defic Syndr. 1988;1(5):425-30. Unique Identifier : AIDSLINE MED/89125347
Chirmule N; Kalyanaraman V; Oyaizu N; Pahwa S; Department of Pediatrics, North Shore University Hospital,; Cornell University Medical College, Manhasset, NY 11030.
Infection with the human immunodeficiency virus (HIV-1) leads to a wide range of immunological abnormalities. We have shown that native envelope glycoproteins (gp120) of HIV-1 inhibit antigen-specific and anti-CD3 induced lymphoproliferation of normal lymphocytes. We have demonstrated that gp120 binds to CD4 positive


Cis-acting sequences responsive to the rev gene product of the human immunodeficiency virus.
J Acquir Immune Defic Syndr. 1988;1(5):441-52. Unique Identifier : AIDSLINE MED/89125350
Dayton AI; Terwilliger EF; Potz J; Kowalski M; Sodroski JG; Haseltine WA; Department of Pathology, Harvard Medical School, Dana-Farber; Cancer Institute, Boston, MA 02115.
Expression of high levels of the structural proteins of the human immunodeficiency virus type 1 (HIV-1) requires the presence of two regulatory genes, the trans-activator (tat), and the regulator of virion protein expression (rev. previously called art or trs). The experiments described here show that expression of vi


Diagnostic findings in patients with acquired immune deficiency syndrome (AIDS).
J Acquir Immune Defic Syndr. 1988;1(5):459-65. Unique Identifier : AIDSLINE MED/89125352
Klatt EC; Department of Pathology, University of Southern California School; of Medicine, Los Angeles.
The clinical and autopsy findings documented in 216 patients with the acquired immune deficiency syndrome (AIDS) are summarized. The respiratory system was most often involved with opportunistic infections and neoplasms diagnostic of AIDS, accounting for one-fourth of all such occurrences. Respiratory failure was the


[Epidemiology of infections caused by human immunodeficiency viruses HIV-1 and HIV-2 in the Ivory Coast]
Med Trop (Mars). 1988 Oct-Dec;48(4):375-9. Unique Identifier : AIDSLINE MED/89126894
Ouattara SA; Diallo D; Meite M; Aron Y; Akran V; Gody M; Schmidt D; Tolstuchow N; De-The G; Institut Pasteur de Cote d'Ivoire, Faculte de Pharmacie,; l'Universite d'Abidjan.
A study of antibodies to HIV1 and HIV2 has been performed among selected groups in Ivory Coast from January to December 1987. In total, 2,578 serum samples were examined. A seropositivity to HIV1 and/or HIV2 was observed in 32 (2.4%) of 1.334 healthy subjects of the general po


Efficacy and safety of two different dose levels of ganciclovir for the treatment of cytomegalovirus chorioretinitis in AIDS patients.
Scand J Infect Dis. 1988;20(5):479-82. Unique Identifier : AIDSLINE MED/89130031
Gaub J; Poulsen AG; Pedersen C; Tinning S; Hojgaard K; Thomson MH; Faber V; Nielsen JO; Department of Infectious Diseases, Rigshospitalet, Copenhagen,; Denmark.
The effect of different dosages of ganciclovir on proved cytomegalovirus chorioretinitis was tested in a randomized trial on 11 homosexual men with AIDS. The effect of 5 mg/kg/day was as good as 10 mg/kg/day. The lower dosage had less toxicity.


[Serologic and clinical study of post-transfusion viral contamination after cardiac surgery. Excluding human immunodeficiency virus]
Arch Mal Coeur Vaiss. 1988 Oct;81(10):1199-203. Unique Identifier : AIDSLINE MED/89133676
Petitjean J; Khayat MC; Laforet F; Quibriac M; Freymuth F; Khayat A; Evrard C; Thomas M; Laboratoire de virologie, CHU de Caen.
The incidence of post-transfusion viral contamination after cardiac surgery is variable but not negligible. The serological and clinical features of such contamination were determined in a series of 100 consecutive patients seen between June, 1983 and January, 1984. The ELISA technique was used for hepatitis A and B v


Interaction of HIV infection with nervous tissue may play a crucial role in the development of AIDS.
Ann Inst Pasteur Virol. 1988 Oct-Dec;139(4):467-76. Unique Identifier : AIDSLINE MED/89105478
Parisi G; Dipartimento di Fisica, Universita di Roma Tor Vergata.
In this note, we first review some of the immunopathogenic mechanisms of HIV infection and discuss the possible role of the idiotypic network in producing immunodeficiency; we then propose that the interaction of HIV with the nervous system is such as to generate signals which are misinterpreted by the nervous system:


Montreal to host V International Conference on AIDS in June 1989 [news]
J Can Dent Assoc. 1988 Dec;54(12):877. Unique Identifier : AIDSLINE MED/89105921
Serological studies on health care workers caring for patients with human immunodeficiency virus.
J Hosp Infect. 1988 Aug;12(2):85-9. Unique Identifier : AIDSLINE MED/89110003
Evans R; Shanson DC; Department of Clinical Microbiology, St Stephen's Hospital,; London.
Between 1982 and July 1987, more than 1200 patients attending St Stephen s Hospital were found to be HIV antibody positive. Four hundred were inpatients and most of the outpatients attended the sexually transmitted disease clinic. Two hundred and twenty-one patients had AIDS, 480 HIV-related disorders and 500 were asy


What about mosquitoes and saliva? Or, is the human immunodeficiency virus transmitted in other ways?
J Okla State Med Assoc. 1988 Jul;81(7):399-400. Unique Identifier : AIDSLINE MED/89110571
Istre GR
Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola.
J Acquir Immune Defic Syndr. 1988;1(1):8-12. Unique Identifier : AIDSLINE MED/89110709
Bottiger B; Palme IB; da Costa JL; Dias LF; Biberfeld G; Department of Immunology, National Bacteriological Laboratory,; Stockholm, Sweden.
A seroepidemiological study of human immune deficiency virus type 1 (HIV-1) and HIV-2/human T-lymphotropic virus type IV (HIV-2/HTLV-IV) infections was performed in Angola in October 1986. Until then five cases of acquired immune deficiency syndrome (AIDS) had been registered in An


A randomized placebo-controlled trial of recombinant human interferon alpha 2a in patients with AIDS. Interferon Alpha Study Group.
J Acquir Immune Defic Syndr. 1988;1(2):111-8. Unique Identifier : AIDSLINE MED/89110711
We performed a randomized, double-blind, placebo-controlled trial to assess the tolerance and efficacy of recombinant human interferon alpha 2a (Roferon A) in patients with acquired immunodeficiency syndrome (AIDS) without Kaposi s sarcoma. A total of 67 patients were enrolled in five medical centers from October 1983


IV International Conference on AIDS, June 12, 1988. Keynote address.
J Acquir Immune Defic Syndr. 1988;1(3):207-8. Unique Identifier : AIDSLINE MED/89110723
Kallings LO; National Bacteriological Laboratory, Stockholm, Sweden.
Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS.
J Acquir Immune Defic Syndr. 1988;1(4):390-5. Unique Identifier : AIDSLINE MED/89110746
Detels R; English PA; Giorgi JV; Visscher BR; Fahey JL; Taylor JM; Dudley JP; Nishanian P; Munoz A; Phair JP; et al; Multicenter AIDS Cohort Study, National Institute of Allergy and; Infectious Disease, Bethesda, Maryland.
Successive interval slopes of CD4+ cells each constructed from levels at three consecutive 6 month visits were compared over 3 years of follow-up among 565 persistently HIV-1 antibody-positive, 326 persistently antibody-negative, and 51 seroconverting homosexual men who had at least 500 CD4+ cells/mm3 at baseline and


Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus.
J Acquir Immune Defic Syndr. 1988;1(4):396-404. Unique Identifier : AIDSLINE MED/89110747
Munoz A; Carey V; Saah AJ; Phair JP; Kingsley LA; Fahey JL; Ginzburg HM; Polk BF; Department of Epidemiology, Johns Hopkins School of Public; Health, Baltimore, MD 21205.
Longitudinal data on four visits scheduled at 6 month intervals were available on a cohort of 1,827 homosexual men who were human immunodeficiency virus (HIV) seropositive at entry. To identify predictors of the rate of decline of CD4 T-lymphocytes, we used an autoregressive model that relates CD4 counts to predictor


[Prognostic significance of the T4 lymphocyte count in patients infected with CDC Class II and III HIV]
Schweiz Med Wochenschr. 1988 Dec 10;118(49):1844-6. Unique Identifier : AIDSLINE MED/89114339
Ruttimann S; Lavanchy JD; Meyer JL; Steinmann E; Medizinische Universitats-Poliklinik, Departement fur Innere; Medizin, Kantonsspital, Basel.
From 1985 to 1987 101 patients infected with the human immunodeficiency virus (HIV) were seen at our outpatient clinic and prospectively analyzed in a cohort study. We evaluated the follow-up in 41 patients of CDC classes II and III with regard to the number of T-helper lymphocytes (T4) and clinical progression. The p


Report from Stockholm.
Sci Am. 1988 Aug;259(2):14-5. Unique Identifier : AIDSLINE MED/89114361
Benditt J
[Electron microscopic immunohistochemistry in the diagnosis of human lymphotropic viral diseases]
Vopr Onkol. 1988;34(12):1439-42. Unique Identifier : AIDSLINE MED/89115131
Timar J; Smirnova EA; Lapis K
Immunohistochemistry is finding an ever increasing application for electron microscopic diagnosis of human viral diseases. Certain progress has been made in the use of peroxidase-DAB/OsO4 as an electron-dense marker, and colloid gold. The paper discusses immunohistochemistry application for electron microscopic detect


[Infection caused by the human immunodeficiency virus type 2 in the USSR]
Zh Mikrobiol Epidemiol Immunobiol. 1988 Oct;(10):18-20. Unique Identifier : AIDSLINE MED/89115646
Pokrovskii VV; Suvorova ZK; Mangushev TN
The serological study of 20 sera, showing atypical reaction with HIV-1 in the immunoblotting assay, for the presence of HIV-2 infection revealed some cases of this infection among Africans who had arrived to the USSR from Western Africa (5 cases) and Burundi (1 case); besides, in


Esophageal candidiasis and immunodeficiency associated with acute HIV infection [letter]
AIDS. 1988 Oct;2(5):399-400. Unique Identifier : AIDSLINE MED/89117829
Cilla G; Perez Trallero E; Furundarena JR; Cuadrado E; Iribarren JA; Neira F
Decline in CD4+ cell numbers reflects increase in HIV-1 replication.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):433-40. Unique Identifier : AIDSLINE MED/89118012
De Wolf F; Roos M; Lange JM; Houweling JT; Coutinho RA; van der Noordaa J; Schellekens PT; Goudsmit J; Department of Virology, University of Amsterdam.
Changes in CD4+ cell numbers were studied in relation to the presence of HIV-1 antigen (HIV-1-Ag) in serum from homosexual men followed prospectively. During 30 months of follow-up the mean CD4+ cell number (x 10(9) per liter) was stable in 134 at entry HIV-1 antibody (HIV-1-Ab) seropositives, who remained HIV-1-Ag ne


Perspectives for the chemotherapy of AIDS.
Chemioterapia. 1988 Dec;7(6):357-64. Unique Identifier : AIDSLINE MED/89119616
De Clercq E; Rega Institute for Medical Research, Katholieke Universiteit; Leuven, Belgium.
Several steps in the replicative cycle of human immunodeficiency virus (HIV) could be envisaged as targets for anti-AIDS drugs. The anionic compound PMEA [9-(2-phosphonyl-methoxyethyl)adenine], the 2 3 -dideoxynucleoside analogues D4T (2 ,3-deidehydro-2 ,3 -dideoxythymidine), AzddUrd 3 -azido-2 ,3 -dideoxyuridine), Fd


HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus.
Eur J Immunol. 1988 Dec;18(12):1917-24. Unique Identifier : AIDSLINE MED/89120927
Michel F; Hoffenbach A; Langlade-Demoyen P; Guy B; Girard M; Lecocq JP; Wain-Hobson S; Kieny MP; Plata F; Laboratoire de Biologie et d'Immunologie Moleculaires des; Retrovirus, Institut Pasteur, Paris, France.
Infection by the human immunodeficiency virus (HIV) induces T cell immunity in humans, chimpanzees and macaques. The protective value of this immune response is not clear. We have consequently developed a murine experimental system to study HIV-specific CD4 and CD8 T lymphocyte immunity in vitro and in vivo. BALB/c, D


HTLV-V: a new human retrovirus associated with cutaneous T-cell lymphoma (mycosis fungoides).
Int J Dermatol. 1988 Sep;27(7):473-4. Unique Identifier : AIDSLINE MED/89122382
Fine RM; Department of Dermatology, Emory University School of Medicine,; Decatur, Georgia.
The D-mannose-specific lectin from Gerardia savaglia blocks binding of human immunodeficiency virus type I to H9 cells and human lymphocytes in vitro.
J Acquir Immune Defic Syndr. 1988;1(5):453-8. Unique Identifier : AIDSLINE MED/89125351
Muller WE; Renneisen K; Kreuter MH; Schroder HC; Winkler I; Institut fur Physiologische Chemie, Universitat, Mainz, F.R.G.
The new D-mannose-specific lectin from Gerardia savaglia is shown to prevent infection of H9 cells with human immunodeficiency virus type 1 (HIV-1; strain HTLV-IIIB). At a concentration of 0.2 microM, complete protection was achieved. Even at a 50-fold higher concentration, this lectin is not toxic for the cells. More


[The Nurses' Association of New Brunswick and AIDS]
Can Nurse. 1989 Jan;85(1):13, 46. Unique Identifier : AIDSLINE MED/89106097
I have AIDS.
Can Nurse. 1989 Jan;85(1):14-7. Unique Identifier : AIDSLINE MED/89106098
Morgan D
[Prevention, why resist it?]
Can Nurse. 1989 Jan;85(1):34-7. Unique Identifier : AIDSLINE MED/89106104
Laurin JC
Prevention, why resist it? Based on a 1988 speech the author gave to infection control professionals in Montreal, this article draws a parallel between individuals resistance to change and their reaction to infection control programs. Gladly, many of the same well-honed techniques that help change along can be applie


More on AIDS autopsies: the importance of compliance with universal precautions [letter]
Hum Pathol. 1989 Jan;20(1):92-3. Unique Identifier : AIDSLINE MED/89108425
Simons EL
Monoclonal antibody solution hybridization assay for detection of human immunodeficiency virus nucleic acids.
J Clin Microbiol. 1989 Jan;27(1):120-5. Unique Identifier : AIDSLINE MED/89109461
Viscidi RP; O'Meara C; Farzadegan H; Yolken R; Department of Medicine, Johns Hopkins University School of; Medicine, Baltimore, Maryland 21205.
In this report we describe a novel, nonisotopic hybridization assay for the measurement of viral RNA in biological samples. The assay involved a solution-phase reaction between a biotinylated DNA probe and RNA target sequences. Labeled hybrids were detected in an immunoreaction by using a solid-phase anti-biotin antib


Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis [see comments]
J Clin Microbiol. 1989 Jan;27(1):179-81. Unique Identifier : AIDSLINE MED/89109473
Vasudevachari MB; Uffelman KW; Mast TC; Dewar RL; Natarajan V; Lane HC; Salzman NP; Division of Molecular Virology and Immunology, Georgetown; University School of Medicine, Washington, D.C. 20007.
A passive hemagglutination test (PHA) was developed for detecting antibodies to human immunodeficiency virus type 1 (HIV-1) utilizing sheep erythrocytes cross-linked with purified envelope glycoprotein (gp160) of HIV-1. In an analysis of 216 human serum samples, 100% correlation was observed in 86 reactive and 124 non


Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus.
J Clin Microbiol. 1989 Jan;27(1):41-8. Unique Identifier : AIDSLINE MED/89109497
Rappocciolo G; Toso JF; Torpey DJ 3d; Gupta P; Rinaldo CR Jr; Department of Infectious Diseases and Microbiology, Graduate; School of Public Health, University of Pittsburgh, Pennsylvania; 15261.
Mononuclear leukocytes from human immunodeficiency virus (HIV)-seronegative and -seropositive homosexual men lysed HIV-infected U937 cells to a significantly greater degree than uninfected U937 cells. Depletion of cell subsets with monoclonal antibodies and complement indicated that the effector cells were primarily o


Isolation of human immunodeficiency virus from peripheral blood lymphocytes stored in various transport media and frozen at -60 degrees C.
J Clin Microbiol. 1989 Jan;27(1):88-90. Unique Identifier : AIDSLINE MED/89109507
Gallo D; Kimpton JS; Johnson PJ; Viral and Rickettsial Disease Laboratory, State of California; Department of Health Services, Berkeley 94704.
The peripheral blood lymphocytes from 48 heparinized blood specimens from human immunodeficiency virus (HIV) antibody-positive individuals were divided into two aliquots. One aliquot was reconstituted in one of the following five media. Medium 1 consisted of tryptose broth with 0.5% gelatin; medium 2 consisted of RPMI


Human immunodeficiency virus infection and porphyria cutanea tarda.
J Am Acad Dermatol. 1989 Jan;20(1):17-20. Unique Identifier : AIDSLINE MED/89109715
Hogan D; Card RT; Ghadially R; McSheffrey JB; Lane P; Department of Medicine, University of Saskatchewan, Saskatoon,; Canada.
A recent report documents three homosexual men with porphyria cutanea tarda associated with acquired immune deficiency syndrome (AIDS). We report two brothers with hemophilia and human immunodeficiency virus (HIV) exposure who developed porphyria cutanea tarda. These brothers are heterosexual, have familial porphyria


Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis.
J Am Acad Dermatol. 1989 Jan;20(1):76-82. Unique Identifier : AIDSLINE MED/89109724
Kaplan MH; Sadick NS; Wieder J; Farber BF; Neidt GW; Department of Medicine, Cornell University Medical College, North; Shore University Hospital, Manhasset, NY 11030.
Four patients with psoriasis complicating human immunodeficiency virus (HIV) infection showed marked improvement in their psoriasis after being treated with oral zidovudine. The antipsoriatic effect persisted in two patients in spite of worsening helper T cell depletion. The antipsoriatic effect appeared to be dose-de


Immunodeficiency in patients with hemophilia: an underlying deficiency and lack of correlation with factor replacement therapy or exposure to human immunodeficiency virus.
J Allergy Clin Immunol. 1989 Jan;83(1):165-70. Unique Identifier : AIDSLINE MED/89109890
Jin ZW; Cleveland RP; Kaufman DB; Department of Pediatrics and Human Development, Michigan State; University, East Lansing 48824.
Nineteen patients with hemophilia, five of whom were classified as untreated, were immunologically evaluated by the measurement of cell surface markers, natural killer cell activity, mitogenic responses, polyclonal immunoglobulin production, and serologic evidence of human immunodeficiency virus infection. No correlat


Management of HIV-1 infection in the hospital setting.
Infect Control Hosp Epidemiol. 1989 Jan;10(1):3-7. Unique Identifier : AIDSLINE MED/89109936
Weber DJ; Rutala WA; Department of Medicine, University of North Carolina School of; Medicine, Chapel Hill 27599-7030.
Third Party Payors' view of AIDS.
J Med Assoc Ga. 1989 Jan;78(1):27-8. Unique Identifier : AIDSLINE MED/89110219
Shanor P
Updated recommendations for ophthalmic practice in relation to the human immunodeficiency virus.
J Ophthalmic Nurs Technol. 1989 Jan-Feb;8(1):15-20. Unique Identifier : AIDSLINE MED/89111034
Leads from the MMWR. Years of potential life lost before age 65--United States, 1987.
JAMA. 1989 Feb 10;261(6):823, 827. Unique Identifier : AIDSLINE MED/89111210
Cessation of zidovudine therapy may lead to increased replication of HIV-1 [letter]
JAMA. 1989 Feb 10;261(6):865-6. Unique Identifier : AIDSLINE MED/89111217
Wainberg MA; Falutz J; Fanning M; Gill J; Gelmon K; Montaner JS; O'Shaughnessy M; Tsoukas C; Ruedy J
Disinfecting barbers' instruments [letter]
N Engl J Med. 1989 Feb 9;320(6):402. Unique Identifier : AIDSLINE MED/89112295
Koffler M; Yust I
Screening for human immunodeficiency virus infections [letter]
N Engl J Med. 1989 Feb 16;320(7):461-3. Unique Identifier : AIDSLINE MED/89112307
More on transmission of HIV by blood transfusion [letter]
N Engl J Med. 1989 Feb 16;320(7):463. Unique Identifier : AIDSLINE MED/89112308
Perkins HA
On infection control [letter]
N Y State Dent J. 1989 Jan;55(1):6, 8. Unique Identifier : AIDSLINE MED/89112671
Carl W
Drugs that keep AIDS patients alive.
RN. 1989 Feb;52(2):35-41. Unique Identifier : AIDSLINE MED/89114179
Robertson S
A battery of once-obscure drugs is buying time for AIDS patients. Expect toxicity when you administer them, and know the interventions that can keep the patient s discomfort at a minimum.


[Professional risk of infection by the AIDS virus]
Schweiz Monatsschr Zahnmed. 1989;99(1):127. Unique Identifier : AIDSLINE MED/89114352
Culand H
AIDS and the dentist [letter]
S Afr Med J. 1989 Jan 21;75(2):87. Unique Identifier : AIDSLINE MED/89114565
Several dozen call AIDS hotline.
W V Med J. 1989 Feb;85(2):65. Unique Identifier : AIDSLINE MED/89115271
Sex practice correlates of human immunodeficiency virus transmission and acquired immunodeficiency syndrome incidence in heterosexual partners and offspring of U.S. hemophilic men.
Am J Hematol. 1989 Feb;30(2):68-76. Unique Identifier : AIDSLINE MED/89116145
Lawrence DN; Jason JM; Holman RC; Heine P; Evatt BL; Division of Host Factors, Centers for Disease Control, Atlanta,; GA.
We assessed the risk of human immunodeficiency virus (HIV) transmission from heterosexual seropositive hemophilic men to their female sex partners through an HIV serosurvey and questionnaire study conducted during 1984-1987. Five percent of 21 female partners of asymptomatic men and 11% of 35 partners of HIV-symptomat


Yersinia enterocolitica bacteremia in a patient with the acquired immunodeficiency syndrome.
Am J Med. 1989 Feb;86(2):254-5. Unique Identifier : AIDSLINE MED/89116267
Cohen JI; Rodday P; Brigham and Women's Hospital, Boston, Massachusetts 02115.
The rash of roses.
Arch Dermatol. 1989 Feb;125(2):196-8. Unique Identifier : AIDSLINE MED/89117170
Hall CB
Cell association of HIV in AIDS-related encephalopathy and dementia.
APMIS. 1989 Jan;97(1):79-90. Unique Identifier : AIDSLINE MED/89117963
Porwit A; Parravicini C; Petren AL; Barkhem T; Costanzi G; Josephs S; Biberfeld P; Dept. of Pathology, Karolinska Hospital, Stockholm, Sweden.
The presence of HIV gag and env proteins (HIV Ag) and virus replicating cells was studied by immunohistochemistry and in situ hybridization, respectively, in brain specimens from five HIV infected patients. HIV antigens were detected in 3 of 5 brains in micronodular areas characterized by increased cellularity and the


Evaluation of a rapid test for detection of antibodies against human immunodeficiency virus (HIV).
APMIS. 1989 Jan;97(1):95-6. Unique Identifier : AIDSLINE MED/89117966
Josefsen D; Myrmel H; Department of Microbiology and Immunology, Gade Institute,; Haukeland Hospital, Bergen, Norway.
A new test for rapid detection of HIV antibodies (HIVCHEK) was evaluated. A total of 107 sera were examined. Of these, 60 were from healthy blood donors and the rest from a serum panel containing HIV positives and samples with false positive reactions in ELISA and unspecific bands in the western blot (WB). There was c


Informed consent to HIV testing [letter]
Can Med Assoc J. 1989 Feb 1;140(3):262. Unique Identifier : AIDSLINE MED/89119279
Parker JE
Hopelessness and helplessness: treating the doctors who treat AIDS patients.
Can Med Assoc J. 1989 Feb 15;140(4):440-3. Unique Identifier : AIDSLINE MED/89119318
LeBourdais E
Learning from Mark.
Can Nurse. 1989 Feb;85(2):22-3. Unique Identifier : AIDSLINE MED/89119406
Tisdale R
[Facing AIDS in Zambia]
Can Nurse. 1989 Feb;85(2):35-7. Unique Identifier : AIDSLINE MED/89119410
Pelletier PG
An alternative approach to AIDS in Zambia . Zambians have lived with what we now call AIDS for 20 years. Today, an estimated eight percent of newborns are infected with the virus. Yet dealing with AIDS in this traditional society is an onerous task. While the country s 10,000 nurses


Follow-up of monoclonal gammopathies in asymptomatic HIV-infected subjects [letter]
Clin Chem. 1989 Feb;35(2):338-9. Unique Identifier : AIDSLINE MED/89119826
Lefrere JJ; Fine JM; Marneux M; Lambin P; Salmon C
Evidence for an HIV-related nephropathy: a clinico-pathological study.
Clin Nephrol. 1989 Jan;31(1):12-7. Unique Identifier : AIDSLINE MED/89119866
Soni A; Agarwal A; Chander P; Yoo J; Singal D; Salomon N; Robinson B; Treser G; Department of Internal Medicine, New York Medical College,; Lincoln Medical Center, Bronx 10451.
The existence of an HIV-related nephropathy as a distinct disease entity is controversial. We observed a high incidence of renal disease in our AIDS patients. Of 182 patients, 59 patients (32.4%) were found to have heavy proteinuria (greater than 2 g/24 h). Of these, 24 patients had slow progression of renal insuffici


Admission of AIDS patients to a medical intensive care unit: causes and outcome [see comments]
Crit Care Med. 1989 Feb;17(2):113-7. Unique Identifier : AIDSLINE MED/89120146
Rogers PL; Lane HC; Henderson DK; Parrillo J; Masur H; Critical Care Medicine Department, National Institute of Allergy; and Infectious Disease, Bethesda, MD.
As the number of cases of AIDS increases, it is important to determine whether ICUs can be productively and safely used for this patient population. From July 1981 to March 1987, 216 patients were admitted to the medical ICU: 166 (77%) were admitted for procedures and 50 (23%) were admitted for life-sustaining support


Is AIDS a biasing factor in teacher judgment?
Except Child. 1989 Jan;55(4):342-5. Unique Identifier : AIDSLINE MED/89120887
Walker DW; Hulecki MB
This study examined the effect that knowledge of a student having AIDS (Acquired Immune Deficiency Syndrome) would have on regular-education teacher judgment regarding special education placement. Regular-education, third-grade teachers in Indiana were sent one of two psychological reports. The reports were identical


Highlights of the 40th Institute on Hospital and Community Psychiatry.
Hosp Community Psychiatry. 1989 Feb;40(2):113-8. Unique Identifier : AIDSLINE MED/89121913
Moriarty K; Wagner J
The management of HIV infection in state psychiatric hospitals.
Hosp Community Psychiatry. 1989 Feb;40(2):153-7. Unique Identifier : AIDSLINE MED/89121918
Cournos F; Empfield M; Horwath E; Kramer M; Washington Heights Community Service, New York State Psychiatric; Institute, New York 10032.
Patients with AIDS and related illnesses are entering state mental hospitals in increasing numbers. State hospitals in New York City generally did not plan for patients infected with human immunodeficiency virus (HIV) until the first patient appeared; however, over the past five years, approaches to managing these pat


Warning third parties at risk of AIDS: APA's policy is a barrier to treatment.
Hosp Community Psychiatry. 1989 Feb;40(2):158-61. Unique Identifier : AIDSLINE MED/89121919
Perry S; Consultation-Liaison Service, New York Hospital-Cornell Medical; Center, New York 10021.
The American Psychiatric Association has adopted a policy stating that psychiatrists may warn third parties who are placed at risk by the behavior of a patient infected with human immunodeficiency virus (HIV). The author argues that although the policy appears reasonable and has well-established precedent, the public


Warning third parties at risk of AIDS: APA's policy is a reasonable approach.
Hosp Community Psychiatry. 1989 Feb;40(2):162-4. Unique Identifier : AIDSLINE MED/89121920
Zonana H; Yale University School of Medicine, New Haven, Connecticut 06519.
The author argues that the American Psychiatric Association s AIDS policy on confidentiality and disclosure provides reasonable guidelines for psychiatrists struggling to balance their obligation to maintain the confidentiality of individual patients infected with human immunodeficiency virus (HIV) with their obligati


Papulonodular demodicidosis associated with acquired immunodeficiency syndrome.
J Am Acad Dermatol. 1989 Feb;20(2 Pt 1):197-201. Unique Identifier : AIDSLINE MED/89123979
Dominey A; Rosen T; Tschen J; Veterans Administration Medical Center, Houston, TX 77211.
We describe a papulonodular variant of demodicidosis seen in two patients with acquired immunodeficiency syndrome and its successful treatment with 1% gamma benzene hexachloride and 1% permethrin cream rinse. Alterations in T cell function may allow otherwise commensal organisms to proliferate to the point of causing


Granuloma annulare in patients with human immunodeficiency virus infections.
J Am Acad Dermatol. 1989 Feb;20(2 Pt 1):232-5. Unique Identifier : AIDSLINE MED/89123985
Ghadially R; Sibbald RG; Walter JB; Haberman HF; Department of Dermatology, University of Toronto, Ontario,; Canada.
We present four cases of granuloma annulare occurring in patients with human immunodeficiency virus (HIV) infection. These patients had either an extensive localized form or generalized granuloma annulare. The patient with generalized granuloma annulare was clinically reminiscent of the previously described papular er


Syphilis associated with human immunodeficiency virus infection [letter]
J Am Acad Dermatol. 1989 Feb;20(2 Pt 1):295. Unique Identifier : AIDSLINE MED/89123999
Held JL; Grossman ME
Atypical granuloma annulare in patients with the acquired immunodeficiency syndrome [letter; comment]
J Am Acad Dermatol. 1989 Feb;20(2 Pt 1):299-300. Unique Identifier : AIDSLINE MED/89124004
Jones SK; Harman RR
Acquired immunodeficiency syndrome and disseminated histoplasmosis [letter]
J Infect. 1989 Jan;18(1):101-2. Unique Identifier : AIDSLINE MED/89124409
Puente Puente S; Laguna Cuesta F; Jauregui Ibabe C; Martinez Santos P
Human immunodeficiency virus infection in the United Kingdom: quarterly report 3.
J Infect. 1989 Jan;18(1):77-88. Unique Identifier : AIDSLINE MED/89124420
Up to 31 March 1988, 1429 cases meeting the World Health Organization /Centers for Disease Control (U.S.A.) definition of the acquired immune deficiency syndrome (AIDS) were reported in the U.K. of which 59 were in visitors and 1370 in U.K. residents. In the same period there were 8459


Zidovudine. Proceedings of a symposium. London, 27 September 1988.
J Infect. 1989 Jan;18 Suppl 1:1-101. Unique Identifier : AIDSLINE MED/89124430
Zidovudine--the first year of experience.
J Infect. 1989 Jan;18 Suppl 1:23-31. Unique Identifier : AIDSLINE MED/89124432
Williams I; Gabriel G; Cohen H; Williams P; Tedder RS; Machin S; Weller IV; Academic Department of Genitourinary Medicine, University College; and Middlesex School of Medicine, London, U.K.
Use of zidovudine for drug misusers infected with human immunodeficiency virus.
J Infect. 1989 Jan;18 Suppl 1:59-66. Unique Identifier : AIDSLINE MED/89124437
Cowan FM; Jones G; Bingham J; Flegg PJ; MacCallum LR; Whitelaw J; Hargreave D; Gray JA; Welsby PD; Brettle RP; Department of Infectious Diseases, City Hospital, Edinburgh, U.K.
The use of zidovudine in drug misusers, especially current drug misusers, has not been extensively studied. Since periods of abstinence may be interspersed with drug misuse, it is necessary to establish the safety of zidovudine in injection drug misuse-related human immunodeficiency virus (HIV) infection under a varie


Zidovudine experience at the Hospitals for Sick Children, Great Ormond Street, London.
J Infect. 1989 Jan;18 Suppl 1:83. Unique Identifier : AIDSLINE MED/89124441
Ball LM; Hospital for Sick Children, London, U.K.
Antibodies to human immunodeficiency virus in the semen of heterosexual men.
J Infect Dis. 1989 Feb;159(2):324-7. Unique Identifier : AIDSLINE MED/89124483
Belec L; Georges AJ; Steenman G; Martin PM; Institut Pasteur, Bangui, Central African Republic.
HLA antigen contamination of commercial Western blot strips for detecting human immunodeficiency virus [see comments]
J Infect Dis. 1989 Feb;159(2):357-8. Unique Identifier : AIDSLINE MED/89124491
Drabick JJ; Baker JR Jr; Department of Clinical Investigation, Walter Reed Army Medical; Center, Washington, D.C.
Public access to experimental drug therapy: AIDS raises yet another conflict between freedom of the individual and welfare of the individual and public.
J Infect Dis. 1989 Mar;159(3):412-5. Unique Identifier : AIDSLINE MED/89124504
Richman DD; Department of Pathology, University of California, San Diego.
The case for patient access to experimental therapy.
J Infect Dis. 1989 Mar;159(3):416-9. Unique Identifier : AIDSLINE MED/89124505
Delaney M; Project Inform., San Francisco, California 94110.
Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease.
J Infect Dis. 1989 Mar;159(3):467-71. Unique Identifier : AIDSLINE MED/89124512
Fox CH; Kotler D; Tierney A; Wilson CS; Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and; Infectious Diseases, Bethesda, Maryland 20892.
Thirty formaldehyde-fixed, paraffin-embedded endoscopic biopsy specimens from the colon and rectum of 25 patients with acquired immunodeficiency syndrome were examined using a [35S]HIV-RNA in situ hybridization procedure. Nine of the specimens contained cells that bound significant amounts of probe. Cells were conside


The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco.
J Infect Dis. 1989 Mar;159(3):569-72. Unique Identifier : AIDSLINE MED/89124526
Rutherford GW; Schwarcz SK; Lemp GF; Barnhart JL; Rauch KJ; Warner WL; Piland TH; Werdegar D; AIDS Office, San Francisco Department of Public Health,; California 94103.
Tonsillar and pharyngeal tuberculosis in a patient without HIV antibodies [letter]
J Infect Dis. 1989 Mar;159(3):598. Unique Identifier : AIDSLINE MED/89124537
Pedrol E; Estruch R; Barcelo J; Urbano-Marquez A
Cryptococcosis in AIDS patients: observations concerning CNS involvement.
J Neurol. 1989 Jan;236(1):38-42. Unique Identifier : AIDSLINE MED/89124993
Weinke T; Rogler G; Sixt C; de Matos-Marques B; Pohle HD; Staib F; Seibold M; Universitatsklinikum Rudolf Virchow, II. Medizinische Klinik,; Berlin.
The clinical course and response to therapy of seven patients with cryptococcosis and AIDS were reviewed. One patient was still in the primary stage of cryptococcosis in AIDS, i.e. the stage that is characterized by the sole cultural detection of Cryptococcus neoformans in the respiratory tract. The other six patients


AIDS prevention in primary care clinics: testing the market.
J Gen Intern Med. 1989 Jan-Feb;4(1):34-8. Unique Identifier : AIDSLINE MED/89125105
Mathews WC; Linn LS; Robert Wood Johnson Clinical Scholars Program, UCLA School of; Medicine.
To assess attitudes toward educational programs about AIDS, 540 patients and 36 of their medical providers in primary care clinics were systematically sampled to ascertain what age groups should be exposed to a pamphlet entitled Am I at Risk for AIDS?, as well as what was acceptable content for posters and pamphlets p


HIV-associated nephropathy [letter]
J Pediatr. 1989 Feb;114(2):336. Unique Identifier : AIDSLINE MED/89125229
Strauss J; Abitbol C; Zilleruelo G; Scott G; Paredes A; Mitchell C; Parks W; Pardo V
Genetic recombination of human immunodeficiency virus.
J Virol. 1989 Mar;63(3):1455-9. Unique Identifier : AIDSLINE MED/89125748
Clavel F; Hoggan MD; Willey RL; Strebel K; Martin MA; Repaske R; Laboratory of Molecular Microbiology, National Institute of; Allergy and Infectious Diseases, Bethesda, Maryland 20892.
We investigated genetic recombination of the human immunodeficiency virus (HIV) in a tissue culture system. A clonal cell line expressing a single integrated HIV provirus with a termination codon affecting pol gene expression was transfected with different defective mutants derived from an infectious molecular clone o


HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987 [see comments]
JAMA. 1989 Feb 17;261(7):1008-12. Unique Identifier : AIDSLINE MED/89125784
Des Jarlais DC; Friedman SR; Novick DM; Sotheran JL; Thomas P; Yancovitz SR; Mildvan D; Weber J; Kreek MJ; Maslansky R; New York State Division of Substance Abuse Services, NY 10013.
Intravenous drug users are the second largest group to develop the acquired immunodeficiency syndrome, and they are the primary source for heterosexual and perinatal transmission in the United States and Europe. Understanding long-term trends in the spread of human immunodeficiency vir


Six-year slowing noted in previously growing rate of US blood collections, transfusions [news]
JAMA. 1989 Feb 17;261(7):968-9. Unique Identifier : AIDSLINE MED/89125798
Marwick C
HIV-related disease in i.v. drug use.
JAMA. 1989 Feb 17;261(7):970. Unique Identifier : AIDSLINE MED/89125799
Goodwin FK
Human immunodeficiency virus-associated skin lesions [letter]
JAMA. 1989 Feb 17;261(7):991. Unique Identifier : AIDSLINE MED/89125806
Omura EF; Omura GA
The suitability of HIV-positive individuals for marriage and pregnancy [letter]
JAMA. 1989 Feb 17;261(7):993. Unique Identifier : AIDSLINE MED/89125809
Waterborne Mycobacterium avium infection [letter]
JAMA. 1989 Feb 17;261(7):994. Unique Identifier : AIDSLINE MED/89125811
Yagupsky P; Menegus MA
Respiratory syncytial virus pneumonia in a human immunodeficiency virus-infected man [letter]
JAMA. 1989 Feb 24;261(8):1147. Unique Identifier : AIDSLINE MED/89125820
Murphy D; Rose RC 3d
Mandatory reporting of HIV testing would deter men from being tested [letter] [see comments]
JAMA. 1989 Mar 3;261(9):1275-6. Unique Identifier : AIDSLINE MED/89125848
Kegeles SM; Coates TJ; Lo B; Catania JA
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users.
JAMA. 1989 Mar 3;261(9):1289-94. Unique Identifier : AIDSLINE MED/89125855
Selwyn PA; Schoenbaum EE; Davenny K; Robertson VJ; Feingold AR; Shulman JF; Mayers MM; Klein RS; Friedland GH; Rogers MF; Department of Epidemiology and Social Medicine, Montefiore; Medical Center, Bronx, NY 10467-2490.
To determine the effects of human immunodeficiency virus (HIV) infection on pregnancy outcomes, we prospectively studied female intravenous drug users in a methadone program in New York City. Of 191 women with HIV status known prior to pregnancy, 17 (24%) of 70 seropositives and 26 (22%) of 121 seronegatives became pr


HIV disease in reproductive age women: a problem of the present [editorial]
JAMA. 1989 Mar 3;261(9):1326-7. Unique Identifier : AIDSLINE MED/89125862
Landesman SH; Minkoff HL; Willoughby A
Duty to warn.
JAMA. 1989 Mar 3;261(9):1355, 1360. Unique Identifier : AIDSLINE MED/89125866
Wein M; Brown University School of Medicine.
Should medical students treat HIV-infected patients?
JAMA. 1989 Mar 3;261(9):1358. Unique Identifier : AIDSLINE MED/89125868
Pan R; University of Pittsburgh School of Medicine.
Caring for HIV-infected patients should not be required.
JAMA. 1989 Mar 3;261(9):1358-9. Unique Identifier : AIDSLINE MED/89125869
Picone J; University of Pittsburgh School of Medicine.
[Diagnosis of malignant lymphoma]
Gan No Rinsho. 1989 Jan;Spec No:579-92. Unique Identifier : AIDSLINE MED/89125968
Minato K
A patient with biliary tract obstruction and AIDS [letter]
Md Med J. 1989 Jan;38(1):34. Unique Identifier : AIDSLINE MED/89126825
Golding MI; Doman DB; Goldberg HJ
AIDS grant for U.
Minn Med. 1989 Jan;72(1):48. Unique Identifier : AIDSLINE MED/89127018
HIV-infected hemophiliacs [news]
Minn Med. 1989 Jan;72(1):48. Unique Identifier : AIDSLINE MED/89127019
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection [see comments]
N Engl J Med. 1989 Mar 2;320(9):545-50. Unique Identifier : AIDSLINE MED/89127440
Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH; Department of Epidemiology and Social Medicine, Montefiore; Medical Center-Albert Einstein College of Medicine, New York; 10467.
To determine the risk of active tuberculosis associated with human immunodeficiency virus (HIV) infection, we prospectively studied 520 intravenous drug users enrolled in a methadone-maintenance program. Tuberculin skin testing and testing for HIV antibody were performed in all subjects. Forty-nine of 217 HIV-seroposi


Failure of zidovudine to maintain remission in patients with AIDS [letter]
N Engl J Med. 1989 Mar 2;320(9):594-5. Unique Identifier : AIDSLINE MED/89127452
Bach MC
Japan's science budget expands [news]
Nature. 1989 Feb 2;337(6206):394. Unique Identifier : AIDSLINE MED/89127474
Anderson A
Children infect mothers in AIDS outbreak at a Soviet hospital [news]
Nature. 1989 Feb 9;337(6207):493. Unique Identifier : AIDSLINE MED/89127504
Belitsky V
[Testing for HIV infection in cardiology (letter)]
Ned Tijdschr Geneeskd. 1989 Jan 7;133(1):44-5. Unique Identifier : AIDSLINE MED/89127577
Adult T cell leukemia in hemodialysis patients from the Kagoshima district, an area in which human T cell leukemia virus type I is highly endemic.
Nephron. 1989;51(2):257-60. Unique Identifier : AIDSLINE MED/89127716
Uematsu T; Hanada S; Saito T; Otsuka M; Komidori K; Osaki K; Uemura S; Ueda H; Harada R; Hashimoto S; Second Department of Internal Medicine, Faculty of Medicine,; Kagoshima University, Japan.
We report 2 cases of adult T cell leukemia (ATL) from hemodialysis (HD) patients with chronic renal failure (CRF) in the Kagoshima district, an endemic area of human T cell leukemia virus type I(HTLV-I) in Japan . The positivity of antibodies to ATL-associated antigen(anti-ATLA) in H


[Serum erythropoietin levels in several diseases]
Nephron. 1989;51 Suppl 1:39-46. Unique Identifier : AIDSLINE MED/89127741
Rhyner K; Egli F; Niemoller M; Wieczorek A; Greminger P; Vetter W; Departement fur Innere Medizin, Universitatsspital Zurich,; Schweiz.
The accurate radioimmunological measurement of serum erythropoietin (EPO) levels has only been possible since the development of highly specific antibodies directed against recombinant human EPO. In the present study, we determined the serum EPO levels in 100 healthy volunteers and in over 300 patients with anemias an


Spinal cord pathology in pediatric acquired immunodeficiency syndrome.
Neurology. 1989 Feb;39(2 Pt 1):227-35. Unique Identifier : AIDSLINE MED/89127824
Dickson DW; Belman AL; Kim TS; Horoupian DS; Rubinstein A; Department of Pathology (Neuropathology), Albert Einstein College; of Medicine, Bronx, NY 10461.
We examined the spinal cords from 15 consecutive autopsies of infants and children with AIDS using a battery of histochemical and immunocytochemical stains, and in four cases, electron microscopy. Corticospinal tract (CST) signs were a notable clinical finding in 14; however, the age of onset, rate of progression, sev


Absence of humorally mediated damage within the central nervous system of AIDS patients.
Neurology. 1989 Feb;39(2 Pt 1):278-80. Unique Identifier : AIDSLINE MED/89127836
Lenhardt TM; Wiley CA; Laboratory Department, Naval Hospital, San Diego, La Jolla, CA.
The pathogenesis of CNS damage by human immunodeficiency virus infection is unclear. Because there is little detectable virus within the CNS, we evaluated the role of the humoral immune system in mediating CNS tissue destruction. The paucity and nonspecific nature of immunoglobulin deposition rules against significant


[AIDS: the acquired immunodeficiency syndrome]
Minerva Med. 1989 Jan;80(1):5-10. Unique Identifier : AIDSLINE MED/89127881
Mazzarello MG; U.S.S.L. n. 74, Ospedale Sant'Antonio, Ovada, Alessandria.
AIDS (acquired immune deficiency syndrome) is a disease of major medical, epidemiological, psychological and social importance. Its aetiological agent is one of the retroviruses that attacks the individual s immune system and destroys its ability to combat other diseases. The available virological data make it clear t


UMDNJ notes.
N J Med. 1989 Jan;86(1):60-1. Unique Identifier : AIDSLINE MED/89127952
Bergen SS Jr
AMNJ report (Academy of Medicine of New Jersey).
N J Med. 1989 Jan;86(1):61-2. Unique Identifier : AIDSLINE MED/89127953
Rush BF Jr
Suit to declare AIDS communicable disease [news]
N Y State Dent J. 1989 Feb;55(2):5. Unique Identifier : AIDSLINE MED/89127978
Why we won't use an AIDS vaccine.
Postgrad Med. 1989 Feb 1;85(2):31. Unique Identifier : AIDSLINE MED/89128651
Grossman J
Opportunistic infections in normal hosts [letter]
Rev Infect Dis. 1989 Jan-Feb;11(1):152-3. Unique Identifier : AIDSLINE MED/89129891
Matlow AG; Rachlis AR
AIDS paper raises red flag at PNAS [news]
Science. 1989 Feb 10;243(4892):733. Unique Identifier : AIDSLINE MED/89130140
Booth W
The incidence of intra-abdominal surgery in acquired immunodeficiency syndrome: a statistical review of 904 patients.
Surgery. 1989 Feb;105(2 Pt 1):175-9. Unique Identifier : AIDSLINE MED/89130355
LaRaja RD; Rothenberg RE; Odom JW; Mueller SC; Department of Surgery, Cabrini Medical Center, New York, N.Y.; 10003.
This communication concerns the incidence of intra-abdominal surgery in 904 patients with acquired immunodeficiency syndrome who were admitted to the Cabrini Medical Center during a 3-year period from January 1985 to January 1988. It was found that 36, or 4.2%, of the patients underwent surgery, including 12 cholecyst


[HIV testing of hospital patients (letter)]
Tidsskr Nor Laegeforen. 1989 Jan 20;109(2):247-8. Unique Identifier : AIDSLINE MED/89130498
Wisborg T; Brattebo G
AIDS-related thrombocytopenia. Experience of a medium-term treatment with intravenous IgG in haemophilia B patients.
Vox Sang. 1989;56(1):57-8. Unique Identifier : AIDSLINE MED/89130992
Leipnitz G; Kohler M; Pindur G; Wenzel E; Department of Haemostaseology and Transfusion Medicine,; University of the Saarland, Homburg/Saar, FRG.
Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection [see comments]
Vox Sang. 1989;56(1):59-61. Unique Identifier : AIDSLINE MED/89130993
Lelie PN; van der Poel CL; Reesink HW; Huisman HG; Boucher CA; Goudsmit J; Central Laboratory of the Netherlands Red Cross Blood Transfusion; Service, Red Cross Bloodbank, Amsterdam.
AIDS estimates [news]
Wis Med J. 1989 Jan;88(1):39. Unique Identifier : AIDSLINE MED/89131054
Virus clearance in HIV-infected patients.
Am Fam Physician. 1989 Feb;39(2):360. Unique Identifier : AIDSLINE MED/89132291
Interferon alfa for Kaposi's sarcoma in early AIDS.
Am Fam Physician. 1989 Feb;39(2):363. Unique Identifier : AIDSLINE MED/89132292
Mycobacterium kansasii diffuse pulmonary infection in a patient with acquired immune deficiency syndrome. Successful therapy with an antituberculous regimen.
Am J Clin Pathol. 1989 Feb;91(2):236-8. Unique Identifier : AIDSLINE MED/89132412
Jacobson MA; Isenberg WM; Department of Medicine, University of California, San Francisco.
Mycobacterium kansasii is a rare cause of disseminated mycobacterial infection in patients with the acquired immune deficiency syndrome (AIDS). It occurs as the index AIDS diagnosis in only 0.2% of AIDS cases. Previously reported cases of AIDS-associated M. kansasii infection have manifested as diffuse interstitial pn


The diagnosis of esophageal candidiasis in patients with acquired immune deficiency syndrome: is endoscopy always necessary? [see comments]
Am J Gastroenterol. 1989 Feb;84(2):143-6. Unique Identifier : AIDSLINE MED/89132496
Porro GB; Parente F; Cernuschi M; Department of Infectious Diseases, L. Sacco Hospital, Milan,; Italy.
Oral and esophageal candidiasis represents a common infection in patients with acquired immune deficiency syndrome (AIDS). Because the relationship between the infection in both sites is not well known, we submitted to routine upper digestive endoscopy 57 patients with AIDS. Furthermore, we evaluated the diagnostic ac


Tubuloreticular inclusions in colonic mucosa as diagnostic markers of AIDS.
Am J Gastroenterol. 1989 Feb;84(2):195-7. Unique Identifier : AIDSLINE MED/89132509
Ozick L; Chander P; Agarwal A; Soni A; Department of Medicine, New York Medical College, Lincoln; Hospital, Bronx.
Tubuloreticular inclusions (TRI) are known to be associated with viral infections and are considered highly specific of the acquired immune deficiency syndrome (AIDS) in the appropriate clinical setting. We describe a homosexual man without any evidence of AIDS who presented with diarrhea. A search for the usual patho


Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men.
Am J Epidemiol. 1989 Mar;129(3):596-603. Unique Identifier : AIDSLINE MED/89132539
van Griensven GJ; de Vroome EM; Tielman RA; Goudsmit J; de Wolf F; van der Noordaa J; Coutinho RA; Municipal Health Service, Dept. of Public Health and Environment,; Amsterdam, The Netherlands.
For the study of the impact of human immunodeficiency virus (HIV) antibody testing on high-risk sexual behavior with nonsteady and steady sexual partners, 307 homosexual men (118 seronegative, 75 seropositive, and 114 untested) were interviewed at three consecutive six-month intervals between July 1985 and December 19


Handle with care.
Am J Nurs. 1989 Feb;89(2):196-8. Unique Identifier : AIDSLINE MED/89132640
Worth C
Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection.
Ann Intern Med. 1989 Mar 1;110(5):365-8. Unique Identifier : AIDSLINE MED/89133267
Oksenhendler E; Bierling P; Ferchal F; Clauvel JP; Seligmann M; Hopital Saint-Louis, Paris, France.
STUDY OBJECTIVE: To determine whether zidovudine is effective in increasing the platelet count in patients with thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. DESIGN: Nonrandomized controlled trial with two consecutive regimens. SETTING: Immunopathology and hematology clinics at two


Intravenous immunoglobulin therapy in human immunodeficiency virus-associated thrombocytopenia [letter; comment]
Arch Intern Med. 1989 Feb;149(2):467. Unique Identifier : AIDSLINE MED/89133647
Fisher AE
Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome. A possible role for human immunodeficiency virus [see comments]
Arch Pathol Lab Med. 1989 Feb;113(2):192-5. Unique Identifier : AIDSLINE MED/89133738
Scaravilli F; Daniel SE; Harcourt-Webster N; Guiloff RJ; Department of Neuropathology, National Hospital, Queen Square,; London, England.
We describe the clinical and postmortem findings in a 57-year-old man with human immunodeficiency virus who presented with neurologic symptoms attributed to stroke. In addition to multiple foci of ischemic necrosis, pathologic examination of the brain showed chronic basal meningitis and vasculitis. No microorganisms w


Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals.
Arch Neurol. 1989 Feb;46(2):129-33. Unique Identifier : AIDSLINE MED/89133860
Goethe KE; Mitchell JE; Marshall DW; Brey RL; Cahill WT; Leger GD; Hoy LJ; Boswell RN; Department of Psychology, Wilford Hall US Air Force Medical; Center, Lackland Air Force Base, Tex. 78236-5300.
Although individuals with acquired immunodeficiency syndrome (AIDS) are often impaired on a variety of neuropsychological tasks, questions remain as to when neuropsychological decline can be reliably detected during the course of human immunodeficiency virus (HIV) infection. Detailed neuropsychological testing was acc


Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC column.
Biochem Biophys Res Commun. 1989 Jan 31;158(2):413-22. Unique Identifier : AIDSLINE MED/89134240
Balzarini J; Cools M; De Clercq E; Rega Institute for Medical Research, Katholieke Universiteit; Leuven, Belgium.
There is a close linear correlation between the log partition coefficient (Pa) of a series of 2 -deoxyriboside (dR), 2 ,3 -didehydro-3 -dideoxyriboside (ddeR), 2 ,3 -dideoxyriboside (ddR), 3 -fluoro-2 ,3 -dideoxyriboside (FddR) and 3 -azido-2 ,3 -dideoxyriboside (AzddR) derivatives of uracil, cytosine, thymine, guanin


T cell lines established from multiple sclerosis cerebrospinal fluid T cells using human retroviruses.
J Neuroimmunol. 1989 Feb;21(2-3):213-26. Unique Identifier : AIDSLINE MED/89109531
Merrill JE; Kagan JM; Schmid I; Strom SR; Quan SG; Chen IS; Department of Neurology, UCLA School of Medicine 90024.
Cerebrospinal fluid (CSF) lymphocytes from patients with multiple sclerosis (MS) were transformed with human T cell leukemia/lymphoma virus (HTLV I and HTLV II) and the resulting cell lines characterized by cell surface phenotyping and functional assessment. The lines were predominantly of the CD4 helper/induce phenot


Knowledge and concerns about acquired immunodeficiency syndrome and their relationship to behavior among adolescents with hemophilia.
Pediatrics. 1989 Feb;83(2):204-10. Unique Identifier : AIDSLINE MED/89112918
Overby KJ; Lo B; Litt IF; Department of Pediatrics, Stanford University School of Medicine,; California.
The knowledge and concerns regarding acquired immunodeficiency syndrome (AIDS) and their relationship to certain behaviors among adolescents with hemophilia, a pediatric risk group with human immunodeficiency virus (HIV) antibody positivity rate as high as 70% to 90%, are described. Information was obtained from 26 pa


Acquired immunodeficiency syndrome may present as severe restrictive lung disease.
Am J Med. 1989 Feb;86(2):237-40. Unique Identifier : AIDSLINE MED/89116260
Murphy PM; Fox C; Travis W; Koenig S; Fauci AS; Laboratory of Clinical Investigation, National Institute of; Allergy and Infectious Diseases, Bethesda, Maryland 20892.
Prevalence of human immunodeficiency virus infection among voluntary blood donors.
Indian J Med Res. 1989 Jan;89:1-3. Unique Identifier : AIDSLINE MED/89122164
John TJ; Babu PG; Pulimood BR; Jayakumari H
HIV infection was found among voluntary blood donors at the Christian Medical College Hospital, Vellore (south India ), the prevalence rate of infection among these donors being 1.63 per 1000. Based on these findings, the authors recommend that appropriate steps be taken immediately


T cell recognition of HIV synthetic peptides in a natural infection.
J Immunol. 1989 Feb 15;142(4):1166-76. Unique Identifier : AIDSLINE MED/89124356
Schrier RD; Gnann JW Jr; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA; Department of Immunology, Research Institute of Scripps Clinic,; La Jolla, CA 92037.
Because T cell responses are critical for defense against viral infections, a series of synthetic peptides derived from the predicted sequence for HIV-1 proteins gp41, pg120, gag, and viral polymerase were used to test the T cell proliferative response of HIV-1 seropositive individuals. Of HIV-1-infected donors from v


Anticardiolipin antibody in the acquired immunodeficiency syndrome: a marker of Pneumocystis carinii infection? [letter] [see comments]
J Infect. 1989 Jan;18(1):100-1. Unique Identifier : AIDSLINE MED/89124408
Di Prima MA; Sorice M; Vullo V; Mastroianni CM; Amendolea MA; Masala C
Zidovudine: experience at the Newcastle Haemophilia Centre.
J Infect. 1989 Jan;18 Suppl 1:53-8. Unique Identifier : AIDSLINE MED/89124436
Jones P; Newcastle Haemophilia Centre, Royal Victoria Infirmary, U.K.
Zidovudine was first prescribed for patients from the anti-human immunodeficiency virus (HIV) positive cohort of haemophiliacs in Newcastle in May 1987. Prior to this therapy, seven patients had died of acquired immune deficiency syndrome, and episodes of serious opportunistic infection were common. To date, 22 patien


The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.
J Virol. 1989 Mar;63(3):1265-74. Unique Identifier : AIDSLINE MED/89125720
Hadzopoulou-Cladaras M; Felber BK; Cladaras C; Athanassopoulos A; Tse A; Pavlakis GN; BRI-Basic Research Program, National Cancer Institute, Frederick,; Maryland 21701-1013.
The study of expression of several human immunodeficiency virus type 1 proviral mutants in human cells in the presence or absence of rev (trs/art) protein reveals that rev increases the levels of unspliced and env mRNA and the accumulated structural viral proteins. rev protein produced from appropriate expression vect


In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes.
J Virol. 1989 Mar;63(3):1474-9. Unique Identifier : AIDSLINE MED/89125752
Cann AJ; Rosenblatt JD; Wachsman W; Chen IS; Jonsson Comprehensive Cancer Center, Los Angeles, California.
The tax gene of the human T-cell leukemia virus types I and II (HTLV-I and HTLV-II) is essential for viral replication and acts by increasing the level of RNA transcription. The tax genes of HTLV-I and HTLV-II encode proteins of 40 and 37 kilodaltons, respectively. By in vitro mutagenesis of the tax gene, we have inve


Use of D4 peptide in HIV inhibition.
JAMA. 1989 Feb 17;261(7):970. Unique Identifier : AIDSLINE MED/89125800
Goodwin FK
Pregnancy-associated deaths due to AIDS in the United States.
JAMA. 1989 Mar 3;261(9):1306-9. Unique Identifier : AIDSLINE MED/89125858
Koonin LM; Ellerbrock TV; Atrash HK; Rogers MF; Smith JC; Hogue CJ; Harris MA; Chavkin W; Parker AL; Halpin GJ; Division of Reproductive Health, Center for Chronic Disease; Prevention and Health Promotion, Atlanta, GA 30333.
From 1981 to 1988, eighty percent of all women with the acquired immunodeficiency syndrome (AIDS) reported to the Centers for Disease Control were of reproductive age. Six pregnancy-associated deaths due to AIDS in this country have been reported in the medical literature. We identified 20 unpublished cases of women w


Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-1989. A 32-year-old man with AIDS and a cavitary pulmonary lesion [see comments]
N Engl J Med. 1989 Mar 2;320(9):582-7. Unique Identifier : AIDSLINE MED/89127447
Unproved AIDS drug is made available for limited use [news]
Nature. 1989 Feb 9;337(6207):493. Unique Identifier : AIDSLINE MED/89127505
Shulman S
Elevated serum levels of soluble interleukin-2 receptors in HIV infection: no correlation with activated T cells.
Nouv Rev Fr Hematol. 1989;31(1):9-11. Unique Identifier : AIDSLINE MED/89128424
Lang JM; Coumaros G; Levy S; Falkenrodt A; Steckmeyer M; Partisani M; Aleksijevic A; Lehr L; Koehl C; Service d'Onco-Hematologie, Hopital de Hautepierre, Strasbourg,; France.
Serum levels of soluble interleukin-2 receptors (sIL-2R) were measured in 105 HIV-seropositive individuals simultaneously with T cell subsets and activated T cells (CD3+ and HLA-DR+). Significantly elevated levels of serum sIL-2R were found (564 +/- 259 U/ml versus 258 +/- 87 U/ml in 70 controls, p less than 0.001), a


Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocyte and Ga-67 scintigraphy.
Radiology. 1989 Mar;170(3 Pt 1):677-80. Unique Identifier : AIDSLINE MED/89129326
Fineman DS; Palestro CJ; Kim CK; Needle LB; Vallabhajosula S; Solomon RW; Goldsmith SJ; Department of Nuclear Medicine, Mount Sinai Medical Center, New; York, NY 10029.
Thirty-six patients with acquired immunodeficiency syndrome (AIDS), who were febrile but without localizing signs, underwent indium-111 leukocyte scintigraphy 24 hours after injection of labeled white blood cells (WBCs) and were restudied 48 hours after injection of gallium-67 citrate. Fifty-six abnormalities were ide


Therapeutic challenge for Isospora belli enteritis in an AIDS patient who developed Lyell syndrome after co-trimoxazole therapy.
Am J Gastroenterol. 1989 Feb;84(2):207-9. Unique Identifier : AIDSLINE MED/89132518
Romeu J; Clotet B; Tural C; Carles J; Foz M; Department of Internal Medicine, Universitat Autonoma de; Barcelona, Hospital de Badalona Germans Trias i Pujol, Spain.
'To shave or not to shave' [letter]
J Can Dent Assoc. 1989 Jan;55(1):20. Unique Identifier : AIDSLINE MED/89105930
Freedman GL
[Frequency of blood contamination of the dentist during conservative and prosthetic treatment]
Fogorv Sz. 1989 Jan;82(1):19-22. Unique Identifier : AIDSLINE MED/89107616
Bori Z; Ferenczi I; Lajta B
The endangerment caused by the blood contents of spray formed in the course of oonserving and prosthetical work of dentists performed by dental drill was examined. It was found that the protective mask in case of grinding and drilling the front teeth becomes always while in case of treating the molars less frequently


Low dose total body irradiation: a potent anti-retroviral agent in vivo.
Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):165-70. Unique Identifier : AIDSLINE MED/89108876
Shen RN; Hornback NB; Lu L; Chen LT; Brahmi Z; Broxmeyer HE; Department of Radiation Oncology, Indiana University School of; Medicine, Indianapolis 46223.
Immunosuppression characterizes many human diseases including leukemia and AIDS. Friend virus (FV)-induced murine leukemia is a useful model for studying both malignancy and immunosuppression. In a previous series of experiments, we have demonstrated that untreated FV-infected mice died within 40 days post-infection,


Skin diseases aggravated by pregnancy.
J Am Acad Dermatol. 1989 Jan;20(1):1-13. Unique Identifier : AIDSLINE MED/89109698
Winton GB; Department of Medicine, Walter Reed Army Medical Center,; Washington, DC 20307-5001.
During pregnancy, immunologic, endocrine, metabolic, and vascular changes occur that make the pregnant woman susceptible to aggravation of certain skin diseases. These diseases can be organized into five broad categories: infections, diseases of altered immunity, metabolic diseases, connective tissue disorders, and mi


A quality assurance program for human immunodeficiency virus seropositivity screening of dried-blood spot specimens.
Infect Control Hosp Epidemiol. 1989 Jan;10(1):8-13. Unique Identifier : AIDSLINE MED/89109938
Hannon WH; Lewis DS; Jones WK; Powell MK; Division of Environmental Health Laboratory Sciences, Centers for; Disease Control, Atlanta, GA 30333.
Epidemiologic projects have been implemented for using dried-blood spot (DBS) specimens routinely collected on filter paper from neonates as a seroepidemiologic resource to monitor seroprevalence of human immunodeficiency virus (HIV) among childbearing women. To ensure the quality of the data base produced from the na


Bacterial prostatitis in patients infected with the human immunodeficiency virus.
J Urol. 1989 Feb;141(2):334-6. Unique Identifier : AIDSLINE MED/89111175
Leport C; Rousseau F; Perronne C; Salmon D; Joerg A; Vilde JL; Department of Infectious and Tropical Diseases, Claude Bernard; Hospital, Paris, France.
Bacterial prostatitis was diagnosed in 17 of 209 human immunodeficiency virus-infected men hospitalized from October 1985 to October 1987. A history of urogenital disease was found in 13 of 17 patients. Clinical signs of prostatitis were present in 16 of 17 patients, including fever in 13, urinary symptoms in 11 and t


[False positive results of HIV virus tests in patients undergoing chronic hemodialysis]
Orv Hetil. 1989 Jan 8;130(2):67-70. Unique Identifier : AIDSLINE MED/89112737
Ujhelyi E; Gal G; Mako J; Fust G; Buki B; Nagy K; Ferenc DT; Dietrich MP; Hengster P; Mayer V; et al
The sera of 173 haemodialysis patients treated in two dialysis centers in Hungary were tested for the presence of HIV (HTLV III/LAV) antibodies. Four different commercial enzyme immunoassay (EIA) kits and two types (CEM/LAV, and H9/


Human immunodeficiency virus infection in childhood, adolescence, and pregnancy: a status report and national research agenda [see comments]
Pediatrics. 1989 Feb;83(2):293-308. Unique Identifier : AIDSLINE MED/89112933
Nicholas SW; Sondheimer DL; Willoughby AD; Yaffe SJ; Katz SL; Columbia University Pediatric AIDS Program, Babies Hospital, New; York.
Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: a review [see comments]
Am J Med. 1989 Feb;86(2):194-8. Unique Identifier : AIDSLINE MED/89116250
Ratner L; Department of Medicine, Washington University, St. Louis,; Missouri 63110.
Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome [letter] [see comments]
Am J Med. 1989 Feb;86(2):258. Unique Identifier : AIDSLINE MED/89116271
Armignacco O; Capecchi A; De Mori P; Grillo LR
The pharmacokinetics of zidovudine administered by continuous infusion in children.
Ann Intern Med. 1989 Feb 15;110(4):279-85. Unique Identifier : AIDSLINE MED/89116730
Balis FM; Pizzo PA; Murphy RF; Eddy J; Jarosinski PF; Falloon J; Broder S; Poplack DG; National Institutes of Health, Bethesda, Maryland.
STUDY OBJECTIVE: To define the pharmacokinetics of zidovudine (azidothymidine) in children with human immunodeficiency virus infection. DESIGN: Plasma, urine, and cerebrospinal fluid were obtained following a single 80 mg/m2 body surface dose infused over 1 hour (n = 9), and during a continuous infusion of 0.5 (n = 3)


Occupational hazards in the OR. A historical perspective.
AORN J. 1989 Jan;49(1):276-83. Unique Identifier : AIDSLINE MED/89117128
Trotti JC; McCarthy RT; Brooke Army Medical Center, San Antonio, Tex.
The area of research and prevention of occupational health hazards that affect operating room nurses has not been formalized. There are many devices and substances that present actual and potential dangers to OR nurses. Historically, more attention has been paid to the effect of these substances and equipment on the p


Anti-idiotypic antibodies as vaccine candidates. The immune network.
Arch Dermatol. 1989 Feb;125(2):271-5. Unique Identifier : AIDSLINE MED/89117187
Rico MJ; Hall RP 3d; Department of Medicine, Duke University Medical Center, Durham,; NC 27710.
Antibodies specific for determinants within the variable region of an antibody molecule are known as anti-idiotypic antibodies. Anti-idiotypic antibodies specific for determinants within the antigen binding site of the antibody may mimic the original antigen and are said to bear an internal image of the antigen. These


Role of the virology laboratory in diagnosis and management of patients with central nervous system disease.
Clin Microbiol Rev. 1989 Jan;2(1):1-14. Unique Identifier : AIDSLINE MED/89119412
Chonmaitree T; Baldwin CD; Lucia HL; Department of Pediatrics, University of Texas Medical Branch,; Galveston 77550.
A number of viruses cause acute central nervous system disease. The two major clinical presentations are aseptic meningitis and the less common meningoencephalitis. Clinical virology laboratories are now more widely available than a decade ago; they can be operated on a modest scale and can be tailored to the needs of


Consultation-liaison psychiatry and HIV-related disorders.
Hosp Community Psychiatry. 1989 Feb;40(2):146-53. Unique Identifier : AIDSLINE MED/89121917
Fernandez F; Holmes VF; Levy JK; Ruiz P; Baylor College of Medicine, Houston, Texas.
Acquired immune deficiency syndrome (AIDS) and related disorders are increasingly and unsettlingly prevalent. The authors describe neuropsychiatric, psychosocial, and ethical-legal problems associated with HIV infections that are commonly encountered in a consultation-liaison psychiatry setting. Because of HIV s poten


Cardiac involvement in the acquired immune deficiency syndrome.
Int J Cardiol. 1989 Feb;22(2):143-6. Unique Identifier : AIDSLINE MED/89122334
Bestetti RB; Department of Pathology, Faculty of Medicine of Ribeirao Preto,; Sao Paulo University, Brazil.
Crystallization of the aspartylprotease from the human immunodeficiency virus, HIV-1.
J Biol Chem. 1989 Feb 5;264(4):1919-21. Unique Identifier : AIDSLINE MED/89123247
McKeever BM; Navia MA; Fitzgerald PM; Springer JP; Leu CT; Heimbach JC; Herbert WK; Sigal IS; Darke PL; Department of Biophysical Chemistry, Merck Sharp and Dohme; Research Laboratories, Rahway, New Jersey 07065.
The aspartylprotease of the human immunodeficiency virus HIV-1 (NY5) has been crystallized in a form suitable for x-ray diffraction analysis. The crystals are tetragonal bipyramids and produce an x-ray diffraction pattern that exhibits the symmetry associated with space group P4(1)2(1)2 (or its enantiomorph, P4(3)2(1)


Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.
J Biol Chem. 1989 Feb 5;264(4):2307-12. Unique Identifier : AIDSLINE MED/89123305
Darke PL; Leu CT; Davis LJ; Heimbach JC; Diehl RE; Hill WS; Dixon RA; Sigal IS; Department of Molecular Biology, Merck, Sharp and Dohme Research; Laboratories, West Point, Pennsylvania 19486.
The protease of human immunodeficiency virus has been expressed in Escherichia coli and purified to apparent homogeneity. Immunoreactivity toward anti-protease peptide sera copurified with an activity that cleaved the structural polyprotein gag p55 and the peptide corresponding to the sequence gag 128-135. The enzyme


Recovery of Mycobacterium avium-M. intracellulare from blood specimens by using the routine BACTEC 6B blood culture system.
J Clin Microbiol. 1989 Feb;27(2):348-9. Unique Identifier : AIDSLINE MED/89123812
Horn R; Laszlo A; Robson HG; Department of Clinical Microbiology, Royal Victoria Hospital,; Montreal, Quebec, Canada.
We describe a simple technique for recovery of Mycobacterium avium-M. intracellulare from blood culture specimens by using the BACTEC 460, a system used for routine blood cultures in many hospital laboratories. A total of 26 of 215 blood specimens (12%) from 11 of 48 patients (23%) with acquired immunodeficiency syndr


Chronic Shigella flexneri infection preceding development of acquired immunodeficiency syndrome.
J Clin Microbiol. 1989 Feb;27(2):353-5. Unique Identifier : AIDSLINE MED/89123814
Simor AE; Poon R; Borczyk A; Department of Microbiology, Mount Sinai Hospital, Toronto,; Ontario, Canada.
Shigella sp. is known to be an important cause of diarrhea in homosexual men, although chronic infection is infrequently recognized. We describe recurrent and relapsing symptomatic infection due to Shigella flexneri in a human immunodeficiency virus-infected homosexual man subsequently developed acquired immunodeficie


Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
J Infect. 1989 Jan;18 Suppl 1:77. Unique Identifier : AIDSLINE MED/89124438
Smiley L; Burroughs Wellcome Co., Research Triangle Park, North Carolina.
Preliminary report of a multicentre study of zidovudine plus or minus acyclovir in patients with acquired immune deficiency syndrome or acquired immune deficiency syndrome-related complex.
J Infect. 1989 Jan;18 Suppl 1:79-80. Unique Identifier : AIDSLINE MED/89124439
Fiddian AP; Wellcome Research Laboratories, Beckenham, Kent, U.K.
Treatment of children symptomatic with human immunodeficiency virus infection.
J Infect. 1989 Jan;18 Suppl 1:81-2. Unique Identifier : AIDSLINE MED/89124440
Wilfert CM; McKinney R Jr; Division of Infectious Diseases, Duke University Medical School,; North Carolina.
Current and future trials with zidovudine.
J Infect. 1989 Jan;18 Suppl 1:93-6. Unique Identifier : AIDSLINE MED/89124443
Yeo JM; Wellcome Research Laboratories, Beckenham, U.K.
The first placebo-controlled trial of zidovudine in the management of HIV infection involved patients with the acquired immune deficiency syndrome (AIDS) following their first episode of Pneumocystis carinii pneumonia and patients with severe AIDS-related complex (ARC). Zidovudine was shown to increase survival, and t


Diagnosis of infection with the human immunodeficiency virus.
J Infect Dis. 1989 Feb;159(2):320-3. Unique Identifier : AIDSLINE MED/89124482
Phair JP; Wolinsky S; Department of Medicine, Northwestern University Medical School,; Chicago, Illinois 60611.
A personal view of efforts in treatment of human immunodeficiency virus infection in 1988.
J Infect Dis. 1989 Mar;159(3):390-9. Unique Identifier : AIDSLINE MED/89124501
Merigan TC; Department of Medicine, Stanford University School of Medicine,; California 94305.
This presentation summarizes the US national cooperative trials for AIDS treatment and some specific efforts in the treatment of viral infections. The underlying principles behind clinical efforts in the control of the human immunodeficiency virus are described to date. In addition, concerns are voiced regarding the o


Immunomodulation in infection caused by human immunodeficiency virus [editorial]
J Lab Clin Med. 1989 Feb;113(2):135-6. Unique Identifier : AIDSLINE MED/89124704
Phair JP
Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome.
J Lab Clin Med. 1989 Feb;113(2):139-44. Unique Identifier : AIDSLINE MED/89124706
Silvestris F; Gernone A; Frassanito MA; Dammacco F; Istituto di Patologia Medica, University of Bari School of; Medicine, Italy.
The immunologic effects of a year-long therapeutic trial with the synthetic thymic hormone thymopentin were investigated in 29 patients with human immunodeficiency virus--induced lymphadenopathy syndrome. Peripheral T4 and T8 lymphocyte subsets and in vitro immunoglobulin synthesis with pokeweed mitogen (PWM) were mon


Rapid screening tests for HIV [letter]
JAMA. 1989 Feb 24;261(8):1147-9. Unique Identifier : AIDSLINE MED/89125821
Leads from the MMWR. Recommendations of the Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine.
JAMA. 1989 Mar 3;261(9):1265-7. Unique Identifier : AIDSLINE MED/89125846
Shigellosis and AIDS. Report of a case and brief review of the literature.
Neth J Med. 1989 Feb;34(1-2):93-7. Unique Identifier : AIDSLINE MED/89127640
Boers M; Peeters AJ; van Berkel M; de Graaf P; van der Meer JW
This report describes the fatal outcome of an infection with Shigella flexneri in a 39-yr-old man with the acquired immunodeficiency syndrome (AIDS). The pertinent literature is reviewed.


HIV infection and renal transplantation [letter]
Nephron. 1989;51(1):144-5. Unique Identifier : AIDSLINE MED/89127682
Novoa D; Carballo E; Romero R; Arcocha V; Sanchez-Guisande D
Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.
Proc Natl Acad Sci U S A. 1989 Feb;86(3):755-64. Unique Identifier : AIDSLINE MED/89128857
Duesberg PH; Department of Molecular Biology, University of California,; Berkeley 94720.
AIDS is an acquired immunodeficiency syndrome defined by a severe depletion of T cells and over 20 conventional degenerative and neoplastic diseases. In the U.S. and Europe, AIDS correlates to 95% with risk factors, such as about 8 years of promiscuous male homosexuality, intravenous drug use, or hemophilia. Since AID


Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.
Proc Natl Acad Sci U S A. 1989 Feb;86(3):807-11. Unique Identifier : AIDSLINE MED/89128866
Krausslich HG; Ingraham RH; Skoog MT; Wimmer E; Pallai PV; Carter CA; Department of Microbiology, State University of New York, Stony; Brook 11794.
Retroviral capsid proteins and replication enzymes are synthesized as polyproteins that are proteolytically processed to the mature products by a virus-encoded proteinase. We have purified the proteinase of human immunodeficiency virus (HIV), expressed in Escherichia coli, to approximately 90% purity. The purified enz


Intestinal and hepatic manifestations of AIDS.
Adv Intern Med. 1989;34:43-71. Unique Identifier : AIDSLINE MED/89132065
Kotler DP; College of Physicians and Surgeons, Columbia University.
Flow cytometric indirect immunofluorescence assay with high sensitivity and specificity for detection of antibodies to human immunodeficiency virus (HIV).
Am J Clin Pathol. 1989 Feb;91(2):210-4. Unique Identifier : AIDSLINE MED/89132407
Sligh JM; Roodman ST; Tsai CC; Department of Pathology, St. Louis University School of Medicine,; Missouri 63104.
A flow cytometric immunofluorescence assay (FIFA) was developed to detect antibodies to human immunodeficiency virus (HIV) using live cell indirect immunofluorescence and analysis by flow cytometry. A panel of 107 sera, previously tested for anti-HIV antibody with the Abbott Enzyme-Linked Immunosorbent Assay test and


Interferon therapy for Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) [see comments]
Ann Intern Med. 1989 Mar 1;110(5):335-7. Unique Identifier : AIDSLINE MED/89133262
Groopman JE; Scadden DT; New England Deaconess Hospital, Harvard Medical School, Boston,; Massachusetts 02215.
Endocrine complications of the acquired immunodeficiency syndrome [see comments]
Arch Intern Med. 1989 Feb;149(2):330-3. Unique Identifier : AIDSLINE MED/89133623
Aron DC; Endocrinology Section, Veterans Administration Medical Center,; Cleveland, OH 44106.
Acquired immunodeficiency syndrome (AIDS) is a multisystem disorder characterized by defects in the immune system that result in opportunistic infections and neoplasms. While endocrine dysfunction has not been a prominent clinical feature of AIDS, all endocrine glands may be affected by the opportunistic infections an


Pneumococcal polysaccharide vaccine.
MMWR Morb Mortal Wkly Rep. 1989 Feb 10;38(5):64-8, 73-6. Unique Identifier : AIDSLINE MED/89112137
Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.
J Clin Microbiol. 1989 Feb;27(2):257-60. Unique Identifier : AIDSLINE MED/89123790
Reddy MM; Lange M; Grieco MH; R. A. Cooke Institute of Allergy, St. Luke's-Roosevelt Hospital; Center, New York, New York 10019.
Soluble CD8 levels in sera were quantitated in asymptomatic intravenous drug abusers, homosexuals, and patients with lymphadenopathy or acquired immunodeficiency syndrome. Soluble CD8 levels were elevated in human immunodeficiency virus-seronegative intravenous drug abusers and homosexuals, probably reflecting infecti


Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
J Infect. 1989 Jan;18 Suppl 1:41-51. Unique Identifier : AIDSLINE MED/89124434
Stambuk D; Hawkins D; Gazzard BG; St Stephen's Hospital, Chelsea, London, U.K.
Zidovudine was used in an open uncontrolled study for treatment of 145 human immunodeficiency virus (HIV) patients, 102 with acquired immune deficiency syndrome (AIDS) and 43 with symptomatic HIV disease (acquired immune deficiency syndrome related-complex, ARC). The mean period of follow-up was 6 +/- 2.5 months. The


Markers for progression to acquired immune deficiency syndrome and zidovudine treatment of asymptomatic patients.
J Infect. 1989 Jan;18 Suppl 1:85-91. Unique Identifier : AIDSLINE MED/89124442
Lange JM; de Wolf F; Mulder JW; Coutinho RA; van der Noordaa J; Goudsmit J; Department of Virology, University of Amsterdam, The Netherlands.
Eighteen asymptomatic men with persistent human immunodeficiency virus type I (HIV-I) p24 antigenaemia were treated with zidovudine 250-500 mg (+/- acyclovir 800 mg) 6-hourly for 4-12 weeks, and subsequently with zidovudine 500 mg (+/- acyclovir 1600 mg) 12-hourly for 36 weeks.


Interferon-gamma and Mycobacterium avium-intracellulare infection.
J Infect Dis. 1989 Mar;159(3):599-600. Unique Identifier : AIDSLINE MED/89124538
Squires KE; Murphy WF; Madoff LC; Murray HW
Hemophiliacs with HIV seroconversion associated with heat-treated products: are they actively infected? [letter; comment]
JAMA. 1989 Mar 3;261(9):1275. Unique Identifier : AIDSLINE MED/89125847
Damjanovic V
[Hemophilia and AIDS]
Schweiz Rundsch Med Prax. 1989 Jan 10;78(1-2):3-4. Unique Identifier : AIDSLINE MED/89129853
Marbet GA
Restriction of HIV-1 replication in promonocytic cells: a role for IFN-alpha.
Virology. 1989 Feb;168(2):399-405. Unique Identifier : AIDSLINE MED/89130954
Mace K; Duc Dodon M; Gazzolo L; Laboratoire d'Immuno-Virologie Moleculaire et Cellulaire, UMR; 0005 du CNRS, Faculte de Medecine Alexis Carrel, Lyon, France.
A comparative study of the replication kinetics of human immunodeficiency virus type 1 (HIV-1) was performed in the promonocytic U937 cells and in the T lymphoblastoid H9 cells. If a productive HIV-1 infection of both cell types could be established, the time which elapses before most of the cells could express viral


A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: a clinical and molecular analysis.
Am J Hematol. 1989 Mar;30(3):128-39. Unique Identifier : AIDSLINE MED/89132547
Ehrlich GD; Davey FR; Kirshner JJ; Sninsky JJ; Kwok S; Slamon DJ; Kalish R; Poiesz BJ; Department of Medicine, State University of New York Health; Science Center, Syracuse 13210.
HTLV-I is associated with adult T-cell leukemia/lymphoma (ATL) characterized by monoclonal expansions of CD4+ T-lymphocytes. In this report we describe a histologically benign, polyclonal HTLV-I infection in a patient exhibiting both an absolute CD4+ and CD8+ lymphocytosis. Three T-cell lines containing integrated HTL


Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes.
J Immunol. 1989 Feb 1;142(3):773-80. Unique Identifier : AIDSLINE MED/89110048
Gowda SD; Stein BS; Mohagheghpour N; Benike CJ; Engleman EG; Department of Pathology, Stanford University School of Medicine,; CA 94305.
The relationship of T cell activation to HIV entry and generation of viral DNA intermediates was studied in freshly isolated CD4+ T lymphocytes. Unstimulated cells exposed to infectious virus for up to 48 h did not synthesize any detectable unintegrated HIV DNA duplex forms or integrated genomic provirus. However, act


Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
J Infect. 1989 Jan;18 Suppl 1:33-40. Unique Identifier : AIDSLINE MED/89124433
Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE; et al; Department of Immunology and Medicine, St Mary's Hospital and; Medical School, London, U.K.
We have treated 113 patients with zidovudine since its licensure, 80 with acquired immunodeficiency syndrome and 33 with acquired immunodeficiency syndrome-related complex. This paper reports on the efficacy and toxicity observed in these patients. Improved well-being, reduced frequency and severity of opportunist inf


Plasma dehydroepiandrosterone levels in HIV infection [letter]
JAMA. 1989 Feb 24;261(8):1149. Unique Identifier : AIDSLINE MED/89125822
Merril CR; Harrington MG; Sunderland T
[Prevalence of anti-HIV1 seropositivity in hemodialysed patients in Southeastern France (letter)]
Presse Med. 1989 Jan 7-14;18(1):33. Unique Identifier : AIDSLINE MED/89128743
Cassuto-Viguier E; Montagne M; Quaranta JF; Barillon D; Guignier A; Salvadori JM; Knebelmann G; Saingra S; Bracco J; Tirtaine C; et al
[Induced expectoration in the search for Pneumocystis carinii in HIV seropositive patients. Value and limitations (letter)]
Presse Med. 1989 Jan 21;18(2):81. Unique Identifier : AIDSLINE MED/89128758
Delacour T; Roux P; Fay M; Camus F; Denis M; Dombret MC; Brochard M; Mayaud C; Girard PM; Michon C; et al
Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel translational control mechanism.
Cell. 1989 Jan 27;56(2):303-12. Unique Identifier : AIDSLINE MED/89106222
Edery I; Petryshyn R; Sonenberg N; Department of Biochemistry, McGill University, Montreal, Quebec,; Canada.
All mRNAs of human immunodeficiency virus 1 (HIV-1) contain in their 5 untranslated region a sequence termed TAR that responds to trans-activation by the tat (trans-activating) protein. This RNA sequence assumes a stable secondary structure, and its cap structure is relatively inaccessible. Here we report that these


1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent.
J Med Chem. 1989 Feb;32(2):461-6. Unique Identifier : AIDSLINE MED/89110935
Mansuri MM; Starrett JE Jr; Ghazzouli I; Hitchcock MJ; Sterzycki RZ; Brankovan V; Lin TS; August EM; Prusoff WH; Sommadossi JP; et al; Bristol-Myers Pharmaceutical Research and Development Division,; Wallingford, Connecticut 06492-7660.
The nucleoside analogue 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine ( d4T , 1) was prepared by ring opening of the 3 ,5 -anhydro compound 5. This method has been refined such that it can be used to prepare d4T on a large scale. The triphos


Colony-stimulating factors and host defense.
Ann Intern Med. 1989 Feb 15;110(4):297-303. Unique Identifier : AIDSLINE MED/89116733
Weisbart RH; Gasson JC; Golde DW; Department of Medicine, UCLA School of Medicine.
Colony-stimulating factors are growth factors responsible for the proliferation and the maturation of bone marrow stem cells to fully differentiated granulocytes and monocytes. In addition to their effects on hematopoiesis, some colony-stimulating factors prime mature cells for enhanced chemotaxis, phagocytosis, and k


Transsynaptic spread of varicella zoster virus through the visual system: a mechanism of viral dissemination in the central nervous system [published erratum appears in Hum Pathol 1989 Aug;20(8):820]
Hum Pathol. 1989 Feb;20(2):174-9. Unique Identifier : AIDSLINE MED/89121962
Rostad SW; Olson K; McDougall J; Shaw CM; Alvord EC Jr; Department of Pathology, University of Washington School of; Medicine, Seattle 98195.
We report a patient with pathologic evidence of anterograde spread of varicella zoster virus (VZV) through the visual system. A 29-year-old homosexual man developed the acquired immunodeficiency syndrome (AIDS) 2 months before the onset of left herpes zoster ophthalmicus. During the next 11 months, the zoster infectio


Human SSAV-related endogenous retroviral element: LTR-like sequence and chromosomal localization to 18q21.
Genomics. 1989 Jan;4(1):68-75. Unique Identifier : AIDSLINE GENBANK/J03061
Brack-Werner R; Barton DE; Werner T; Foellmer BE; Leib-Mosch C; Francke U; Erfle V; Hehlmann R; Abt. fur Molekulare Zellpathologie, Gesellschaft fur; Strahlen-und Umweltforschung, Neuherberg, Federal Republic of; Germany.
A new family of human endogenous retroviral sequences was recently discovered by way of its relationship to the simian sarcoma-associated virus (SSAV). One molecular clone, termed S71, contains sequences related to the genes coding for the group-specific antigens (gag) and polymerase (pol) proteins of SSAV. At the 3


Identification and purification of the enhancer-binding factor of human immunodeficiency virus-1. Multiple proteins and binding to other enhancers.
J Biol Chem. 1989 Feb 15;264(5):2826-31. Unique Identifier : AIDSLINE MED/89123381
Maekawa T; Itoh F; Okamoto T; Kurimoto M; Imamoto F; Ishii S; Tsukuba Life Science Center, Institute of Physical and Chemical; Research (RIKEN), Ibaraki, Japan.
The enhancer-binding factor of human immunodeficiency virus (HIV)-1 was purified from human B cells by sequence-specific duplex oligonucleotide affinity chromatography. Gel retardation assay and footprint analysis showed that the purified factor bound specifically to the HIV-1 enhancer sequence, and protected both dir


Unexpected isolation of Bordetella pertussis from patients with acquired immunodeficiency syndrome.
J Clin Microbiol. 1989 Feb;27(2):337-8. Unique Identifier : AIDSLINE MED/89123807
Ng VL; York M; Hadley WK; Department of Laboratory Medicine, University of California, San; Francisco.
We isolated Bordetella pertussis from three patients with acquired immunodeficiency syndrome who underwent diagnostic bronchoscopy for evaluation of respiratory symptoms. The B. pertussis isolates were recovered from medium (charcoal-yeast extract agar) formulated to enhance recovery of Legionella spp., and one of the


GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
J Immunol. 1989 Feb 15;142(4):1177-82. Unique Identifier : AIDSLINE MED/89124357
Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ; Department of Surgery, Duke University Medical Center, Durham, NC; 27710.
Fresh circulating PBMC from HIV-1 seropositive individuals have been found to mediate specific, non-MHC restricted lysis of targets expressing the major envelope glycoprotein of HIV-1, gp120, in 6-h 51Cr release assays. This gp120 specific cell-mediated cytotoxicity (CMC) is broadly reactive against target cells infec


Cytomegalovirus cholecystitis and colitis associated with the acquired immunodeficiency syndrome.
J Infect. 1989 Jan;18(1):73-5. Unique Identifier : AIDSLINE MED/89124419
Ong EL; Ellis ME; Tweedle DE; Ferguson G; Haboubi NY; Knox WF; Monsall Hospital, Regional Department of Infectious Diseases and; Tropical Medicine, Manchester, U.K.
Cytomegalovirus ( CMV ) is an important cause of acalculous gangrenous cholecystitis in immunocompromised persons. We report a case of acalculous acute cholecystitis and active colitis associated with CMV in a patient suffering from the acquired immune deficiency


Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men.
J Infect Dis. 1989 Mar;159(3):472-9. Unique Identifier : AIDSLINE MED/89124513
Rahman MA; Kingsley LA; Breinig MK; Ho M; Armstrong JA; Atchison RW; Lyter DW; Rinaldo CR Jr; Department of Epidemiology, University of Pittsburgh, Graduate; School of Public Health, Pennsylvania 15261.
We investigated the association between human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) infections in 593 homosexual men. The status of EBV infection in this group was evaluated based on serological evidence of EBV-specific antibody responses. The geometric mean titers (GMT) of antibody to EBV capsid a


Suppression of human peripheral blood mononuclear cell function by methadone and morphine.
J Infect Dis. 1989 Mar;159(3):480-7. Unique Identifier : AIDSLINE MED/89124514
Peterson PK; Gekker G; Brummitt C; Pentel P; Bullock M; Simpson M; Hitt J; Sharp B; Department of Medicine, Hennepin County Medical Center,; Minneapolis, Minnesota 55415.
Recent studies have shown that in vitro exposure of peripheral blood mononuclear cells (PBMC) to morphine results in suppressed respiratory-burst activity of monocytes and impaired interferon-gamma (IFN-gamma) production by lymphocytes. To investigate the potential in vivo effect of an opiate on these cell functions,


Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein.
J Virol. 1989 Mar;63(3):1181-7. Unique Identifier : AIDSLINE MED/89125710
Hauber J; Malim MH; Cullen BR; Howard Hughes Medical Institute, Duke University Medical Center,; Durham, North Carolina 27710.
The tat trans-activators encoded by the known strains of primate immunodeficiency virus share a conserved, highly basic protein domain. Mutagenesis of this sequence in the tat gene of human immunodeficiency virus type 1 is shown here to reduce, but not eliminate, the trans-activation of human immunodeficiency virus ty


Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains.
J Virol. 1989 Mar;63(3):1223-31. Unique Identifier : AIDSLINE MED/89125715
Hartley JW; Fredrickson TN; Yetter RA; Makino M; Morse HC 3d; Laboratory of Immunopathology, National Institute of Allergy and; Infectious Diseases, Bethesda, Maryland 20892.
C57BL mice (Fv-1b) develop a severe immunodeficiency disease following inoculation as adults with LP-BM5 murine leukemia virus (MuLV), a derivative of Duplan-Laterjet virus which contains B-tropic ecotropic and mink cell focus-inducing MuLVs and a putative defective genome which may be the proximal cause of disease. T


18th annual UCLA symposium. Abstracts: Human retroviruses.
J Cell Biochem Suppl. 1989;13B:233-321. Unique Identifier : AIDSLINE MED/89126451
Murine models for acquired immune deficiency syndrome.
Life Sci. 1989;44(3):iii-xv. Unique Identifier : AIDSLINE MED/89126797
Watson RR; Department of Family and Community Medicine, Arizona Health; Sciences Center, University of Arizona, Tucson 85724.
The mouse has been suggested as a host for comparative studies of several aspects of Human Acquired Immune Deficiency Syndrome (AIDS). Models include studies where part or all of the genome of Human Immunodeficiency Virus (HIV) has been incorporated into murine DNA in living mice. However, the most promising opportuni


Further fears of HIV in India [news]
Nature. 1989 Feb 9;337(6207):496. Unique Identifier : AIDSLINE MED/89127506
Jayaraman KS
Designing CD4 immunoadhesins for AIDS therapy.
Nature. 1989 Feb 9;337(6207):525-31. Unique Identifier : AIDSLINE MED/89127515
Capon DJ; Chamow SM; Mordenti J; Marsters SA; Gregory T; Mitsuya H; Byrn RA; Lucas C; Wurm FM; Groopman JE; et al; Department of Molecular Biology, Genentech, Inc., South San; Francisco, California 94080.
A newly-constructed antibody-like molecule containing the gp120-binding domain of the receptor for human immunodeficiency virus blocks HIV-1 infection of T cells and monocytes. Its long plasma half-life, other antibody-like properties, and potential to block all HIV isolates, make it a good candidate for therapeutic u


Crystal structure of a retroviral protease proves relationship to aspartic protease family.
Nature. 1989 Feb 9;337(6207):576-9. Unique Identifier : AIDSLINE MED/89127525
Miller M; Jaskolski M; Rao JK; Leis J; Wlodawer A; Crystallography Laboratory, NCI-Frederick Cancer Research; Facility, Maryland 21701.
Retroviral gag, pol and env gene products are translated as precursor polyproteins, which are cleaved by virus-encoded proteases to produce the mature proteins found in virions. On the basis of the conserved Asp-Thr/Ser-Gly sequence at the putative protease active sites, and other biochemical evidence, retroviral prot


Sequence requirement for specific interaction of an enhancer binding protein (EBP1) with DNA.
Nucleic Acids Res. 1989 Jan 25;17(2):499-516. Unique Identifier : AIDSLINE MED/89128426
Clark L; Hay RT; Department of Biochemistry and Microbiology, University of St; Andrews, Fife, UK.
Short DNA sequence motifs have been identified in viral and cellular enhancers which represent the binding sites for a variety of trans- acting factors. One such HeLa cell factor, EBP1, has been purified and shown to bind to sequences in the SV40 enhancer. The PRDII element in the human beta-interferon gene regulatory


Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.
Proc Natl Acad Sci U S A. 1989 Feb;86(3):821-4. Unique Identifier : AIDSLINE MED/89128869
Gentz R; Chen CH; Rosen CA; Department of Molecular Oncology, Roche Research Center, Nutley,; NJ 07110.
Expression of the human immunodeficiency virus tat-encoded protein (Tat) is required for virus replication. A genetic approach was used to facilitate the purification of biologically active Tat. A recombinant Tat protein containing a stretch of six histidine residues and a protease cleavage site was engineered and pur


Diagnostic implications of Ga-67 chest-scan patterns in human immunodeficiency virus-seropositive patients.
Radiology. 1989 Mar;170(3 Pt 1):671-6. Unique Identifier : AIDSLINE MED/89129325
Kramer EL; Sanger JH; Garay SM; Grossman RJ; Tiu S; Banner H; Division of Nuclear Medicine, NYU Medical Center, NY 10016.
Consecutive gallium-67 scans (n = 237) of 180 human immunodeficiency virus-seropositive patients with suspected pulmonary infections were evaluated for intensity and pattern of gallium distribution. Scan findings were correlated with the history, chest radiographic findings, and clinicopathologic diagnoses. Pneumocyst


Epstein-Barr virus and the elderly host.
Rev Infect Dis. 1989 Jan-Feb;11(1):64-73. Unique Identifier : AIDSLINE MED/89129895
Schmader KE; van der Horst CM; Klotman ME; Department of Medicine, Duke University Medical Center, Durham,; North Carolina 27710.
The ability of the Epstein-Barr virus (EBV) to cause latent lifelong infection in the host and its capabilities of transformation may have important implications for the elderly host. Reports in the literature and hospital records were reviewed to determine the activity of EBV in the elderly. Seroepidemiologic surveys


Knowledge of 'cat AIDS' still growing [news]
Vet Rec. 1989 Jan 14;124(2):28. Unique Identifier : AIDSLINE MED/89130882
Ganciclovir for CMV retinitis in AIDS.
Am Fam Physician. 1989 Feb;39(2):364. Unique Identifier : AIDSLINE MED/89132293
Association of human immunodeficiency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia [see comments]
Am J Obstet Gynecol. 1989 Feb;160(2):352-3. Unique Identifier : AIDSLINE MED/89132669
Henry MJ; Stanley MW; Cruikshank S; Carson L; Department of Pathology, Hennepin County Medical Center,; Minneapolis, MN 55415.
Human papillomavirus infection plays an important causal role in cervical intraepithelial neoplasia and carcinoma. The rate of infection with human papillomavirus as well as the incidence of cervical intraepithelial neoplasia and carcinoma are increased in immunosuppressed patients. We report a possible association be


Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy.
Am J Pathol. 1989 Feb;134(2):373-83. Unique Identifier : AIDSLINE MED/89132749
Ringler DJ; Wyand MS; Walsh DG; MacKey JJ; Chalifoux LV; Popovic M; Minassian AA; Sehgal PK; Daniel MD; Desrosiers RC; et al; Harvard Medical School, New England Regional Primate Research; Center, Southborough, MA 01772.
Simian immunodeficiency virus (SIV) is a lentivirus with genetic relatedness to the human immunodeficiency viruses (HIV-1 and HIV-2). It induces a fatal syndrome in rhesus monkeys that closely parallels the clinical course of AIDS in humans. The authors used double-labeling immunohistochemical procedures on rhesus lym


Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization.
Am J Pathol. 1989 Feb;134(2):385-93. Unique Identifier : AIDSLINE MED/89132750
Wyand MS; Ringler DJ; Naidu YM; Mattmuller M; Chalifoux LV; Sehgal PK; Daniel MD; Desrosiers RC; King NW; Harvard Medical School, New England Regional Primate Research; Center, Southborough, MA 01772.
Lymph nodes and spleens were collected at autopsy and by biopsy from 29 rhesus monkeys infected with simian immunodeficiency virus (SIV). Lymph nodes were classified morphologically into stages of follicular hyperplasia, follicular involution, follicular depletion with normal or expanded paracortices, follicular and p


Intranuclear inclusions correlate with the ultrastructural detection of herpes-type virions in oral hairy leukoplakia.
Am J Surg Pathol. 1989 Feb;13(2):114-9. Unique Identifier : AIDSLINE MED/89132909
Fowler CB; Reed KD; Brannon RB; Department of Oral Pathology, Wilford Hall, Lackland AFB, TX; 78236-5300.
Hairy leukoplakia (HL) is an Epstein-Barr virus-associated lesion of the oral mucosa that occurs in persons infected with human immunodeficiency virus. Ultrastructural studies have demonstrated herpes-type virions in 63-100% of cases of HL. In this investigation, incisional biopsy specimens from 52 consecutive patient


Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells.
J Clin Invest. 1989 Feb;83(2):610-5. Unique Identifier : AIDSLINE MED/89109577
Lunardi-Iskandar Y; Nugeyre MT; Georgoulias V; Barre-Sinoussi F; Jasmin C; Chermann JC; Unite d'Oncogenese Appliquee (Institut Nationale de la Sante; et de la Recherche Medicale), Hopital Paul Brousse, Villejuif,; France.
HIV-1 infection in vitro of normal bone marrow mononuclear cells (BMMC) depleted of mature T cells was studied. BMMC depleted of either CD3, CD2, or both could replicate HIV-1 irrespective of the presence of macrophages/monocytes. Infected bone marrow cells were shown to differentiate during the culture into CD3+, CD4


Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
J Immunol. 1989 Feb 1;142(3):971-8. Unique Identifier : AIDSLINE MED/89110079
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF; Department of Medicine, Duke University Medical Center, Durham,; NC 27710.
Antigenic sites on human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins that are immunogenic in man were studied with envelope gene (env)-encoded synthetic peptides and a mAb to HTLV-I gp46 envelope glycoprotein. Antibodies in 78% of sera from HTLV-I seropositive subjects reacted with synth


Neuropathology of the brain in HIV infection.
Lancet. 1989 Feb 11;1(8633):309-11. Unique Identifier : AIDSLINE MED/89126668
Lantos PL; McLaughlin JE; Schoitz CL; Berry CL; Tighe JR; Department of Neuropathology, Institute of Psychiatry, London.
The brains of 26 patients infected with the human immunodeficiency virus (HIV) were examined post mortem. All patients were men, aged 20-67 years (mean 38.8). 13 (50%) were homosexual, 3 (12%) were bisexual, 8 (31%) were haemophiliac, 1 was both an intravenous drug addict and homosexual, and 1 denied belonging to any


Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS [letter]
Lancet. 1989 Feb 11;1(8633):332-3. Unique Identifier : AIDSLINE MED/89126696
Vento S; di Perri G; Luzzati R; Cruciani M; Garofano T; Mengoli C; Concia E; Bassetti D
Breastfeeding and HIV [letter]
Lancet. 1989 Feb 11;1(8633):333. Unique Identifier : AIDSLINE MED/89126697
Kennedy KI; Fortney JA; Sokal DC
Seizure after zidovudine overdose [letter]
Lancet. 1989 Feb 18;1(8634):384-5. Unique Identifier : AIDSLINE MED/89126743
Routy JP; Prajs E; Blanc AP; Drony S; Moriceau M; Sarrazin C; Viallet F
HIV-2 in west Africa in 1966 [letter]
Lancet. 1989 Feb 18;1(8634):385. Unique Identifier : AIDSLINE MED/89126744
Kawamura M; Yamazaki S; Ishikawa K; Kwofie TB; Tsujimoto H; Hayami M
Overdosage of zidovudine [letter]
Lancet. 1989 Feb 18;1(8634):385. Unique Identifier : AIDSLINE MED/89126745
Staszewski S; Rehmet S; Odewald J; Gottstein A; Helm EB
Consensus statements on HIV transmission.
Lancet. 1989 Feb 18;1(8634):396. Unique Identifier : AIDSLINE MED/89126769
AIDS in the UK and world wide [news]
Lancet. 1989 Feb 18;1(8634):397. Unique Identifier : AIDSLINE MED/89126770
Immunoadhesins for HIV infection [news]
Lancet. 1989 Feb 18;1(8634):397. Unique Identifier : AIDSLINE MED/89126771
Peptide-T in the treatment of psoriasis and psoriatic arthritis. A case report.
Acta Derm Venereol. 1989;69(1):86-8. Unique Identifier : AIDSLINE MED/89131477
Marcusson JA; Wetterberg L; Department of Dermatology, Huddinge Hospital, Sweden.
The following is a description of the improvement of a HIV-negative patient with psoriasis and monoarthritis who received treatment with Peptide-T, a synthetic octapeptide that shares a segment of the envelope glycoprotein (gp 120) of the human immunodeficiency virus.


An autopsy of epidemiologic methods: the case of poppers in the early epidemic of the acquired immunodeficiency syndrome (AIDS) [see comments]
Am J Epidemiol. 1989 Mar;129(3):455-7. Unique Identifier : AIDSLINE MED/89132523
Vandenbroucke JP; Pardoel VP; Department of Clinical Epidemiology, University of Leiden, The; Netherlands.
Immunological characterization and detection of the major core protein p24 of the human immunodeficiency virus (HIV) using monoclonal antibodies.
J Acquir Immune Defic Syndr. 1988;1(4):326-32. Unique Identifier : AIDSLINE MED/89110736
Kusk P; Ulrich K; Zeuthen J; Pallesen G; Laboratory of Tumor Virology, Fibiger Institute, Danish Cancer; Society, Copenhagen.
Eight different monoclonal antibodies (MAbs) were raised against a lysate of the HTLV-IIIb isolate of human immunodeficiency virus (HIV). All eight MAbs recognized the major core protein p24 as well as the gag precursors p39 and p55. Three different epitopes were defined by the eight MAbs when an antigen-catching ELIS


[HTLV-I negative T helper/inducer phenotype chronic lymphocytic leukemia associated with OKT3 epitope deficiency--a case report]
Rinsho Ketsueki. 1988 Sep;29(9):1417-21. Unique Identifier : AIDSLINE MED/89111337
Ishikawa T; Yabe H; Nagai K; Nakayama S; Hattori T; Takatsuki K; Uchiyama T; Uchino H; Ito T
Immunologic thrombocytopenic purpura and human immunodeficiency virus (HIV) in a married heterosexual couple [letter]
Ann Intern Med. 1989 Feb 15;110(4):322-3. Unique Identifier : AIDSLINE MED/89116739
Larach JC; Leslie WT
Conserved immunogenic region of a major core protein (p24) of human and simian immunodeficiency viruses.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):409-17. Unique Identifier : AIDSLINE MED/89118010
Koito A; Hattori T; Matsushita S; Maeda Y; Nozaki C; Sagawa K; Takatsuki K; Second Department of Internal Medicine, Kumamoto University; Medical School, Japan.
A murine monoclonal antibody (MoAb), VAK 4, has been known to specifically react with a major core protein (p24) as well as with its precursor (p55-57) and intermediate precursor (p40) of human immunodeficiency virus strain IIIB (HTLV-IIIB). Radioimmunoprecipitation assays revealed that VAK 4 MoAb precipitated a major


A rapid and simple colorimetric test for the study of anti-HIV agents.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):441-8. Unique Identifier : AIDSLINE MED/89118013
Schwartz O; Henin Y; Marechal V; Montagnier L; Unite d'Oncologie Virale, Institut Pasteur, Paris, France.
We report here the use of a simple, rapid, reproducible, and quantitative assay to detect the putative activity of anti-HIV agents. It can be employed with different T cell cultures, such as peripheral blood lymphocytes or CEM-C113 cells, a sensitive clone of CEM cells. It can be used alone as a rapid screening test i


Nucleotide dimers suppress HIV expression in vitro.
AIDS Res Hum Retroviruses. 1988 Dec;4(6):449-55. Unique Identifier : AIDSLINE MED/89118014
Busso M; Mian AM; Hahn EF; Resnick L; Department of Dermatology, Mount Sinai Medical Center, Miami; Beach, FL 33140.
A series of nucleotide homo- and heterodimers [3 -azido-3 -deoxythymidilyl-(5 ,5 )-2 ,3 -di-deoxy-5 adenylic acid (AZT-P-ddA), 3 -azido-3 -deoxythymidilyl-(5 ,5 )-2 , 3 -dideoxy;-5 -adenylic acid, 2-cyanoethyl ester [AZT-P(CyE)-ddA], 3 -azido-3 -deoxythymidilyl-(5 ,5 )-2 ,3 -dideoxy-5 -inosinic acid (AZT-P-ddI), and


[Serological screening of HIV antibody in China]
Chung Hua Liu Hsing Ping Hsueh Tsa Chih. 1988 Jun;9(3):138-40. Unique Identifier : AIDSLINE MED/89119506
Zeng Y
[Paradoxical hypergammaglobulinemia in AIDS]
Dtsch Med Wochenschr. 1989 Feb 3;114(5):192-5. Unique Identifier : AIDSLINE MED/89120613
Kekow J; Sterry W; Gross WL; I. Medizinische Universitatsklinik, Abteilung Allgemeine Innere; Medizin, Kiel.
Biosynthesis and analysis of a genetically engineered HIV-1 reverse transcriptase/endonuclease polyprotein in Escherichia coli.
Gene. 1988 Aug 15;68(1):35-42. Unique Identifier : AIDSLINE MED/89121492
Leuthardt A; Le Grice SF; Central Research Units, F. Hoffmann-La Roche & Co. Ltd., Basel,; Switzerland.
Elimination of the protease domain from the polymerase open reading frame (pol) of the human immunodeficiency virus type 1 (HIV-1) leads, in Escherichia coli, to synthesis and accumulation of a non-processed 98-kDa reverse transcriptase/endonuclease (RT/ENDO) polyprotein. A partially purified preparation of this rever


Individuals infected with HIV possess antibodies against IL-2.
Immunology. 1988 Dec;65(4):611-5. Unique Identifier : AIDSLINE MED/89122086
Bost KL; Hahn BH; Saag MS; Shaw GM; Weigent DA; Blalock JE; Department of Physiology and Biophysics, UAB 35294.
Studies are presented here which demonstrate that antibodies reacting with human interleukin-2 ( IL-2 ) are present in the sera of patients infected with the human immunodeficiency virus (HIV). It is likely that these antibodies are present due to a homology between the


Application of single-donor fibrin glue to burns.
J Burn Care Rehabil. 1988 Nov-Dec;9(6):619-22. Unique Identifier : AIDSLINE MED/89123602
Stuart JD; Kenney JG; Lettieri J; Spotnitz W; Baker J; Department of Plastic Surgery, University of Virginia,; Charlottesville.
Early tangential excision and immediate grafting of the burn-injured patient has been shown to be effective. Along with the use of this technique, however, comes the potential for significant blood loss, prolonged operative time, and partial loss of graft due to underlying hematoma formation. Based on experience using


Distinction between HIV-1 and HIV-2 infection using novel synthetic lipopeptide conjugates as antigens in enzyme immunoassays.
J Virol Methods. 1988 Dec;22(2-3):173-82. Unique Identifier : AIDSLINE MED/89123715
Boltz T; Hummel RP; Troger W; Rubsamen-Waigmann H; Biesert L; Muller-Lantzsch N; Koch P; Bessler W; Jung G; Institut fur Immunobiologie, Universitat Freiburg, F.R.G.
A novel immunoassay technique using synthetic lipopeptide (Pam3Cys-Ser) linked to immunodominant peptide domains of HIV-1 and HIV-2 envelope proteins as an antigen adsorbent has been developed. Attachment of peptides to microtiter plates can be considerably improved with this method by employing the hydrophobic proper


Quantitation of infectious human immunodeficiency virus using a modified plaque forming assay.
J Virol Methods. 1988 Dec;22(2-3):303-8. Unique Identifier : AIDSLINE MED/89123727
Kiernan RE; McPhee DA; Doherty RR; NHMRC Special Unit for AIDS Virology, Macfarlane Burnet Centre; for Medical Research, Fairfield Hospital, Victoria, Australia.
This report describes a modified plaque forming assay which has been used for quantitation of infectious human immunodeficiency virus (HIV) in cell culture supernatant fluid. The number of infectious units determined by the plaque assay correlates closely with the 50% infectious dose determined by a conventional assay


Characteristics of B cell proliferation and activation in murine AIDS.
J Immunol. 1989 Feb 15;142(4):1144-9. Unique Identifier : AIDSLINE MED/89124353
Klinman DM; Morse HC 3d; Infectious Diseases Branch, National Institute of Neurological; and Communicative Disorders and Stroke, Bethesda, MD 20892.
A syndrome characterized by lymphadenopathy, hypergammaglobulinemia, and immunodeficiency develops in C57BL/6 mice inoculated with LP-BM5 murine leukemia viruses. By studying the number and antigenic specificity of B cells activated in the course of this disease, we found that a series of reproducible changes in the h


Targets for antiviral therapy of human immunodeficiency virus infection.
J Infect. 1989 Jan;18 Suppl 1:5-13. Unique Identifier : AIDSLINE MED/89124435
Jeffries DJ; Department of Virology, St Mary's Hospital Medical School,; Paddington, London, U.K.
The development of potent anti-retroviral drugs is central to the control of human immunodeficiency virus (HIV) infection and the prevention of disease. Despite the benefit (albeit limited) shown by the early trials of zidovudine in patients with acquired immune deficiency syndrome (AIDS), there is general agreement t


Detection of human immunodeficiency virus in cell-free seminal fluid [see comments]
J Acquir Immune Defic Syndr. 1988;1(5):419-24. Unique Identifier : AIDSLINE MED/89125346
Borzy MS; Connell RS; Kiessling AA; Department of Pediatrics, Doernbecher Memorial Hospital for; Children, Portland, Oregon.
Human immunodeficiency virus (HIV) was detected by assay of reverse transcriptase activity in a virus pellet obtained by differential sucrose density centrifugation of cell-free semen from three patients with the acquired immune deficiency syndrome (AIDS), one individual with AIDS-related complex (ARC), and in an asym


Identification of simian immunodeficiency virus SIVMAC env gene products.
J Virol. 1989 Mar;63(3):1416-9. Unique Identifier : AIDSLINE MED/89125740
Veronese FD; Joseph B; Copeland TD; Oroszlan S; Gallo RC; Sarngadharan MG; Bionetics Research, Inc., Rockville, Maryland 20850-4373.
A monoclonal antibody recognizing an antigenic determinant on the env transmembrane protein, gp32 of simian immunodeficiency virus SIVMAC has been developed and designated SF8/5E11. The reactivity of this antibody was found to be type specific, since it did not cross-react with either SIVSMM or SIVMNe transmembrane pr


Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus.
J Virol. 1989 Mar;63(3):1451-4. Unique Identifier : AIDSLINE MED/89125747
Gowda SD; Stein BS; Steimer KS; Engleman EG; Department of Pathology, Stanford University School of Medicine,; California 94305.
Human cells infected with a recombinant vaccinia virus containing human immunodeficiency virus type 1 gag-pol genes produced large amounts of human immunodeficiency virus gag proteins beginning at 1 h and peaking at 48 h postinfection. We show that these polyproteins are processed accurately into mature forms and that


Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study.
J Thorac Cardiovasc Surg. 1989 Feb;97(2):194-203. Unique Identifier : AIDSLINE MED/89126456
Rousou J; Levitsky S; Gonzalez-Lavin L; Cosgrove D; Magilligan D; Weldon C; Hiebert C; Hess P; Joyce L; Bergsland J; et al; University of Illinois, Department of Surgery, Chicago 60680.
A multicenter study was conducted to test the efficacy and safety of fibrin sealant as a topical hemostatic agent in patients undergoing either reoperative cardiac surgery (redo) or emergency resternotomy. A total of 333 patients from 11 centers in the United States were included in th


Molecular evolution of the human and simian immunodeficiency viruses.
Mol Biol Evol. 1988 Nov;5(6):645-59. Unique Identifier : AIDSLINE MED/89126935
Yokoyama S; University of Illinois, Urbana-Champaign 61820.
Molecular evolution and phylogeny of different human immunodeficiency virus type 1 (HIV1) strains, of a type 2 (HIV2) strain, and of two simian immunodeficiency viruses (SIVAGM and SIVMAC) have been studied by comparing the nucleotide sequences of the two regions of their pol genes which encode the reverse transcripta


Hypomania in an AIDS patient receiving amitriptyline for neuropathic pain.
Neurology. 1989 Feb;39(2 Pt 1):305. Unique Identifier : AIDSLINE MED/89127844
Holmes VF; Fricchione GL; State University of New York, Stony Brook 11794-8101.
Rapid and simple metachromatic stain for Pneumocystis carinii.
South Med J. 1989 Feb;82(2):245-6. Unique Identifier : AIDSLINE MED/89130257
Woosley JT; Department of Pathology, University of North Carolina School of; Medicine, Chapel Hill.
Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids.
Virology. 1989 Feb;168(2):267-73. Unique Identifier : AIDSLINE MED/89130938
Tersmette M; van Dongen JJ; Clapham PR; de Goede RE; Wolvers-Tettero IL; Geurts van Kessel A; Huisman JG; Weiss RA; Miedema F; Central Laboratory of the Netherlands Red Cross Blood Transfusion; Service, Amsterdam, The Netherlands.
Human immunodeficiency virus (HIV) infection was studied by means of CD4-expressing human-murine T-cell hybrids, containing a variable amount of human chromosomes. Fusion of the HPRT- murine cell line BW5147 with human T-cell acute lymphoblastic leukemia or normal human blood cells resulted in a panel of human-murine


[New chemical compounds with antiviral action]
Verh K Acad Geneeskd Belg. 1988;50(4):349-65. Unique Identifier : AIDSLINE MED/89131172
Herdewijn P
Retroviral gene transfer: applications to human therapy.
Adv Exp Med Biol. 1988;241:29-33. Unique Identifier : AIDSLINE MED/89131992
Gilboa E; Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Immunohistochemical analysis of peripheral T-cell lymphoma in Japanese patients.
Am J Clin Pathol. 1989 Feb;91(2):152-8. Unique Identifier : AIDSLINE MED/89132396
Doi S; Nasu K; Arita Y; Tanabe S; Matsuyama F; Kamesaki H; Fukuhara S; Nishikori M; Miwa H; Kita K; et al; First Department of Internal Medicine, Kyoto University, Japan.
The authors immunohistochemically analyzed the phenotype of 40 cases of peripheral T-cell lymphoma, including 12 adult T-cell leukemia/lymphoma (ATL) cases. Molecular genetic analysis of the T-cell receptor beta-chain and immunoglobulin heavy chain genes were also applied to cases of angioimmunoblastic lymphadenopathy


Preventing alcohol-impaired driving through community self-regulation training.
Am J Public Health. 1989 Mar;79(3):287-90. Unique Identifier : AIDSLINE MED/89132886
Worden JK; Flynn BS; Merrill DG; Waller JA; Haugh LD; Office of Health Promotion Research, University of Vermont,; Burlington 05405.
A community education program was designed to train the individual drinker to self-regulate his or her blood-alcohol concentration (BAC) below a level of impairment (.05 g/dl or 11 mmol/L). Drink calculators (cardboard wheels and wallet cards) were disseminated to customers of bars and licensed beverage outlets; barte


NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
Ann Intern Med. 1989 Mar 1;110(5):373-85. Unique Identifier : AIDSLINE MED/89133269
Fauci AS; Gallo RC; Koenig S; Salk J; Purcell RH; National Institute of Allergy and Infectious Diseases, National; Institutes of Health, Bethesda, MD 20892.
The development of a safe and effective vaccine for infection with human immunodeficiency virus (HIV) is complicated by several unique scientific, logistic, and ethical issues. These issues include a lack of understanding of protective immunity to HIV and disease development, the absence of an adequate and convenient


Private hospital to bar patients with AIDS virus. [News].
New York Times. 1988 Jun 25;:28. Unique Identifier : AIDSLINE KIE/26987
Gulf Coast Regional Blood Center v. Houston.
South Western Reporter, 2d Series. 1988 Feb 11 (date of decision);745:557-563. Unique Identifier : AIDSLINE KIE/26992
A court order directing a blood center to make available to the plaintiff in a wrongful death action certain documents identifying blood donors was upheld by the Court of Appeals of Texas. The court reasoned that the blood center could not assert a privacy interest equal to the plaintiff s right to discover the ident


Stricken with AIDS, Californian presses for more disclosure. [News].
New York Times. 1988 Oct 9;:1, 36. Unique Identifier : AIDSLINE KIE/27115
Gross J
An Institutional Response to AIDS. [Videorecording].
Urbana, Ill.: Carle Medical Communications, 1984 1 cassette; 17 min.; sd.; color; VHS, Beta, or 3/4 in Unique Identifier : AIDSLINE KIE/27118
Health Insurance Asssociation of America v. Corcoran.
New York Supplement, 2d Series. 1988 Jun 16 (date of decision);531:456-464. Unique Identifier : AIDSLINE KIE/27125
The Supreme Court of New York held that a regulation that prohibited requiring or considering body fluid tests for evidence of the human immunodeficiency syndrome (HIV) in the application for health insurance or the risk management determinations of insurability is not authorized by a consumer protection statute or by


Tarrant County Hospital District v. Hughes.
South Western Reporter, 2d Series. 1987 Apr 9 (date of decision);734:675-685. Unique Identifier : AIDSLINE KIE/27134
A Texas Court of Appeals held that a discovery order requiring a hospital to produce the names of the donors of blood transfused to a patient who contracted AIDS did not violate the blood donors rights of privacy. The court reasoned that in balancing the interest served by the state action with the donors interest


Glover v. Eastern Nebraska Community Office of Retardation.
Federal Supplement. 1988 Mar 29 (date of decision);686:243-251. Unique Identifier : AIDSLINE KIE/27093
Ruling that an involuntary intrusion into the body by the state for purposes of withdrawing blood constitutes a search and seizure under the Fourth Amendment, the United States District Court for Nebraska held that the policy adopted by a multiple-county health services agency which re



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 1989. AEGiS.